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Nature and Nature’s laws lay hid in night;
God said ‘Let Newton be!' And all was light.
Alexander Pope (1688-1744)
Epitaph, intended for Sir Isaac Newton
It did not last: the Devil howling ‘Ho!
Let Einstein be!' Restored the status quo.
Sir John Collins Squire (1884-1958)
Courtesy o f Colin L. Davey, MSc (Otago) PhD (Cantab.), biochemist
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Sepsis: The context
Sepsis is the leading cause of death in critically ill patients1. The yearly incidence 
is increasing, and more than 18 million cases of sepsis occur worldwide each year. 
Sepsis kills some 1,400 people worldwide every day. The mortality rates associated 
with sepsis are extremely high: 30% to 50% for severe sepsis and 50% to 6 0% 
for septic shock according to recent epidemiological studies1'3. This imposes a 
huge burden on modern healthcare systems. Cost-of-illness studies focusing on 
direct costs per sepsis patient have yielded estimates between €20,000  and 
€30,0 0 0 . Indirect costs arising from loss of productivity losses due to mortality 
are likely to be 3-4 times higher than the direct costs 4. In addition to the 
economical aspects, the loss of lives and long-term physical and psychological 
sequelae represent a significant burden in terms of hum an suffering.
Susceptibility to and outcome from infectious disease is heritable5. For example, 
it has been shown that the genetic contribution to death from infection is five 
times greater than the genetic contribution to cancer6. The promise that the age 
of genomic personalized medicine is within our reach may be true, but in the 
meantime optimization of currently available treatm ent approaches seems 
necessary.
Uniform definitions have been adopted for the spectrum of the sepsis syndrome, 
including the systemic inflammatory syndrome (SIRS), sepsis, severe sepsis, and 
septic shock. International treatment guidelines based on best available evidence 
have been developed and implemented worldwide7. However, our understanding 
of the complex pathophysiology of sepsis remains incomplete, and therefore our 
approach towards diagnosis and treatment may often be ineffective or insufficient. 
Sepsis is characterized by complex abnormalities of the im m une system and 
coagulation pathways8, 9. The hemodynamic changes found in septic shock, the 
most severe form of sepsis, include severe vasodilation, myocardial depression 
and impaired microcirculatory blood flow, resulting in redistribution of regional 
blood flow. If uncorrected, these perfusion abnormalities rapidly lead to multiple 
organ dysfunction and death.
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New therapies and treatm ent strategies for severe sepsis are constantly being 
developed and investigated in an attempt to decrease the mortality as well as the 
short and long-term morbidity associated with severe sepsis.
Gastrointestinal perfusion in sepsis
Gastrointestinal mucosal hypoperfusion is thought to be important in septic 
shock patients, both as an indicator of inadequate resuscitation and potentially 
as a mechanism by which multiorgan failure may occur. Loss of gut barrier 
function may lead to translocation of bacteria, endotoxin, and other inflammatory 
mediators, thereby increasing systemic inflammation, and resulting in distant 
organ dysfunction. Most experimental sepsis models show intestinal 
microvascular vasoconstriction and hypoperfusion 10. The observed changes in 
microcirculatory blood flow in splanchnic organs are quite heterogeneous, both 
in early hypodynamic and in resuscitated hyperdynamic septic shock11. Different 
control mechanisms have been implicated in this impairment of mucosal vascular 
perfusion. Abnormalities in the nitric oxide system induced by inflammation are 
considered to be one of the mechanisms responsible for the observed distributive 
defects. Cellular hypoxia resulting from these perfusion abnormalities, combined 
with the direct cytotoxic effects of inflammatory mediators, may result in 
increased gut permeability and impaired immunological gut barrier function12. 
This in turn could lead to a vicious circle of augmentation of the inflammatory 
response and distant organ dysfunction: “The gut as motor of sepsis”. For 
example, hemorrhagic shock can induce the gut to become a cytokine-generating 
organ 13. In vitro studies have documented that mesenteric lymph, following 
hemorrhagic shock, activates neutrophils, is toxic to endothelial cells, and 
increases endothelial permeability14. In other experiments, ligation of intestinal 
lymphatic flow prevented lung injury after hemorrhagic shock15. In a recent 
porcine study, mesenteric lymph collected following hemorrhagic shock increased 
neutrophil activation and endothelial cell permeability as opposed to lymph from 
control anim alsl6. These results indicate that the lymphatic route could be the 
primary route by which gut injury causes distant organ injury.
Global hemodynamic m easurem ents are routinely performed in septic shock 
patients and are used to guide fluid resuscitation and administration of vasoactive
12 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
agents. However, these m easurem ents do not provide reliable data on gut 
perfusion, either because of regional redistribution of blood flow, or because gut 
blood flow may paradoxically be preserved when cardiac output is decreased. 
Conversely, therapy used to treat shock can apparently normalise clinical or global 
variables, but still allow the existence of occult defective tissue oxygenation17. 
Measuring variables of splanchnic perfusion is thought to be a better predictor 
of the presence of uncompensated shock than markers of global perfusionl8, 19. 
Abnormal gastrointestinal perfusion and failure to normalize these perfusion 
deficits is a strong predictor of poor outcome of sepsis. Sepsis treatm ent has 
variable and often unknown effects on the gastrointestinal perfusion. For 
example, a vasoconstrictive drug may increase the perfusion pressure of a vascular 
bed but at the same tim e decrease the actual flow. This could have potential 
detrimental effects on cellular oxygen delivery, organ perfusion and function. 
More importantly, currently there are no treatment strategies available that are 
able to improve gastrointestinal perfusion, and by doing so, improving clinical 
outcome parameters such as organ failure and mortality.
Different m easurem ent techniques and tools have been developed and 
investigated to study the gastrointestinal perfusion. Tonometry is the most widely 
used and most accessible technique for this purpose. With this minimally invasive 
technique, intraluminal partial pressure of CO2 is measured. Most studies have 
applied tonometry in the stomach, but other sites such as the jejunum, the 
rectum, and sigmoid colon have been examined as well. The difference between 
intraluminal and arterial partial pressures of CO2 is called the CO2 gap or the 
CO2 gradient, which should be smaller than 10 mmHg. An increased gradient is 
indicative of gut hypoxia, especially when the gradient is greater than 20 mmHg. 
Ischemic hypoxia due to hypoperfusion results in a more pronounced increase 
in pCO2 gradient than hypoxic hypoxia or anaemic hypoxia 20 21. The pCO2 gap is 
therefore largely dependent on mucosal perfusion and is considered to be a valid 
measure for gastrointestinal metabolism perfusion ratio22.
The prognostic value of tonometry has been well established. In an inception 
cohort study in 95 ventilated critically ill patients, the pCO2 gap measured 24 
hours after admission was an independent risk factor and marker for mortality23.
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Septic shock therapies
Standard septic shock therapy includes supportive treatm ent such as fluid 
resuscitation, administration of vasopressors (adrenergic and nonadrenergic 
drugs), and respiratory and renal support. These therapies may have beneficial 
or detrimental effects not only on systemic hemodynamics but also on splanchnic 
hemodynamics, at both the macrocirculatory and microcirculatory levels.
Vasopressors
Vasopressors are necessary to treat the vasodilation characteristic of hypotension 
in septic shock. The effect of conventional vasopressors (noradrenaline, 
dopamine, adrenaline) on mucosal microcirculatory blood flow is not 
straightforward. Vasoconstrictors can potentially have detrimental effects on 
regional perfusion, microcirculation and gastrointestinal mucosal perfusion. 
Normalization of global hemodynamic values therefore does not automatically 
guarantee an improvement in cellular oxygen delivery. The actual effect is 
dependent on the drug used, the clinical situation, and whether a patient has been 
adequately fluid resuscitated. Different drugs have different effects on the 
gastrointestinal mucosal perfusion24, 25.
The available clinically relevant data on the effects of "non-conventional" 
vasopressors such as vasopressin, methylene blue, and potassium channel 
blockers, on splanchnic circulation is very limited, and their safety has not been 
demonstrated. All these drugs can modify the perfusion and metabolism of 
splanchnic organs, changes which cannot be predicted from changes in systemic 
circulation or metabolism26.
Vasopressin is a relatively new drug that has found its use in septic shock 
treatm ent as a potent vasoconstrictor. Vasopressin increases blood pressure, 
improves some measures of renal function and decreases catecholamine 
requirements27-29. Despite its favourable effect on global hemodynamics in septic 
shock patients, few clinically relevant data are available on the effect of vasopressin 
on the splanchnic circulation in sepsis. Interestingly, it has been widely used to 
control the bleeding in patients with bleeding oesophageal varices because of its
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vasoconstrictive effects on the splanchnic circulation in that specific clinical 
scenario30.
Methylene blue (MB) has been shown to have vasocostrictive properties in sepsis. 
Several small studies in septic patients, including two prospective randomized 
controlled studies, have demonstrated an increase in blood pressure mediated 
by an increase in systemic vascular resistance (SVR)31-33. An important 
m echanism  that is potentially responsible for the effects of MB infusion is 
selective inhibition of production of nitric oxide (NO) and cyclic guanosine 
monophosphate (cGMP) 34, 35. Abnormalities in the NO system can be regarded 
as one of the mechanisms responsible for the gastrointestinal mucosal perfusion 
defects observed10. Animal studies have shown that NO acts as a final common 
pathway of mediators and neural pathways in the gastrointestinal tract and also 
is a major inhibitory component of gastrointestinal function36.
Fluid resuscitation
Adequate fluid resuscitation is considered to be an essential part of sepsis 
treatment. For example, early goal-directed resuscitation of severe sepsis and 
septic shock has been shown to reduce in-hospital mortality from 47% to 31% 37. 
The choice of the type of resuscitation fluid is not straightforward and subject of 
much debate. Resuscitation fluids are not innocent bystanders, but impact on 
organ dysfunction and outcome. Recent examples include the potential increase 
in mortality associated with the use of albumin38, and an increase in the incidence 
of renal failure needing dialysis in septic patients with the use of a certain type of 
colloid (10% pentastarch)39.
Hypertonic fluid resuscitation has been studied extensively in experimental and 
hum an traumatic hemorrhagic shock 40-42. The macrocirculatory effects of 
hypertonic infusion in hemorrhagic shock are characterized by rapid plasma 
volume expansion. Experimental evidence also suggests a possible improvement 
of myocardial contractility 43, 44. Hypertonic fluids have been shown to cause 
hemodilution and to reduce shock-induced endothelial and red blood cells 
oedema, increasing blood flow at the capillary level by reducing viscosity and 
hydraulic resistance45. In addition to immediate blood volume expansion and
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restoration of cardiac output in animal models of hemorrhagic shock, hypertonic 
fluid administration has been shown to correct microcirculatory alterations as 
assessed by intravital microscopy45, 46. Data concerning the effects of hypertonic 
fluids in septic patients are scarce 40 47, 48. Although several previous studies in 
patients with sepsis have shown transient improvements of global perfusion49, 50, 
its effect on gastrointestinal perfusion, microcirculatory abnormalities, and the 
immune system in septic shock patients is currently unknown.
Thesis
The main aim of this thesis was to investigate the effects of different novel 
hemodynamic sepsis treatm ents on the gastrointestinal perfusion. However, 
because an intervention to improve the hemodynamic status in sepsis often has 
several other effects e.g. on other regional vascular beds, on the microcirculation, 
and on the im m une system, we expanded our methods to include relevant other 
m easurements, as to further improve our understanding of the effects and 
potential of these treatments.
In part 1, an overview is presented on the role the gastrointestinal perfusion plays 
in sepsis. Its place in the complex pathophysiology of septic shock and m ulti­
organ failure is discussed, as well as its potential target for treatm ent and 
intervention. Currently available measurement tools and techniques to evaluate 
gastrointestinal perfusion are being reviewed.
In part 2, we examine the effects of the novel vasopressor agents vasopressin and 
methylene blue in septic shock patients. In chapter 2.1 we describe a study that 
aims to quantify the effects of vasopressin on the gastrointestinal perfusion by 
using gastric tonometry. In chapter 2.2, the effects of methylene blue on gastric 
tonometry and on intestinal mucosal cellular damage are investigated. In addition, 
the effect of MB on the production of nitric oxide and on kidney damage is 
described in chapter 2.3.
In part 3, we compare hypertonic fluid with isotonic fluid administration in septic 
shock patients. The global cardiovascular effects and differences are described in 
chapter 3.1. In chapter 3.2, we examine whether hypertonic fluid exerts intrinsic
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effects on the gastrointestinal perfusion as assessed by gastric tonometry, and on 
the sublingual microcirculation as assessed by Sidestream Dark Field (SDF) 
imaging. To further understand the in vivo effects of hypertonic fluid 
administration in sepsis, we describe the imm unomodulating effects by 
measuring inflammatory mediator gene expression using real-time reverse 
transcriptase polymerase chain reaction (RT rtPCR) in chapter 3.3.
The thesis ends with a summary.
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Summary
Septic shock is characterized by vasodilation, myocardial depression, and 
impaired microcirculatory blood flow, resulting in redistribution of regional blood 
flow. Animal and hum an studies have shown that gastrointestinal mucosal blood 
flow is impaired in septic shock. This is consistent with abnormalities found in 
many other microcirculatory vascular beds. Gastrointestinal mucosal 
microcirculatory perfusion deficits have been associated with gut injury and a 
decrease in gut barrier function, possibly causing augmentation of systemic 
inflammation and distant organ dysfunction.
A range of techniques have been developed and used to quantify these 
gastrointestinal perfusion abnormalities. The following techniques have been 
used to study gastrointestinal perfusion in humans: tonometry, laser Doppler 
flowmetry, reflectance spectrophotometry, near-infrared spectroscopy, orthogonal 
polarization spectral imaging, indocyanine green clearance, hepatic vein 
catheterization, and measurements of plasma D-lactate. Although these methods 
share the ability to predict outcome in septic shock patients, it is important to 
emphasize that the m easurem ent results are not interchangeable. Different 
techniques m easure different elements of gastrointestinal perfusion. Gastric 
tonometry is currently the most widely used technique because of its non- 
invasiveness and ease of use.
Despite all the recent advances, the usefulness of gastrointestinal perfusion 
parameters in clinical decision-making is still limited. Treatment strategies 
specifically aimed at improving gastrointestinal perfusion have failed to actually 
correct mucosal perfusion abnormalities and hence not shown to improve 
important clinical endpoints.
Current and future treatment strategies for septic shock should be tested for 
their effects on gastrointestinal perfusion; to further clarify its exact role in patient 
management, and to prevent therapies detrimental to gastrointestinal perfusion 
being implemented.
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Introduction
Intestinal mucosal hypoperfusion is thought to be important in septic shock 
patients, both as an indicator of inadequate resuscitation and potentially as a 
mechanism by which multiorgan failure may occur. Loss of gut barrier function 
may lead to translocation of bacteria, endotoxin, and other inflammatory 
mediators, thereby increasing systemic inflammation, and resulting in distant 
organ dysfunction.
Global hemodynamic measurements are routinely performed in septic shock 
patients and are used to guide fluid resuscitation and administration of vasoactive 
agents. However, these measurem ents do not provide reliable data on gut 
perfusion, either because of regional redistribution of blood flow, or because gut 
blood flow may paradoxically be preserved when cardiac output is decreased. 
Conversely, therapy used to treat shock can apparently normalise clinical or global 
variables, but still allow the existence of occult defective tissue oxygenation:. 
Measuring variables of splanchnic perfusion is thought to be a better predictor 
of the presence of uncompensated shock than markers of global perfusion 2 3.
In this review we will discuss the splanchnic circulation and the different 
techniques that are available to measure adequacy of gastrointestinal perfusion. 
We specifically focus on the gastrointestinal perfusion deficits found in septic 
shock, including relevance for the pathogenesis of multiple organ dysfunction, 
and for prognosticating and treating septic patients.
References were obtained from Pubmed and Medline databases from the 
earliest records to November 2006 . We used the following keywords: intestinal, 
gastrointestinal, splanchnic, perfusion, blood flow, circulation, sepsis, septic 
shock, vasodilatory shock, shock, and microcirculation. We also reviewed 
reference lists of all relevant articles. Laboratory, animal, as well as hum an studies 
were included to describe the underlying pathophysiological mechanisms 
implicated in gastrointestinal perfusion abnormalities in septic shock. We then 
focused on studies describing techniques that have been used to measure 
gastrointestinal perfusion in hum an septic shock situations. Retrospective as well 
as prospective studies that reported mortality were included to describe the 
prognostic value of measurement of gastrointestinal perfusion in septic patients. 
Only prospective controlled studies were included to determine the effects of 
treatm ent guided by gastrointestinal perfusion on outcome of septic patients. 
Finally, animal and hum an studies reporting the effects of various interventions
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on gastrointestinal perfusion are discussed, as to give an overview of potential 
treatment strategies that need further studies.
Regulation of gastrointestinal perfusion
Splanchnic blood flow, at both macrovascular and microvascular levels of 
perfusion, is regulated to perform two basic gastrointestinal functions: to digest 
and absorb ingested nutrients, and to sustain barrier function to prevent 
transepithelial migration o f bacteria and antigens.
Three direct branches o f the aorta supply the human gastrointestinal system: 
the celiac artery, the superior mesenteric artery, and the inferior mesenteric artery. 
Total blood flow in this system consumes approximately 25% of cardiac output. 
Following ingestion o f food, blood flow increases by as much as 200%  for 2-3 
hours. The mucosal layer receives 70-80% of the total blood flow, and is capable 
of rapidly recruiting closed capillaries. Blood flow to the mucosa is autoregulated 
by metabolic factors such as decreases in pO2, pH, or osmolarity, increases in 
pCO2, or adenosine. Other potential vasoactive mediators of the enteric circulation 
are neural mediators (e.g. sympathetic and parasympathetic tone), circulating 
humoral mediators (e.g. vasopressin, adrenomedullin, catecholamines), and 
paracrine and autocrine mediators (e.g. nitric oxide, endothelin-i)4.
Gastrointestinal perfusion in septic shock
Septic shock is characterised by cardiac depression, vasodilation, and 
microcirculatory defects resulting in redistribution o f regional blood flow. In a 
broader perspective, severe dysfunction o f the microcirculation in sepsis has been 
well described and classified5.
The metabolic demand for oxygen in the splanchnic region during sepsis is 
increased, partly by an increased hepatic metabolism6. In hyperdynamic shock 
states, mucosal vascular perfusion is compromised, despite decreased total 
peripheral resistance and increased total splanchnic blood flow7, 8. This appears to 
be comparable to the situation in post-cardiac surgery patients, where there is no 
consistent association between local intestinal mucosal perfusion and global 
splanchnic blood flow 9. Most experimental sepsis models show intestinal
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microvascular vasoconstriction and hypoperfusion4. The observed changes in 
microcirculatory blood flow in splanchnic organs are quite heterogeneous, both 
in early hypodynamic and in resuscitated hyperdynamic septic shock10. In early 
septic shock, autoregulation of microcirculatory mucosal blood flow is largely 
intact, and blood seems to be diverted from the muscularis towards the mucosa11. 
Acute bacteraemia causes both endothelial alterations and vascular smooth 
muscle cell changes. Vasomotion (a normally occurring rhythmic process of 
dilation and contraction) is impaired in magnitude and frequency in both inflow 
and premucosal arterioles following E. coli infusion12.
Different control mechanisms have been implicated in this impairment of 
mucosal vascular perfusion. Abnormalities in the nitric oxide system induced by 
inflammation can be regarded as one of the mechanisms responsible for the 
distributive defects observed. Local intestinal oxygen-derived free radicals also 
play a role in the intestinal microvascular sequelae; as the administration of 
lazaroids which are antioxidants that scavenge radicals and block lipid radical 
chain reactions prevents vasoconstriction in both inflow and premucosal 
arterioles in an animal sepsis model13. Gene expression o f endothelin 1, a potent 
vasoconstrictor, is upregulated in sepsis models and implicated in the shift 
towards a more tonically constricted state. Other mediators that have been 
associated with the observed mucosal perfusion abnormalities in sepsis include 
platelet-activating factor and adrenomedullin 4.
Cellular hypoxia from these perfusion abnormalities and from possible 
mitochondrial dysfunction, combined with the direct cytotoxic effects of 
inflammatory mediators, is thought to result in increased gut permeability and 
impaired immunological gut barrier function. Under ischemic conditions, 
enhanced paracellular permeability and epithelial destruction increases the 
mucosal permeability for endotoxin in human endothelial cell lines, an effect that 
has also been described in vivo in rats14.
An impaired gut barrier is thought to play a role in subsequent amplification 
o f systemic inflammation and distant organ dysfunction15. Numerous animal 
experiments have shown the importance of bacterial translocation and systemic 
spill o f mediators in the pathogenesis of multiple organ dysfunction syndrome. 
Haemorrhagic shock can induce the gut to become a cytokine-generating organ16. 
In vitro studies have documented that mesenteric lymph, following haemorrhagic 
shock, activates neutrophils, is toxic to endothelial cells, and increases endothelial
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permeability 17. In other experiments, ligation o f intestinal lymphatic flow 
prevented lung injury after haemorrhagic shock l8. In a recent porcine study, 
mesenteric lymph collected following haemorrhagic shock increased neutrophil 
activation and endothelial cell permeability as opposed to lymph from control 
animals 19. These results indicate that the lymphatic route could be the primary 
route by which gut injury causes distant organ injury, and could explain the 
reported absence of detectable bacteraemia in human studies of increased gut 
permeability 20. However, in one case series several cases o f Saccharomyces 
boulardii fungemia have been described in critically ill patients who received this 
agent enterally as a probiotic, possibly as a result o f translocation21.
Increased gut permeability has been found in sepsis22, pancreatitis 23, 
trauma 24, burns 25, and following cardiopulmonary bypass surgery 26. Some of 
these studies used differential absorption o f various polysaccharides o f differing 
molecular weights to estimate gut permeability. Specific pitfalls to the use o f these 
tests in ICU patients have been described elsewhere27. The association between 
splanchnic mucosal perfusion and systemic inflammation has been studied in 
different patient groups. In septic shock patients, the gastric to arterial pCO2 gap 
correlated well with systemic levels of tumour necrosis factor-alpha and 
interleukin-6, indicating that gut injury and the inflammatory response are 
associated 28. In patients following cardiopulmonary bypass surgery (characterized 
by a systemic inflammatory response) gastrointestinal permeability increased 
despite normal global splanchnic blood flow and oxygen delivery 29.
Intestinal mucosal injury is associated with a poor outcome in critically ill 
patients. In one small study, levels o f serum and urine intestinal fatty acid binding 
protein were measured, which are sensitive and specific markers for intestinal 
mucosal injury. The presence o f detectable intestinal fatty acid binding protein 
was associated with a poor prognosis30.
Techniques to measure gastrointestinal perfusion
Gastrointestinal perfusion can be measured in many different ways. Some 
techniques are able to directly measure intestinal mucosal perfusion (e.g. laser 
Doppler studies o f blood flow); other techniques measure endpoints o f oxygen 
delivery (e.g. lactate measurement with intraluminal microdialysis). Some 
techniques have only been used in animal studies and are therefore not discussed
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Table 1
Summary of techniques to measure gastrointestinal perfusion in patients
Method Variable Advantages Limitations
T o n o m e try G a str ic -a r te r ia l  p C O 2 g a p , 
m u c o s a l-e n d  t id a l p C O 2 g a p , 
pH i
M in im a lly  in v a s iv e ; m e a s u r e  o f  
m u c o s a l  p e r fu s io n ; v a lid a te d ; 
re p r o d u c ib le ; c o m m e rc ia l ly  
a v a ila b le
L im ited  b y  s ite  o f  
m e a s u r e m e n t ; g a s t r ic  fe e d in g  
in te r fe r e s  w ith  m e a s u r e m e n t; 
re q u ir e s  e q u ilib ra t io n  (no rea l 
t im e  m o n ito r in g )
L a s e r  D o p p le r  
flo w m e try
M u c o sa l  h e m a to c r it , m u c o s a l  
red  b lo o d  c e lls  ve lo c ity , b lo o d  
f lo w  in  a r b it ra r y  p e r fu s io n  u n its
U se fu l to  e v a lu a te  
e n d o th e liu m -d e p e n d e n t  
v a s c u la r  r e s p o n s e s ;  re a l-t im e  
v e lo c ity  m e a s u r e m e n t
S m a ll  s a m p lin g  v o lu m e  for 
b lo o d  flo w  m e a s u r e m e n t ; d o e s  
n o t re fle c t  h e te r o g e n e ity  o f  
b lo o d  flo w ; no  m e a s u r e m e n t  o f  
a b s o lu te  b lo o d  flo w
R e fle c ta n c e
s p e c tr o p h o t o m e tr y
T is s u e  m ic ro v a sc u la r  
h a e m o g lo b in  o xyg en  
s a tu r a t io n , re la t iv e  
h a e m o g lo b in  c o n c e n tr a tio n
E s t im a te s  a d e q u a c y  o f  o x y g e n  
d e liv e ry ; c o m m e rc ia l ly  
a v a ila b le ; rea l t im e  m o n ito r in g  
p o ss ib le
N o t a  m e a s u r e  o f  b lo o d  flo w ; 
e n d o s c o p ic  in tro d u c tio n ; b lind  
p ro b e s  n e e d  v a lid a t io n ; lu m in a l 
c o n t e n ts  in te r fe r e  w ith  
m e a s u r e m e n t
N e a r-in fra re d
s p e c tr o sc o p y
Q u a n tita t iv e  t is s u e  o x y g e n a t io n  
in d e x  (ra tio  o x y g e n a te d  
h a e m o g lo b in  to  to ta l 
h a e m o g lo b in )
M in im a lly  in v a s iv e ; m e a s u r e s  
t is s u e  o x y g e n a t io n
P e n e tra te s  in to  m u s c u la r is  
layer; n a s o g a s t r ic  p ro b e s  not 
te s t e d  in h u m a n  s tu d ie s ; 
t r a n s c u t a n e o u s  liver 
o x y g e n a t io n  m e a s u r e m e n t  not 
fe a s ib le  in a d u lts
O rth o g o n a l 
p o la r iz a t io n  sp ec tra l 
im a g in g
F u n ctio n a l c a p illa ry  d e n sity , 
p e rc e n ta g e  o f  p e rfu s e d  sm a ll 
v e s s e ls ,  s e m i-q u a n tita t iv e  
b lo o d  flo w
E a sy ; n o n - in v a s iv e ; 
re p r o d u c ib le ; c o m m e rc ia l ly  
a v a ila b le
S e m i-q u a n tita t iv e ; su b lin g u a l 
m e a s u r e m e n ts  m a y  not 
r e p r e s e n t  s p la n c h n ic  p e r fu s io n ; 
o p e ra to r- d e p e n d a n t
In d o c y a n in e  g re e n  
c le a ra n c e
P la sm a  d is a p p e a r a n c e  r a te  ICG C o m m e rc ia l ly  a v a ila b le ; 
m e a s u r e s  s p la n c h n ic  p e rfu s io n  
a s  w ell a s  g lo b a l liv e r  fu n c t io n
M u lt ip le  v a r ia b le s  d e te r m in e  
r e s u lt s  (h e p a tic  b lo o d  flow , 
h e p a to c e llu la r  u p ta k e , 
e x c re tio n  in to  b ile)
H e p a t ic  ve in  
c a th e te r iz a t io n
L a c ta te , v e n o u s  s a tu r a t io n , 
in d o c y a n in e  g re e n  e x tra c t io n
A llo w s  m e a s u r e m e n t  o x y g e n  
an d  in d o c y a n in e -g re e n  
e x tra c t io n
In v a s iv e ; re q u ir e s  ra d io lo g ic a l  
g u id a n c e ; d u a l h e p a tic  b lo o d  
f lo w  lim its  u se
P la sm a  D -la c ta te P la sm a  D -la c ta te  lev e ls E a sy ; c o r r e la te s  w ith  g a str ic  
t o n o m e tr y  r e su lts
A s s a y  n o t c o m m o n ly  a v a ila b le ; 
n o t a  d ire c t  m e a s u r e  o f  
g a s t r o in t e s t in a l  p e rfu s io n ; 
u n a b le  to  d e te c t  ra p id  c h a n g e s  
in p e rfu s io n
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in detail. Table 1 summarizes currently available techniques and the advantages 
and limitations for their use in septic patients.
Tonometry
There is now more than 20 years experience with tonometry in humans. . With 
this minimally invasive technique, intraluminal partial pressure of CO2 is 
measured.
Most studies have applied tonometry in the stomach, but other sites such as 
the jejunum, the rectum, and sigmoid colon have been examined as well. The 
difference between intraluminal and arterial partial pressures of CO2 is called 
the CO2 gap or the CO2 gradient, which should be smaller than 10 mmHg. An 
increased gradient is indicative of gut hypoxia, especially when the gradient is 
greater than 20 mmHg. Ischemic hypoxia due to hypoperfusion results in a 
more pronounced increase in pCO2 gradient than hypoxic hypoxia or anaemic 
hypoxia 31 32. The pCO2 gap is therefore largely dependent on mucosal perfusion 
and is considered to be a valid measure for gastrointestinal perfusion 33. The use 
o f the pCO2 gap has replaced the use o f mucosal pH (pHi, calculated from 
luminal pCO2 and blood bicarbonate content) because of increased sensitivity 
and specificity for regional ischemia 34, 35. Saline tonometry has been replaced with 
automated air tonometry because of technical problems, including long 
equilibration time, variability and lack of quality in the determination of saline 
pCO2, which is discussed elsewhere in more detail36'38.
The variability o f gastric pCO2 in intensive care patients has been compared 
with systemic hemodynamic parameters. In patients with acute respiratory or 
circulatory failure, the coefficient of variation for gastric-arterial pCO2 gradient 
was 15%, compared to 10%  for thermodilution cardiac output measurements 6. 
One o f the limitations o f tonometry is that it only provides information o f the site 
o f measurement (e.g. gastric perfusion), which is important in view o f the known 
heterogeneity in microvascular perfusion within the gastrointestinal tract.
Laser Doppler fowmetry
Laser Doppler flowmetry provides continuous measurement o f microcirculatory 
blood flow. The principle of this method is the Doppler shift, the frequency change 
that light undergoes when reflected by moving objects e.g. red blood cells 39. The 
output voltage varies linearly with the product o f mean red blood cell velocity and 
red blood cell concentration. This is referred to as red cell flux, which is
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proportional to blood flow at all but very high haematocrits. The tissue penetration 
o f the laser is approximately 1-3 mm, allowing the study o f mucosal blood flow 
without interference from the greater muscularis blood flow. Due to variable 
optical properties o f different tissues, absolute blood flow cannot be measured. 
Laser Doppler devices indicate microcirculatory blood flow in arbitrary perfusion 
units. The results are usually expressed as changes relative to baseline. It has been 
used to measure microcirculatory blood flow in many tissues including muscle 
and intestine40. As a non-invasive instrument, it can also provide information on 
endothelium-dependent vascular responsiveness in the skin microcirculation 41. 
To assess intestinal mucosal perfusion in humans, custom-made laser Doppler 
catheters have been developed for placement in the lumen of the proximal 
jejunum under fluoroscopic guidance 42. Jejunal mucosal perfusion is calculated 
as the product o f jejunal mucosal hematocrit and red blood cells velocity, both of 
which are measured variables. For example, this technique has been used to study 
the effects o f different vasoconstrictors on jejunal mucosal perfusion after cardiac 
surgery. In a prospective randomized crossover study in 10 patients, 
noradrenaline and phenylephrine were randomly and sequentially infused to 
increase mean arterial blood pressure by 30%. Neither o f the vasoconstrictors 
asserted a significant effect on jejunal mucosal perfusion, or on gastric to arterial 
pCO2 gradient 43.
Positioning o f the probes is essential to ensure continuous and steady contact 
with the surface o f the measurement site. The technique gives an average o f blood 
velocities and does not take into account the heterogeneity o f blood flow in the 
window studied, making it less suitable for monitoring o f gut perfusion in septic 
patients.
Reflectance spectrophotometry
The technique o f reflectance spectrophotometry for assessment o f gastric mucosal 
blood flow was first described by Sato et al. in 197944. This optical technology uses 
white light (wavelengths between 390 nm and 780 nm) to illuminate tissues. The 
light that returns (reflects) to the detector is analyzed quantitatively. Using visible 
light, the recovered signal is predominantly due to haemoglobin absorption in 
the superficial 0.25 mm o f tissue. To measure mucosal microvascular 
haemoglobin oxygen saturation and relative haemoglobin concentration, light 
from a xenon high-pressure arc lamp is transmitted to the mucosal surface using 
a single flexible microlightguide. This microlightguide is introduced through the
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operation canal o f a gastroscope, and attached to the mucosal surface under visual 
control. With newer commercially available instruments, it is also possible to 
obtain a stable signal without endoscopy by using a probe that is embedded in a 
nasogastric or rectal tube. Validation studies applying these probes in patients are 
awaited.
In typical gastrointestinal mucosa, the average haemoglobin saturation is 
approximately 70%. The microvascular haemoglobin oxygenation reflects the 
balance between regional oxygen delivery and oxygen uptake. Decreased values 
may be caused by decreased delivery, enhanced uptake, or a combination o f both. 
This technique has been applied to measure intestinal mucosal perfusion in ulcer 
disease, portal hypertension, cardiopulmonary bypass, septic shock, and in 
response to infusion o f vasoactive agents 45. For example, septic shock patients 
showed a decrease in average gastric mucosal haemoglobin oxygen saturation to 
51%, compared to 70% in healthy controls. Infusion o f dopexamine increased 
mucosal saturation in the septic patients by an average o f 10% 46.
Because reflectance spectrophotometry measurements are easily obtained 
several times per second, real-time monitoring o f perfusion is possible. However, 
and in contrast to laser Doppler flowmetry, reflectance spectrophotometry does 
not measure blood flow, but provides an estimate of the adequacy of oxygen 
delivery to the mucosa. Several factors can impact the quality o f measurements, 
such as the presence o f optically active materials in the lumen (e.g. bile, stool, 
blood), the effect o f pressure when the probe touches the mucosa, and the 
endoscope light. Newer systems correct for an uneven baseline and obtain 
measurements without touching the mucosa.
Near-infrared spectroscopy
Near-infrared spectroscopy is another non-invasive optical technique to measure 
tissue oxygenation. Near-infrared light penetrates more deeply into tissues than 
visible light, therefore enabling measurements in the muscularis propria or 
deeper structures. Tissue penetration is directly related to the spacing between 
illumination and detection fibres. At 25 mm spacing approximately 95% of the 
reflected optical signal is from a depth o f 0-23 mm. Absorption and hence 
reflection of near-infrared light depends on the oxygenation state of 
haemoglobin. Each tissue type has a so-called path length through which the 
near-infrared light travels. The absolute concentrations of oxygenated and 
deoxygenated haemoglobin cannot be measured without knowledge o f this path
34 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
G a s t r o i n t e s t i n a l  p e r f u s i o n  i n  s e p t i c  s h o c k
length. This problem has been overcome by the development of newer 
generations o f near-infrared spectrometers, often referred to as spatially resolved 
spectroscopy, allowing additional measurement of a quantitative tissue 
oxygenation index, which represent the ratio o f oxygenated haemoglobin to total 
haemoglobin.
This technique has been applied in superficial muscles as a non-invasive 
measure o f peripheral perfusion in haemorrhagic and septic shock40. It has also 
been used to measure liver tissue oxygenation transcutaneously in critically ill 
children, and a good correlation (r=0.72, p<0.000i) with invasively measured 
central venous oxygen saturation was shown47. However, there are several 
limitations to the latter observations that prevent this tool from being generally 
applicable in the measurement o f hepatosplanchnic perfusion in septic patients. 
Measurements of single point liver tissue oxygenation show a large inter­
individual variation 47. Also, in adults, the liver is usually not as accessible as in 
small children, and differences in subcutaneous fat and oedema may result in 
significant inter-individual differences in measured liver tissue oxygenation. 
Furthermore, liver oxygenation may not be a good marker for splanchnic 
perfusion because o f the dual hepatic blood supply and lack o f autoregulation.
In animal studies, side-illuminating near-infrared spectroscopy nasogastric 
probes have been shown to rapidly reflect changes in splanchnic perfusion. In an 
experimental haemorrhagic shock model, bowel pH obtained with intraluminal 
near-infrared spectroscopy correlated well with pH measured with 
microelectrodes 48. Human studies o f intraluminal near-infrared spectroscopy in 
septic shock are currently awaited.
Orthogonal polarization spectral (OPS) imaging
This recently developed and non-invasive technique uses reflected light to produce 
real-time images o f the microcirculation49. It allows microscopic visualization of 
the microcirculation as well as o f the flow o f red blood cells in the microvessels. 
In order to improve spatial resolution and allow for better visualization o f the 
smallest capillaries, an improved imaging modality called sidestream dark-field 
imaging has been developed. With this technique, the light guide is surrounded 
by 530 nm light-emitting diodes. Because this wavelength is absorbed by the 
haemoglobin of red blood cells, these cells can be seen as dark cells flowing in 
the microcirculation.
Tissue perfusion is assessed and quantified by using the functional capillary
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density, which is the length o f perfused capillaries per observation area in cm/cm2, 
and by semi-quantitative measurement o f blood flow velocities in capillaries. 
Although the technique can be used to visualize microcirculation in many organs 
(e.g. during surgery), it is most commonly applied sublingually. Hand-held devices 
are commercially available. Limitations include artefacts secondary to movement 
and secretions, and observer-related bias including the amount o f pressure that is 
used to obtain the images. Nevertheless, in a recent validation study, agreement 
and kappa coefficients were >85% and >0.75, respectively, for interrater and 
intrarater variability in quantification o f flow abnormalities in vascular beds o f the 
sublingual and stoma region during sepsis50. Interpretation of the obtained images 
is time-consuming, and software has been developed to analyze and quantify the 
images.
Although the oropharynx can be considered as part o f the gastrointestinal 
system, perfusion o f the tongue is regulated in a complex way, which is different 
from the way the splanchnic perfusion is controlled. Sublingual OPS imaging is 
therefore not a direct measure o f gastrointestinal perfusion. However, OPS- 
derived measurements have been shown to correlate well with measurements of 
sublingual capnometry and gastric tonometry in septic patients 51, but more 
validating studies are needed.
Indocyanine green clearance
Global liver function and splanchnic perfusion can be quantified with 
measurements o f indocyanine green dye clearance. After venous injection, 
indocyanine green is eliminated unchanged by the liver into the bile without 
enterohepatic recirculation. Elimination o f indocyanine green is determined by 
hepatic blood flow, hepato-cellular uptake, and excretion into the bile. After 
administration o f a bolus o f indocyanine green, the blood clearance can be 
calculated by taking repeated venous samples or by using intra-arterial fibreoptic 
spectroscopic measurements. Alternatively, the plasma disappearance rate can be 
assessed transcutaneously, with comparable results to venous sam pling52. The 
major advantage o f the latter is that it is a non-invasive technique. Normal values 
in healthy control subjects for indocyanine green clearance and for indocyanine 
green plasma disappearance rate are > 700 ml/m in/m 2 and 18%/min, 
respectively.
As a method to measure splanchnic perfusion, this technique has several 
limitations. Results are not only dependent on perfusion, but also on hepatic uptake 
and excretion, which makes it difficult, to determine what exactly is being
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measured. Estimated hepatic blood flow calculated from systemic indocyanine 
green clearance correlates poorly with values obtained using hepatic vein 
catheterization and the Fick principle, because o f the variability in dye extraction 6.
Hepatic vein catheterization
Monitoring o f hepatic vein oxygen saturation is invasive, and involves the 
insertion o f a hepatic catheter. Fluoroscopic or ultrasound guidance is commonly 
necessary for adequate insertion. A new technique for blind insertion has been 
described, using galactose infusion combined with a specific biosensor 53. The 
use o f these catheters appears to be safe. Several studies have documented that 
the gradient between mixed-venous and hepatic vein saturation is commonly 
increased in septic shock 54. However, as this measurement reflects portal and 
hepatic arterial flow, maintained hepatic venous oxygen saturation does not 
exclude gut hypoperfusion. Hepatic vein lactate measurements can be used to 
detect splanchnic hypoxia, with similar limitations.
Hepatic blood flow can also be determined by hepatic venous sampling during 
constant infusion o f indocyanine-green, therefore enabling the calculation o f the 
indocyanine-green extraction, as discussed earlier. The coefficient o f variation for 
splanchnic blood flow in septic shock patients using hepatic vein catheterization 
derived indocyanine green clearance measurements was 9 % 55. In another study 
using the same technique, the standard error for repeated measurements was
3i% 56.
Plasma D-lactate
Measurement o f plasma D-lactate has been suggested to be a marker of 
splanchnic hypoperfusion. D-lactate is produced by bacterial fermentation in the 
colonic lumen and subsequently absorbed into the blood. Bacterial overgrowth 
and increased gut permeability are both features o f gastrointestinal dysfunction 
during septic shock. During hypoperfusion in the gut, both L-lactate and D-lactate 
are produced in increased amounts. Because humans lack the enzyme D-lactate 
dehydrogenase, liver metabolism of D-lactate is slower than that o f L-lactate. D- 
Lactate may therefore reflect the intestinal perfusion more closely than L-lactate.
Increased D-lactate levels were found in acute intestinal ischemia, acute 
pancreatitis, and severe burns 57-60. In a study in 20 septic shock patients, D- 
lactate levels but not L-lactate levels correlated significantly with gastric 
tonometry results, indicating that D-lactate is a better marker for splanchnic
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hypoperfusion and increased splanchnic luminal CO2 production than L-lactate 
in septic patients 6l.
These results need to be reproduced by subsequent studies. Further clinical 
validation o f the usefulness o f this assay is needed. This technique may not be 
able to rapidly reflect changes in gastrointestinal perfusion (e.g. to study specific 
interventions) because o f the relatively long half-life o f D-lactate. Current clinical 
use is also limited by the fact that the D-lactate assay is not available in most 
institutions.
Future techniques
Other techniques are being developed to measure gastrointestinal (mucosal) 
perfusion or oxygenation. Currently, these methods have limited use in humans, 
and as such are not within the scope o f this review. Examples include contrast- 
enhanced ultrasonography 62, and intestinal luminal microdialysis 63, 64.
Conclusion
Different techniques have been developed to measure gastrointestinal perfusion. 
Realistically, most methods are actually indirect estimates o f gastrointestinal 
perfusion. The clinical usefulness and relevance o f the different techniques is 
dependent on the problem that is being investigated, and results o f different 
methods can sometimes appear seemingly conflicting (e.g. normal global 
splanchnic blood flow does not equal adequate oxygen delivery to the cells). Also, 
there is no technique that is considered the ‘gold standard’ .
In sepsis, heterogeneity in microcirculatory flow seems to be a key 
characteristic. Interruption or decrease o f red blood cell velocity, as well as 
hyperdynamic microcirculatory flow patters (shunting) has been observed. 
Techniques that evaluate the adequacy o f mucosal oxygenation (e.g. reflectance 
spectrophotometry and tonometry) are likely to better reflect the microcirculatory 
disturbances in sepsis than techniques that simply measure flow (e.g. laser 
Doppler flowmetry). Orthogonal polarization spectral imaging is a useful 
technique to quantify microcirculatory abnormalities in sepsis, but studies are 
awaited to further correlate sublingual measurements with gastrointestinal 
mucosal perfusion.
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Table 2
Clinical studies reporting the effects of splanchnic perfusion abnormalities on mortality in 
critically ill patients
Reference
(year)
n Patients Splanchnic
perfusion
Prediction o f mortality Comments
[65]
(2 0 0 3 ) 95 V e n tila te d  c r it ic a lly  ill P C O 2 g ap
O R  1 .5 7  (9 5 %  CI 1 . 10 - 2 .2 4 ) A fte r  2 4  h o u rs  
A u to m a te d  a ir  t o n o m e tr y
[87]
(2 0 0 0 )
2 1 0 C rit ic a lly  ill p H i p H i lo w e r  in  n o n -s u rv iv o rs In te rv e n tio n  t r ia l, pH i g u id e d  re su s c ita t io n
[66]
(1997)
6 2 C rit ic a lly  ill
p H i
P C O 2 g ap
p H i b ut n o t P C O 2 g ap  
p re d ic te d  m o rta lity
[67]
(19 9 8 ) 19 C rit ic a lly  ill t ra u m a p H i
R R  4 .5 ; M o rta lity  5 0 %  v s . 
1 1 %
[68]
(1997)
19 P e d ia tr ic  se p t ic P C O 2 g ap  p H i
P C O 2 g a p  b ut n o t pH i 
p re d ic te d  m o rta lity
A fte r  2 4  h o u rs  
R O C  A U C  0 .7
[69]
(1996) 57
T ra u m a  w ith  o rg a n  
fa ilu re p H i M o rta lity  5 4  %  v s . 7 %
F a ilu re  t o  n o r m a liz e  pH i 
p re d ic ts  m o rta lity
[70]
(1995) 8
P e d ia tr ic  se p t ic  
s h o c k p H i
M e a n  p H i lo w e r  in 
n o n -s u rv iv o rs
[71]
(1995) 35 S e v e r e  s e p s is p H i p H i lo w e r  in  n o n -s u rv iv o rs A t 0 ,  4 ,  an d  2 4  hr
[72]
(1994)
2 0 C rit ic a lly  ill t ra u m a p H i M o rta lity  5 0  v s .  0  %
L ow  p H i o n  a d m is s io n  th a t  
d id  n o t c o rre c t  a ft e r  2 4  hrs
[73]
(1993)
30 V e n tila te d  c r it ic a lly  ill p H i p H i p re d ic ts  m o rta lity
[74]
(1993) 83
A c u te  c irc u la to ry  
fa ilu re p H i L ik e lih o o d  ra tio  2 .3 2 A fte r  2 4  h o u rs
[86]
(1992) 2 6 0 In te n s iv e  c a re p H i p H i lo w e r  in  n o n -s u rv iv o rs
In te rv e n tio n  t r ia l, pH i 
g u id e d  re su s c ita t io n
[75]
(1991) 8 0
In te n s iv e  c a re p H i M o rta lity  6 5 %  v s .  4 4 % O n  a d m is s io n
[76]
(1998) 1 1 4 T rau m a
p H i
p C O 2 ga p
O R  4 .6  
O R  2 .9
[77]
(1999) 68 C a rd ia c  s u r g e ry
p H i
p C O 2 ga p
N o  d if fe r e n c e  b e tw e e n  
s u r v iv o r s  an d  n o n -su rv iv o rs
O n  a d m is s io n  a n d  a fte r  
1 2  h o u rs
[78]
(2 0 0 5 ) 2 8
S e p s is  ( s e v e re  
s e p s is  ex c lu d e d )
p H i
P C O 2 g ap  
IC G C
O R  4 .8  (9 5 %  CI 1 .5 - 14 .6 )  
O R  3 .0  (9 5 %  CI 1.4 -6 .3 )  
O R  3 .9  (9 5 %  C I 1 . 1 - 13 .8 )
R e g io n a l b ut n o t g lo b a l 
v a r ia b le s  p re d ic t  m o rta lity  
a ft e r  s ta b iliz a t io n
[79]
( 2 0 0 1) 2 1 S e p t ic  sh o c k IC G C
L o w  v a lu e  an d  fa i lu r e  to  
in c r e a se  in  n o n -s u rv iv o rs
[80]
(2 0 0 2 )
336 C rit ic a lly  ill IC G -P D R L o w e st  v a lu e  lo w e r  in n o n ­s u r v iv o r s  th a n  in  su r v iv o r s R O C  A U C  0 .8
[81]
(1984) 39 C rit ic a lly  ill s u rg ic a l IC G C L o w e r in n o n -su rv iv o rs
[82]
(2 0 0 4 ) 6 V e n tila te d  w ith  s e p t ic  S IR S
IS O 2, IH b O b s e r v e d  m o rta lity  8 3 %  v s . p re d ic te d  m o rta lity  2 5 %
U n e x p e c te d ly  high 
o b s e r v e d  m o rta lity
[83]
(2 0 0 6 ) 37 S e p t ic  sh o c k D -la c ta te
D e c r e a s e  b e tw e e n  d a y  1 
an d  2  in su r v iv o r s
pH i, in tra m u co sa l p H ; pC O 2 g a p , g a str ic  m u c o sa l-arteria l g ra d ien t o f  pC O 2; IC G C , in d ocyan in e  green  c le a ra n c e ; IC G -P D R , in d ocyan in e  green 
p la sm a  d isa p p e a ra n c e  rate; IS O 2, e n d o sc o p ic  re flectan ce  s p e ctro p h o to m e try  record ed  in d ex o f  g a stro d u o d e n a l m u co sa l oxygen  sa tu ra tio n ; IHb, 
e n d o sc o p ic  re flectan ce  s p e ctro p h o to m e try  record ed  in d ex  o f  g a stro d u o d e n a l m u co sa l h em o glo b in  co n ce n tra tio n ; O R, O d ds Ratio ; RR, R isk  Ratio; 
RO C A U C , R eceiver o p e ra tin g  c h a ra cte rist ic  A re a  u n de r curve
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Prognostic value of impaired gastrointestinal perfusion
Gastrointestinal mucosal hypoperfusion in critically ill patients is associated with 
a poor outcome, as illustrated in table 2.
Several studies in different patient populations, have investigated the 
association between gastric intramucosal pH (pHi), gastric mucosal pCO2, or the 
gastric to arterial pCO2 gradient, and outcome65-77. In the majority o f these studies, 
a low pHi at admission, or failure to normalize pHi after a set time period (most 
often 24 hours), discriminates non-survivors from survivors. However, pHi is 
closely related to the systemic acid-base status, which may partly explain why pHi 
has been shown to be a good prognostic marker. Only one study investigated the 
prognostic role of the gastric to arterial pCO2 gap using automated air tonometry, 
convincingly demonstrating that the pCO2 gap is a marker o f mortality in 
ventilated ICU patients.65
In a recent study, global hemodynamic variables were compared with different 
regional variables in 28 septic patients. After initial resuscitation aimed at 
improving global pressure-related hemodynamics, hepatosplanchnic variables 
but not global hemodynamic variables were independent predictors o f outcome. 
Gastric mucosal pH, mucosal-end tidal CO2 gap, and indocyanine green blood 
clearance were the most important predictors o f outcome78. Indocyanine green 
elimination rate has been shown to correlate with survival in critically ill and septic 
shock patients in other studies as well 79-81. Sakka et al. retrospectively studied 336 
critically ill patients who were monitored with transpulmonary double indicator 
dilution technique. The lowest value o f indocyanine green plasma disappearance 
rate (ICG-PDR) was significantly lower in non-survivors (n=i68) than in survivors 
(n=i68) [median, 6.4%/min vs. 16.5%/min]. The area under the ROC curve as a 
measure o f accuracy was 0.8 when using the lowest ICG-PDR in each patient and 
found to be comparable with values obtained with APACHE II and SAPS II 
scores. The predictive value o f IGC-PDR was found to be independent from the 
underlying disease, as subgroup analysis showed that in sepsis, ARDS, and all 
other patients, the IGC-PDR was always significantly higher in survivors80.
In one small study looking at endoscopic reflectance spectrophotometry, 
values for gastroduodenal blood flow in mechanically ventilated septic patients 
were approximately 40-50% o f values found in healthy control patients. This 
impairment o f gastroduodenal perfusion was associated with a higher in-hospital 
mortality than predicted by APACHE II (83% vs. 25%) 82.
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Persistent abnormalities in the sublingual microcirculation o f septic patients (as 
visualized with orthogonal polarization spectral imaging) are associated with 
organ failure and death. Sakr et al. found that at the onset o f shock, survivors and 
non-survivors had similar vascular density and percentage o f perfused small 
vessels. However, small vessel perfusion significantly improved over time in 
survivors but not in non-survivors. Despite similar haemodynamic and 
oxygenation profiles and use o f vasopressors at the end o f shock, patients dying 
after the resolution o f shock in multiple organ failure had a significantly lower 
percentage o f perfused small vessels than survivors (57.4% vs. 79.3%) 83.
Plasma D-lactate has also been studied as a prognostic marker. A rapid 
decrease in plasma D-lactate levels, but not L-lactate levels, between day 1 and 2 
in septic shock patients, discriminated between survivors and non-survivors.84
In summary, these results show that measurements o f gut perfusion can be 
used to predict outcome in septic patients.
Treatment of gastrointestinal perfusion defects
Gut injury has been shown to be associated with infectious complications, 
systemic inflammation, and organ failure in septic patients. In view of the above­
described correlations between splanchnic perfusion and prognosis, 
interventions targeted at preventing or ameliorating gut injury are warranted. 
However, many o f the studies that we report on below show disappointingly 
negative results; presumably in part due to small sample size and ineffective 
therapies that do not reach their treatment goals. They do clearly demonstrate 
that hyper-aggressive use o f some “traditional” method o f macrovascular 
resuscitation (usually applied in the treatment arm o f the study) often fails to 
improve gastrointestinal microcirculatory function. It is likely that radical new 
approaches to microvascular resuscitation are needed before we can expect to 
achieve positive survival benefits. This is further elaborated on in the discussion 
section.
Global and regional resuscitation
Resuscitation strategies aimed at global hemodynamic parameters often fail to 
improve gastrointestinal perfusion and microcirculation. Prospective randomized 
controlled studies that have investigated the effect o f treatment strategies
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Table 3
Prospective randomized controlled studies reporting the effects of tonometry-based 
resuscitation on outcome
A A A , a b d o m in a l  a o r t ic  a n e u r y s m ; M O F , m u lt ip le  o r g a n  fa i lu r e ;  L O S , le n g th  o f  s ta y ;  A P A C H E  II, A c u t e  P h y s io lo g y  a n d  C h r o n ic  H e a lth  
E v a lu a t io n  II
specifically aimed to improve gastrointestinal perfusion on clinically important 
outcome parameters are listed in table 3.
Two small controlled studies in different patient populations have examined 
whether treatment aimed at increasing gastric intramucosal pH (pHi) improves 
outcome 69, 85. No significant differences were found in mortality or morbidity 
between the treatment groups and the control groups. However, both studies were 
not adequately powered to detect differences in outcome. Moreover, failure o f the 
intervention (fluids and more vasoactive agents) to improve pHi strongly 
predicted poor outcome in both studies.
Three larger controlled studies that investigated the influence o f splanchnic 
perfusion directed therapy in critically ill patients were performed in 260, 210 
and 151 patients 86'88. In all 3 studies, patients in the intervention groups with a 
low pHi received additional fluid resuscitation and vasoactive agents in an attempt 
to correct the abnormal pHi and to improve outcome. In one study, patients in a 
second intervention group additionally received therapies specifically aimed at
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optimising splanchnic perfusion and minimising reperfusion damage, including 
mannitol, hydrocortisone, antioxidants, glutamine, and vasodilator therapy 88. 
Only the Gutierrez trial showed a beneficial effect o f pHi guided treatment 86. In 
this study, patients admitted with a low pHi had similar survival rates in both the 
intervention and the control group (36% vs. 36%). However, in patients with a 
normal admission pHi, survival was significantly better in the intervention than 
in the control group (58% vs. 42%, p < .01). These patients received additional 
resuscitation whenever pHi fell below a certain level. This drop in pHi indicated 
potential inadequate resuscitation despite normal global hemodynamics. The 
authors suggested that timing o f the intervention could be crucial, and that their 
therapeutic approach could be ineffective after prolonged (irreversible?) mucosal 
acidosis as seen in the patients admitted with a low pHi. However, treatment in 
the control arm of this multicenter study was not standardized. This, combined 
with the high mortality in the control group, suggests that the difference in 
mortality may have been unrelated to the treatment o f low pHi. Interestingly, in 
general, attempts at correction o f pHi in the 3 trials usually failed to alter this 
parameter (compared to baseline or to the control group) in a sustained and 
significant manner. This suggests that the additional treatment provided, which 
consisted o f significantly more administration o f fluid and vasoactive agents, in 
fact was ineffective in resuscitating or recruiting the gastrointestinal 
microcirculation. In the two trials that measured pHi in the control patients as 
well 86, 87, admission pHi was significantly lower in non-survivors compared to 
survivors, confirming the prognostic value o f tonometry. An important limitation 
o f these studies is the use o f saline tonometry derived pHi as marker for 
gastrointestinal hypoperfusion (as discussed earlier, this has been replaced by the 
more accurate automated gas tonometry). Also, it is important to realize that the 
patient population studied was heterogeneous and not limited to a diagnosis of 
septic shock. Moreover, different resuscitation protocols were used, including 
infusion o f crystalloids, colloids, and blood products. The effect o f fluid 
resuscitation on gastrointestinal perfusion is variable and dependent on the type 
o f fluid used. Simply optimizing cardiac output by fluid loading in septic patients, 
with or without subsequent reduction o f vasopressor dose, is not necessarily 
associated with an increase in splanchnic blood flow 89, 90. Different fluids have 
different properties (e.g. composition and tonicity), which may result in different 
biological effects in septic shock. Specific to gastrointestinal perfusion, 
hydroxyethyl starch (HES) has shown to have a more pronounced beneficial effect
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on splanchnic perfusion than Ringer’s solution or modified fluid gelatin 91 92. In 
a recent uncontrolled study in septic patients, the effect o f HES fluid challenge 
on gastric mucosal pCO2 was variable between patients. Improvement was more 
pronounced in septic patients with an abnormal baseline pCO2 gap, indicating 
the actual presence o f gastrointestinal mucosal hypoperfusion.93 Theoretically 
and supported by animal studies, hypertonic fluid resuscitation (e.g. 7.5% 
hypertonic saline solution) has the potential to recruit gastrointestinal 
microcirculation 94. In a recent animal study, hypertonic saline decreased thermal 
injury induced bacterial translocation in the gut, and enhanced host response to 
bacterial challenge by augmenting Toll-like receptor expression o f inflammatory 
cells95. The effect o f hypertonic fluid resuscitation on gastrointestinal perfusion, 
microcirculation, and immunomodulation is the subject o f an ongoing 
randomised controlled study in septic shock patients. Finally, transfusion o f red 
blood cells to enhance systemic oxygen delivery in septic patients failed to improve 
gastric pHi in two studies 96, 97.
In conclusion, resuscitation o f septic shock patients on the basis o f tonometry 
has not convincingly been shown to improve outcome. Patient heterogeneity, lack 
o f statistical power, the use o f saline tonometry, and failure o f the treatment 
protocols to actually improve pHi may explain this lack o f efficacy. Persistently 
low pHi despite treatment in these studies identified patients at risk for poor 
outcome, and illustrates the fact that the therapies studied seem generally not 
effective in actually resuscitating mucosal microcirculation.
Vasoactive therapy
The influence of classic vasoactive therapies on gastrointestinal perfusion in septic 
shock has been well described in a recent review article, and will not be further 
elaborated o n 98. In summary, increasing perfusion pressure with vasopressor 
therapy in septic shock patients does not significantly improve or impair 
splanchnic perfusion 99, 100. However, from a microcirculatory perspective, 
vasopressors should be applied with caution 101. We have previously shown that 
vasopressin infusion in septic shock patients treated with high dose noradrenaline 
results in a significant increase in gastric-arterial pCO2 gap 102. Preliminary results 
from the Vasopressin and Septic Shock Trial (VASST) show that vasopressin 
infusion in patients with septic shock may be beneficial in patients that require 
low dose noradrenaline, but demonstrate no improved outcome in patients with 
‘high’ dose (>15 pg/min) noradrenaline dependency. Although no significant
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increase in overt mesenteric ischemia was reported, this potentially may have 
been caused by inadvertent effects on gastrointestinal perfusion.
While pressure-guided resuscitation in septic patients has consistently been 
found to be effective in restoring systemic blood pressure, it does not, by 
definition, have an equivalent correcting effect on microcirculatory perfusion 83.
Vasodilator therapy increases the driving pressure at the entrance o f the 
microcirculation and is potentially able to recruit microcirculatory perfusion103. 
One o f the problems interpreting the results o f administration o f vasodilator 
drugs is that these drugs often have other pharmacological effects as well (e.g. 
reduction in leukocyte adhesion and platelet aggregation). Nitric oxide donors 
such as nitroglycerin improved gut microcirculation in a number o f animal 
experiments 103 and also improved sublingual microcirculatory blood flow in an 
observational uncontrolled human study, as measured by orthogonal polarization 
spectral imaging 104. However, as part o f a complex therapeutic intervention 
protocol to resuscitate trauma patients and prevent ischemia-reperfusion damage, 
vasodilators failed to correct a low pHi 88.
Prostacyclin and its analogue iloprost have vasodilator and cytoprotective 
properties. Administration o f these drugs in septic patients either intravenously or 
aerosolized increased gastric intramucosal pH in two studies 105, 106. In a prospective 
uncontrolled study in 20 septic shock patients, iloprost was infused and plasma 
disappearance rate o f indocyanine green (ICG-PDR) increased significantly 24 h 
after start o f iloprost infusion (baseline: i3.9±i.7%  vs. i8.6±2.2%/min) and 
significantly decreased 1 h after end of infusion (13^1.7% /m in) 107. Iloprost also 
improved cardiac index and global hepato-splanchnic perfusion in another small 
uncontrolled study in septic shock patients 108.
The complex interactions between the exogenous administered vasodilators 
and the endogenous sepsis-induced vasodilatory mechanisms (e.g. through iNOS 
activation) are not well understood. This makes it difficult to resolve the clinical 
conundrum of attempting to administer vasodilator drugs to a critically ill septic 
patient, who is concurrently requiring vasoconstrictors to maintain adequate 
macrocirculatory parameters.
Enteral nutrition
Under normal conditions, blood flow to the gastrointestinal system increases 
during the digestion and absorption o f nutrients. Regulation o f this postprandial
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hyperaemia is complex.4 In several clinical situations, enteral feeding has been 
shown to prevent or ameliorate the increase in gut permeability and systemic 
inflammation induced by the disease state. For example, in one study, multiple 
injured patients who had recovered from shock within 6 hours, where 
randomized in an early enteral nutrition group and a late enteral nutrition group.
Intestinal permeability was measured using a lactose/mannitol (L/M) 
clearance assay. On post injury day 4 L/M ratio was significantly higher in the 
second group; suggesting that immediate enteral nutrition protects against an 
increase in intestinal permeability induced by multiple injury 109. In surgical 
critically ill patients, early administration o f enteral nutrition decreases the 
number o f infectious complications and the length o f hospital stay 110 111. The 
mechanisms by which enteral nutrition is thought to decrease the pathological 
gut permeability, include an increase in hepato-splanchnic blood flow, prevention 
o f gut-associated lymphoid tissue atrophy, and modulation o f immunological 
phenomena 110 112.
Experimental therapies
Endothelium-derived substances such as endothelin and nitric oxide are 
recognized as important mediators o f systemic inflammation. Selective inhibition 
o f inducible nitric oxide synthase blunted the progressive increase in ileal to 
arterial pCO2 gap in an animal model o f long-term endotoxemia113. The use of 
endothelin receptor antagonists has been studied in several animal models of 
septic shock. In one porcine study, bosentan completely restored the gut oxygen 
delivery with a reversal o f intestinal mucosal acidosis as measured by ileal 
tonometry 114. These findings were reproduced in another study with the use of 
laser Doppler flowmetry, confirming the hypothesis that endothelin plays an 
important role in the regulation o f splanchnic microcirculatory flow in septic 
shock115. In patients with severe sepsis, endothelin plasma levels are markedly 
increased116. To our knowledge, there are no studies published to date that look 
at the effects o f endothelin receptor antagonists in septic patients. Timing o f these 
potential interventions would seem to be crucial. The selective inhibition of 
inducible nitric oxide synthase during hyperdynamic, earlier phase o f sepsis 
combined with the blockade o f endothelin receptors at a later stage may represent 
a novel promising strategy for the therapy o f septic shock117.
Blockade o f the angiotensin II type 1 receptor ameliorates splanchnic 
hypoperfusion in acute experimental circulatory failure. In animal models of
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septic shock however, administration o f the angiotensin II type i receptor 
antagonist candesartan had no effect on mucosal acidosis1l8. Although survival 
improved when used as pre-treatment, survival decreased compared to controls 
when candesartan was administered during endotoxemia119.
Discussion
Septic shock is associated with splanchnic perfusion abnormalities, which can be 
measured with several techniques as discussed above. These perfusion 
abnormalities are associated with a poor outcome. The main question now is: If 
impairment o f splanchnic mucosal perfusion in sepsis adversely affects outcome, 
why have trials aimed at improving gut perfusion failed to show survival benefit? 
Several explanations may be considered. First o f all, the majority o f studies have 
looked at intermediate physiologic effects (e.g. gastric intramucosal pH) and not 
at mortality as primary outcome measure. Clearly, i f  an intervention which is 
targeted to improve mucosal microcirculatory perfusion fails to do so it is also 
unlikely to find a significant difference in outcome. The effect o f those treatment 
strategies that are actually potentially capable o f effectively restoring systemic and 
gastrointestinal microcirculatory defects (e.g. hypertonic fluid resuscitation) on 
outcome in septic patients has not yet been studied.
Measurement o f treatment effects on physiologic variables such as splanchnic 
perfusion has potential intrinsic problems. Measurement errors can produce false 
positive as well as false negative results. The magnitude o f treatment effect has 
to be greater than the baseline physiologic variability of the variable studied. 
Knowledge o f this variability is essential in interpreting the results o f these 
measurements. In healthy subjects, splanchnic blood flow has been demonstrated 
to exhibit a circadian variation120. Animal experiments suggest that splanchnic 
haemodynamic parameters could exhibit a more pronounced variability than 
systemic haemodynamics 6. Some of the physiologic variability in splanchnic 
blood flow is explained by abdominal pressure variation during the respiratory 
cycle. However, in patients with acute lung injury, lung recruitment manoeuvres 
and prone positioning interestingly had no significant effect on gastric mucosal 
perfusion121 122.
There is also the possibility that splanchnic hypoperfusion is a marker of 
disease or an epiphenomenon rather than a factor in its pathogenesis. However,
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as outlined above, current experimental evidence supports the hypothesis that 
mucosal microcirculatory abnormalities play a role in the pathogenesis of 
systemic inflammation and multiple organ failure. From this pathophysiological 
understanding, it would seem likely that the main therapeutic benefit o f effective 
mucosal resuscitation treatments would be to prevent an ongoing inflammatory 
insult to the patient. As a consequence, we would expect a benefit in reducing 
late sepsis-associated deaths (usually from multiple organ failure). However, the 
subset o f septic patients who die from the primary infective insult (such as 
fulminant meningococcemia) would not be expected to benefit from treatments 
that act to reduce secondary inflammatory processes.
Clinical research in this specific area is also subject to a more common 
dilemma present in sepsis studies. The pathogenesis and pathophysiology of 
sepsis is complex. Sepsis can be looked at as a self-regulating complex system, 
with multiple cascading non-linear interactions and feedbacks, acting in series 
and in parallel, to form a "scale-free" network. As such, interfering with one 
variable is unlikely to change the course o f the disease process123. Many ‘magic 
bullets’ have been considered, and subsequently shown to yield disappointing 
results in clinical trials. An approach targeted at different elements o f that 
complex system therefore seems more rational. Examples are resuscitation 
strategies that at the same time modulate the immune response, such as 
hypertonic fluid resuscitation and the use o f selective nitric oxide inhibitors as 
vasopressor.
Conclusion
Normal regulation o f gastrointestinal blood flow is impaired in septic shock, 
resulting in mucosal hypoperfusion. Gastrointestinal mucosal hypoperfusion is 
an important marker, and also probably a cause, o f poor prognosis in septic 
patients. Impaired gut barrier function could play a role in amplification of 
systemic inflammation, causing distant multiple organ dysfunction.
The aim of monitoring splanchnic perfusion is to detect, prevent, and reverse 
tissue hypoperfusion. Several techniques have been developed to measure 
gastrointestinal perfusion. These methods share the ability to predict outcome in 
septic shock patients. Gastric tonometry is the most widely used technique 
because o f its non-invasiveness and ease o f use. However, as treatment strategies
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aimed at improving gastrointestinal perfusion have not been able to correct 
mucosal perfusion abnormalities and hence have not shown to improve outcome, 
the use o f these tools in clinical decision-making is currently limited.
New treatment strategies for septic shock should be tested for their effects on 
gastrointestinal perfusion; to further clarify its exact role in patient management, 
and to prevent therapies detrimental to gastrointestinal perfusion being 
implemented.
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Abstract
Objective: To study the effect o f continuous infusion o f vasopressin on the 
splanchnic circulation in severe septic shock patients.
Design: Prospective clinical study.
Setting: Intensive care unit in a teaching hospital.
Patients: Eleven consecutive patients with documented septic shock who remained 
hypotensive despite norepinephrine-infusion at a rate o f > 0.2 Mg/kg/min. 
Interventions: Insertion o f a gastric tonometry catheter; continuous infusion of 
vasopressin 0.04 U/min during 4 hours.
Measurements and Main results: P(g-a)CO2 gap, blood pressure, and cardiac index 
were recorded at baseline and after 15, 30, 60, 120, and 240 minutes.
The median P(g-a)CO2 gap increased from 5 mmHg at baseline to 19 mmHg 
after 4 hours (p=0.022). Blood pressure increased from 61 ± 13 mmHg at baseline 
to 68 ± 9 mmHg after 4 hours (p=0.055). No significant changes in cardiac index 
were noted.
Conclusions: In norepinephrine-dependent septic shock patients, continuous 
infusion o f low dose vasopressin results in a significant increase o f the P(g-a)CO2 
gap compatible with gastrointestinal hypoperfusion.
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Introduction
Septic shock is often characterized by profound vasodilation that requires 
treatment with catecholamines. Norepinephrine-resistant hypotension associated 
with septic shock has a high mortality rate.
Patients with septic shock, compared to other forms o f shock, have low levels 
o f circulating endogenous vasopressin'-3. This may be related to depletion of 
vasopressin stores in the neurohypophysis4. In experimental septic shock, release 
o f vasopressin is inhibited by central nitric oxide production arising from the 
inducible nitric oxide synthase pathway5. Other experimental data indicate that 
sepsis also causes cytokine-mediated downregulation o f vasopressin V(iA) 
receptors6.
Vasopressin is a potent vasoconstrictor in patients with septic shock. 
Vasopressin increases blood pressure, improves some measures o f renal function 
and decreases catecholamine requirements 7-:0. Terlipressin, a long-acting 
vasopressin analogue, also restores blood pressure in patients with catecholamine- 
resistant septic shock n.
Despite its favorable effect on global hemodynamics in septic shock patients, 
few clinically relevant data are available on the effect o f vasopressin on the 
splanchnic circulation"2. In patients with bleeding esophageal varices, 
vasopressin leads to vasoconstriction o f the splanchnic circulation and may stop 
the bleedingi3.
The aim of our study was to investigate the effect o f vasopressin infusion on 
the splanchnic circulation in septic shock patients. We hypothesized that 
vasopressin, being a potent vasoconstrictive agent, decreases gastrointestinal 
blood flow and therefore may be potentially harmful.
Patients and Methods 
Patients
The study was approved by the medical ethical committee o f the Jeroen Bosch 
Hospital. Informed consent was obtained from the nearest relative. Thirteen 
consecutive patients with documented septic shock were screened for inclusion 
in the study. Septic shock was defined according to the ACCP/SCCM consensus 
conference“4. All patients were resuscitated with fluid until no further
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improvement o f cardiac output was obtained and received dobutamine based on 
the judgment o f the treating physician. All patients received a continuous 
infusion o f low dose hydrocortisone. Norepinephrine was added in case of 
persistent hypotension. Patients were included when they met the criteria for 
septic shock and had mean arterial pressures < 70 m mHg despite 
norepinephrine infusion at a rate o f > 0.2 pg/kg/min. Exclusion criteria were 
age below i8 years, pregnancy, and myocardial ischemia or infarction less than 
6 months prior to the study.
Interventions. A gastric tonometry catheter (TonometricsTM-catheter, TONO- 
i6F, Datex-Ohmeda Division, Helsinki, Finland) was inserted in the stomach. 
Calibration was performed according to the manufacturers guidelines. Enteral 
feeding was discontinued and all patients received omeprazole 40 mg 
intravenously i hour before the first measurements. After data collection at 
baseline, patients received vasopressin 0.04 U/min by continuous central venous 
infusion for 4 hours. Catecholamine doses were not changed during the study 
period unless mean arterial pressure dropped below 50 mmHg despite fluid 
resuscitation. Vasopressin was continued after 4 hours in case o f persistent 
hypotension, based on the judgment o f the treating physician.
Measurements
We recorded demographic data as well as the severity o f illness using APACHE 
II (first 24 hours o f admission to the ICU) and SOFA-scores (24 hours prior to 
inclusion in the study). Carbon dioxide partial pressure was measured in the 
stomach (PgCO2 in mmHg) by automated air tonometry using an equilibration 
time o f i0  minutes. Arterial carbon dioxide partial pressure (PaCO2 in mmHg) 
was measured simultaneously (blood gas analyzer, Bayer, Meijdrecht, The 
Netherlands) and P(g-a)CO2 gap was calculated. Blood pressure and cardiac index 
were also recorded. Plasma levels o f vasopressin were measured 
(radioimmunoassay kit, Nichols; Wizard gamma counter, Wallac, Finland). All 
measurements were performed at baseline and after i5, 30, 60, i20, and 240 
minutes. Data on hospital mortality were collected after completion o f the study. 
Statistical and data analysis. Data are presented as mean ± i SD or as median (25­
75th) percentile depending on their distribution. Changes over time were analyzed 
by ANOVA. All statistics were done using SPSS i0.0 (SPSS, Chicago, IL).
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Table 1: Demographic and clinical characteristics
Results
Patient characteristics
Thirteen consecutive patients were eligible for inclusion in the study. In two 
patients it was not possible to measure PgCO2 due to technical problems. The 
demographic and clinical characteristics o f the patients are shown in table 1. 
Septic shock was caused by pneumonia in 5 patients, by abdominal sepsis in 5 
patients and by urosepsis and aspiration pneumonia in 1 patient. All patients were 
mechanically ventilated. Mean APACHE II score was 26.6 (± 8.7), mean SOFA 
score was 10.8 (± 1.8). Hospital mortality was 82% (9/11 patients died).
Measurements
The P(g-a)CO2 gap at baseline and following vasopressin infusion is shown in 
figure 1A. The median P(g-a)CO2 gap increased from 5 mmHg at baseline to 19 
mmHg after 4 hours; this increase was statistically significant (p=0.022). 
Vasopressin infusion resulted in an increase in mean arterial pressure from 61 ± 
13 mmHg at baseline to 68 ± 9 mmHg after 4 hours (p=0.055; figure 1B) without 
a significant decrease in cardiac index ^=0.978). Plasma vasopressin levels 
increased from 17 pg/ml at baseline to 230 pg/ml after 4 hours o f infusion 
(p<o.ooi; figure 1C). There was a strong correlation between median plasma levels 
o f vasopressin and the median P(g-a)CO2 gap (0=0.98) as is shown in figure 2.
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Figure 1A
Median P(g-a)CO2 gap in mmHg during vasopressin infusion with below 25th and 75th percentiles
Time (min)
25th
percentile 1,9 4,8 9,3 10,6 12,8 13,3
75th
percentile 10,9 19,4 20,5 23,9 29,1 26,8
Figure 1B
Mean arterial blood pressure ± SD in mmHg during vasopressin infusion
Time (min)
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Figure 1C
Median plasma levels of vasopressin in pg/ml during infusion with below 25th and 75th percentiles
2501-----------------------------------------------------------------------------
0 15 30
Time (min)
60 120 240
25th
percentile 7 31 47 166 166 220
75th
percentile 33 105 152 235 239 274
Figure 2
Correlation between median P(g-a)CO2 gap in mmHg and median plasma levels of vasopressin 
in pg/ml during vasopressin infusion
plasma vasopressin level (pg/ml)
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Discussion
In this study, we investigated the effect o f low dose vasopressin infusion on gastric 
perfusion in septic shock patients who remained hypotensive despite high dose 
norepinephrine infusion. Infusion o f vasopressin increased plasma levels of 
vasopressin to values that were more than ten times higher than those reported 
during comparable degrees o f hypotension from other causes such as cardiogenic 
shock3. This resulted in an increase in blood pressure, which was not 
accompanied by a reduction in cardiac output, compatible with an impairment 
of the baroreflex in septic shock patients. These findings are consistent with those 
previously reported by others3 9.
We found that vasopressin infusion leads to an immediate and important 
increase in P(g-a)CO2 gap in a dose-dependent fashion. This P(g-a)CO2 gap is a 
reliable measure o f gastrointestinal hypoperfusion. In animal experiments, 
increased levels of circulating vasopressin in different states of shock have been 
shown to contribute to redistribution o f blood from the peripheral to the cerebral 
circulation 15. Although low concentrations o f vasopressin have been shown to have 
vasodilatory effects in selected organs2, the results o f the only placebo-controlled 
trial that has been conducted with vasopressin in septic shock patients show that 
vasopressin treatment results in peripheral vasoconstriction16. Our study shows 
that vasopressin probably also leads to vasoconstriction o f the splanchnic 
vasculature. This finding is consistent with studies in human gastroepiploic 
arteries that demonstrate a concentration-dependent vasoconstriction effect 
starting at levels that are lower than those obtained in our studyi7. An increase in 
gastric pCO2 indicating splanchnic vasoconstriction has also been shown in 
patients who received ornipressin (a vasopressin agonist specific for the Vi 
receptor) to reverse the hypotension associated with combined general/epidural 
anesthesiai8. In animal experiments, endogenous release o f vasopressin during 
endotoxin administration has been associated with gastric, duodenal, and jejunal 
microcirculatory and mucosal injury19. Several studies have demonstrated that 
gastrointestinal hypoperfusion, reflected by a low gastric intramucosal pH, is a 
good predictor o f poor outcome 20-25. Gut intramucosal hypoxia is thought to be 
important both as an indicator o f inadequate resuscitation and as a mechanism 
by which multiorgan failure may occur. However, resuscitation based on the results 
o f gastric tonometry has failed to show improvement in outcome26.
Other vasoconstrictive agents used in septic shock don’t share the apparent
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detrimental effect o f vasopressin on the gastrointestinal perfusion. In one study 
for example, both epinephrine and the combination o f norepinephrine and 
dobutamine in septic shock patients increased gastric mucosal perfusion 27, 28. 
Gastrointestinal hypoperfusion can be reversed by infusion o f prostacyclin29. In 
our study, all patients developed gastric hypoperfusion despite standard use o f 
low dose vasodilating agents.
There are several limitations to this study. The number o f patients studied is 
small, but an increase in the P(g-a)CO2 gap was seen in 10 out o f 11 patients.
Furthermore, the patients included in this study were severely ill which makes 
generalization to all septic shock patients difficult. Although hospital mortality 
was unusually high, the study design permits no further speculations to be made 
on this observation.
Because all patients received high dose norepinephrine infusion as well as 
vasopressin, interaction between these two vasoconstrictive agents cannot be 
ruled out. Several studies indicate that subconstricting doses o f vasopressin are 
able to potentiate the constricting effects o f catecholamines 17 3°' 31. In a recent 
study, low dose terlipressin without administration o f other catecholamines 
increased ileal microcirculation in fluid-challenged endotoxic rats32. It is possible 
therefore, that the effect o f vasopressin observed in our patients reflects the 
potentiating effect o f vasopressin to infused and endogenous catecholamines.
Finally, the vasopressin dose administered to the patients may have been too 
high. We showed that higher levels o f vasopressin led to more profound gastric 
hypoperfusion in a dose-dependent fashion. Landry et al. showed in six septic shock 
patients that administration o f vasopressin at a lower infusion rate o f 0.01 U/min 
resulted in plasma concentrations expected for the level o f hypotension (around 30 
pg/ml) with an increase o f systolic arterial pressure from 83 to 115 mmHg3.
In conclusion, in this prospective study infusion o f low dose vasopressin in severe 
septic shock patients resulted in a rapid increase in P(g-a)CO2 gap compatible 
with gastrointestinal hypoperfusion. In our view, vasopressin treatment o f septic 
shock patients should be limited to controlled clinical trials until its effect on 
clinical outcome such as organ failure and mortality has been clarified.
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Abstract
Objective: We prospectively studied the effect o f methylene blue (MB) infusion 
on gastric mucosal metabolism perfusion ratio, assessed by gastric tonometry, 
and on mucosal cell damage, assessed by urinary levels of intestinal fatty acid 
binding protein (iFABP), in septic shock patients.
Methods: MB infusion (img/kg/hr) during 4 hours in 10 consecutive patients 
with a proven or suspected bacterial infection and with severe vasodilatory shock, 
defined as a mean arterial pressure < 70 mmHg for at least 1 hour despite 
adequate volume resuscitation and norepinephrine infusion at a rate > 0.2 
Pg/kg/min.
Results: MB infusion did not significantly change the P(g-a)CO2 gradient (p=.i6). 
Post-hoc analysis o f the subgroup o f patients with an elevated baseline P(g-a)CO2 
gradient, defined as > 20 mmHg, showed that the median P(g-a)CO2 gradient 
(IQR) decreased from 45 (41-56) mmHg before infusion to 41 (28-52) at the end 
of the 4 h infusion and decreased further to 32 (26-36) mmHg 2 h after cessation 
of MB infusion (p=.0i2). The median urinary iFABP concentration at baseline 
was elevated (210 [79-437] pg/pmol creatinine) and did not change significantly 
after 24 h (116 [53-601] pg/pmol creatinine, p=.i5). The median MAP [IQR] 
increased from 70 [69-71] mmHg at baseline to 77 [67-83] mmHg after 1 h 
(p=.04), the norepinephrine dose did not change significantly. The median [IQR] 
cardiac index decreased from 4.4 ^.2-5.5] l/min/m 2 at baseline to 3.6 [3.3-47] 
l/min/m 2 after 2 h, returning back to baseline values after cessation o f MB 
infusion p=.02).
Conclusion: Although MB infusion in patients with septic shock and advanced 
multi-organ failure increases MAP and decreases CI, it does not compromise the 
gastric mucosal perfusion metabolism ratio as indicated by tonometry, and by the 
release o f a mucosal cellular injury marker.
Trial registration at Australian New Zealand Clinical Trials Registry (ANZCTR) 
www.anzctr.org.au The effects o f methylene blue infusion on gastrointestinal 
perfusion and gut mucosal damage in septic shock patients 
Registration number ACTRN 12608000090314
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Introduction
Septic shock, resulting in refractory hypotension and progression to multiple 
organ failure, is the major cause o f prolonged stay and death in noncoronary 
intensive care units with an estimated mortality between 50% and 6 0 % 1 2. Part 
of the pathogenesis of vasodilation and organ dysfunction in septic shock involves 
the excessive production o f nitric oxide (NO) by inducible NO synthase (iNOS) 
that comes to expression during inflammation3. NO stimulates the soluble 
intracellular enzyme guanylate cyclase (sGC), which increases the generation of 
cyclic guanosine monophosphate (cGMP). Ultimately, this pathway leads to 
vasodilation, myocardial depression, increased vascular permeability, loss o f gut 
barrier function and organ dysfunction.
Non-selective inhibition o f NOS by L-NMMA (NG-monomethyl-L-arginine) 
resulted in an overall increase in mortality in a phase III trial in septic patients4. 
Methylene blue (MB) has been shown to inhibit inducible NOS, scavenge NO, 
and to inhibit sGC, therefore acting in a more selective fashion in comparison 
with L-NMMA, potentially preserving other physiologically beneficial NO 
pathways 5 6. In septic patients, small trials, including two prospective randomized 
controlled studies, have demonstrated an increase in blood pressure mediated by 
an increase in SV R 7'9. MB has been shown to be safe in humans and has been 
used for treatment of cyanide poisoning, methemoglobinemia and malaria for 
many years10.
Gastrointestinal mucosal hypoperfusion is thought to be important in septic 
shock patients, both as an indicator of inadequate resuscitation and as a 
mechanism by which multiple organ failure may occur11. Loss o f gut barrier 
function may lead to translocation of bacteria, endotoxin, and other inflammatory 
mediators, thereby augmenting and sustaining systemic inflammation, and 
possibly resulting in distant organ dysfunction. Abnormalities in the NO system 
can be regarded as one of the mechanisms responsible for the gastrointestinal 
mucosal perfusion defects observed12.
Gastric automated air tonometry is an easy and reproducible technique to 
estimate adequacy of splanchnic perfusion, and an increased gastric to arterial 
pCO2 gradient (P(g-a)CO2 gap) is a marker o f mortality in ventilated intensive 
care patients13.
Intestinal fatty acid binding protein (iFABP) is an intracellular epithelial 
protein in the intestinal mucosa. It has been shown to be a useful biochemical
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marker o f enterocyte injury and gut ischemia in experimental models and in 
humans 14'16 and iFABP levels have been shown to correlate with clinical 
development o f the systemic inflammatory response syndrome (SIRS) and with 
outcome in critically ill patients17, l8.
To our knowledge, the effect o f MB infusion on gastrointestinal perfusion 
and mucosal cell damage in septic shock patients has not been studied previously. 
We examined gastric tonometry and iFABP levels before, during and directly after 
a 4 hr infusion period o f MB in septic shock patients.
Patients and Methods 
Patients
The study was approved by the Central Committee on Research Involving 
Humans in the Netherlands (CCMO). Informed consent was obtained from the 
patient’s nearest relative/next o f kin. Consecutive patients admitted to the 
intensive care unit (ICU) with a proven or suspected bacterial infection and 2 or 
more SIRS criteria19 were screened for inclusion in this study. Patients were 
recruited within 24 h of admission to the ICU when they met the criteria for septic 
shock19 and had mean arterial pressures (MAP) <70 mmHg despite adequate 
fluid replacement and a norepinephrine infusion at a rate o f >0.2 pg/kg/min for 
at least an hour prior to recruitment. Patients were excluded if  they were <18 years, 
pregnant or lactating, or had proven myocardial ischemia or infarction <6 months 
prior to the study. Throughout the study, all patients received standard 
conventional therapy for septic shock and received low-dose hydrocortisone (200 
mg/24h). None o f the patients received activated protein C.
A transpulmonary thermodilution catheter (PiCCO, Pulsion Medizintechnik, 
Munich, Germany) was inserted as per our routine practice for septic shock 
patients. Fluid resuscitation was guided by cardiac output and stroke volume 
variation as measured by pulse contour analysis (patients were considered to be 
fluid responsive i f  SVV >12%) and per discretion o f the treating intenivist.
Interventions
A gastric tonometry catheter (TonometricsTM-catheter, TONO-16F, Datex- 
Ohmeda Division, Helsinki, Finland) was inserted in the stomach. Calibration 
was performed according to the manufacturer’s guidelines. Enteral feeding was
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discontinued and all patients received omeprazole 40 mg intravenously i h before 
the first measurements. Immediately after data collection at baseline, patients 
received a continuous central venous infusion of i mg/kg/hour MB (i% w/v) for 
4 h, which was provided by the department o f pharmacy o f the VieCuri Medical 
Centre. Infusion o f norepinephrine was only increased during the study period 
i f  MAP dropped below 60 mmHg despite additional fluid resuscitation. 
Norepinephrine infusion rate was decreased when MAP reached values > 80 
mmHg. Data o f all patients was analysed.
Measurements
We recorded demographic data as well as the severity o f illness using APACHE 
II, number o f failing organs, and SOFA-scores. Data on hospital mortality were 
collected after completion o f the study.
Hourly transpulmonary thermodilution calibration measurements were 
performed (PiCCO) and global hemodynamic parameters including blood 
pressure, heart rhythm and rate, cardiac index, stroke volume variation (SVV), 
extravascular lung water index (EVLWI), and urine output were recorded. Carbon 
dioxide partial pressure was measured in the stomach (PgCO2 in mmHg) by 
automated air tonometry using an equilibration time o f 10  minutes. Arterial 
carbon dioxide partial pressure (PaCO2 in mmHg) was measured simultaneously 
(blood gas analyzer, Bayer, Meijdrecht, The Netherlands) and P(g-a)CO2 gap was 
calculated. Blood lactate levels were determined by routine clinical chemistry. 
Hematocrit and blood concentrations o f hemoglobin, methemoglobin and 
bilirubin were measured to assess possible side effects o f MB administration, 
such as hemolytic anemia and methemoglobinemia20 21. Urinary excretion of 
iFABP was measured using a commercially available ELISA (Synbio, HK406) at 
t=0, 6, 24 h and calculated as ratio to urine creatinine concentration to correct 
for renal failure and urine dilution22. Using this assay in 15 healthy controls, 
urinary iFABP concentration was 5.4±i.6 pg/ml (unpublished results).
Statistical analysis
Values are given as mean±SD or as median [25-75% range], depending on their 
distribution. Data analysis was performed using ANOVA repeated measures 
using SPSS i4.0 for Windows (SPSS Inc. Chicago, Il, USA). The Wilks’ lambda 
F test o f the multivariate analysis was used to investigate whether a difference 
over time was significant and dependent on the baseline value. We used the
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Tukey-Kramer Multiple-Comparison test for post-hoc comparisons at different 
times.
The primary end point o f this study was the effect o f MB infusion on P(g- 
a)CO2 gap in patients with refractory septic shock. A change o f i0  m mHg in 
P(g-a)CO2 gap was considered to be relevant. In a previous study using the same 
method, we found a standard deviation o f 9 m m H g23. With these data and a 
significance level alpha o f 0.05, a sample size o f 6-ii subjects was calculated to 
reach a power of 80-95%. Therefore, i0 patients were included in the study, which 
results in a power o f 88% (PSPower V2.i.3i).
Results 
Patient characteristics
The demographic and clinical characteristics o f the patients are shown in Table i. 
The effects o f MB on the urinary excretion o f NO-metabolites and markers of 
renal injury in 9 out o f the current i0  patients were previously published24.
All patients had failure o f at least 3 organs, which is reflected by a mean SOFA 
score o f ii.3±2.5. Seven patients died in the ICU, one o f refractory vasodilatory 
shock (within i2 h) and six patients because o f progressive multiple organ failure. 
In the latter group, two patients died within 7 days and the remaining four 
patients within 28 days after the intervention. The mortality was high, but in
Table 1: Demographic and clinical characteristics
82 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
N o v e l  v a s o p r e s s o r s
keeping with the mean calculated predicted mortality rate (61%) and reflects the 
severity o f illness in this selected group o f patients. The median stay at the ICU 
was 17 days [8-28] and the three survivors stayed 64 days [56-122] in the hospital. 
Pathogenic organisms isolated by culture included Escherichia coli (n=2), 
Pseudomonas aeruginosa (n=3), Klebsiella pneumoniae (n=i), Enterobacter 
aerogenes (n=i). All patients received adequate and timely antibiotic treatment 
(data not shown). In 3 patients no positive cultures were obtained. Etiologies for 
infection included respiratory tract infection (n=2), abdominal sepsis following 
abdominal surgery (n=5), skin and soft tissue infection (n=2), and urosepsis (n=i).
Global hemodynamic measurements
All patients were adequately fluid resuscitated. In 4 patients, SVV could not be 
used to predict fluid responsiveness due to atrial fibrillation (n=3) or spontaneous 
breathing mode (pressure support ventilation, n=i)25. These 4 patients were 
volume challenged until no further increase in thermodilution cardiac output was 
noticed before commencement o f the MB infusion. In the other 6 patients, 
median SVV [IQR] before MB infusion was 10.0%  [6.3-10.8], indicating that 
further fluid administration would not result in an increase in stroke volume26. 
The effects o f MB infusion on hemodynamic variables are shown in Figure 1. The 
median MAP [IQR] increased from 70 [69-71] mmHg at baseline to 77 [67-83] 
mmHg after 1 hour (p=.04). The other time points were not significantly different 
from baseline. The median norepinephrine infusion rate did not change from 
baseline during MB infusion. In 2 patients, the norepinephrine infusion rate 
could be decreased (by 67% and 25%, respectively) because MAP was >80 mmHg 
(as per protocol). The norepinephrine infusion rate was not changed in the other 
8 patients.
The median cardiac index showed a decrease from 4.4 [3.2-5^] l/min/m2 at 
the start o f MB infusion, to 3.6 ^.3-4.7] l/min/m2 after 2 h o f infusion and 3.9 
[2.5-4.8] l/min/m 2 after 4 h, returning back to baseline values 4.7 [2-0.6] 
l/min/m2 after MB infusion was stopped (p=.02). Values for EVLWI were < 10 
ml/kg and were not affected by MB infusion (p=.28), see Figure iD. Lactate levels 
were elevated (4.0±3.6 mmol/l) and remained unchanged throughout the study 
period (p=.75).
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MB infusion
Figure 1
Box plots of median arterial pressure 
(A), norepinephrine infusion rate (B), 
cardiac index (C) and extravascular 
lung water index (D) before, during 
and after MB infusion.
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A MB infusion
Figure 2
Box plots of median 
P(g-a)CO2 gap in septic 
shock in all patients (A) 
and in patients with 
normal and elevated 
baseline P(g-a)CO2 gap 
(B) before, during and 
after 4 hours of MB 
infusion.
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Gastrointestinal variables
For the total group o f patients, the P(g-a)CO2 gap did not change significantly 
during or after MB infusion (p=.i6, Figure 2). The median P(g-a)CO2 gap at 
baseline and following MB infusion in patients with a normal baseline P(g-a)CO2 
gap (< 20 mmHg) and in patients with an elevated baseline P(g-a)CO2 gap (>20 
mmHg) is also shown in Figure 2 (post-hoc analysis). In 4 patients with an 
elevated baseline P(g-a)CO2 gradient, the median P(g-a)CO2 gradient decreased 
from 45 [41-56] mmHg before infusion to 41 [28-52] at the end of the 4 h infusion, 
and decreased further to 32 [26-36] mmHg 2 h after infusion (p=.oi2). No 
significant change was found in 6 patients with a normal baseline P(g-a)CO2 
gradient prior to the MB infusion (p=.57). No significant correlation was found 
between the P(g-a)CO2 gradient and infused dose o f norepinephrine (r=o.i8, 
p=.65).
Compared to healthy volunteers, the median urinary iFABP concentration at 
baseline was significantly elevated in all patients (84ipg/ml, [525-2860]),
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indicating important mucosal cellular damage. Corrected for urine creatinine 
concentrations the median iFABP levels tended to decrease from 210 [79-437] 
pg/pmol creatinine at baseline to 116 [53-601] pg/pmol creatinine after 24 hours 
(p=o.i5). No significant correlation was found between the P(g-a)CO2 gradient 
and the iFABP levels (r=o.i4, p=o.65).
Side effects
There were no signs o f hyperbilirubinemia or methemoglobinemia. The mean 
methemoglobin level was 0.7 ± 0.2% at baseline, 0.7 ± 0.2% after 3 hrs, and 0.9 
± 0.1% after 6 hours. The hematocrit and levels o f hemoglobin did not change 
after MB administration (data not shown). In addition, no significant deterioration 
in measures o f oxygenation was found (data not shown). All MB-treated patients 
showed blue colouring o f both urine and skin. No other side effects were 
observed.
Discussion
In the present study we examined the effects o f methylene blue (MB) infusion in 
septic shock patients with advanced multi-organ failure on different measures of 
gastrointestinal perfusion and damage. Our results indicate that MB 
administration in septic shock patients may preserve gastro-intestinal perfusion 
and integrity. MB infusion at used dosages has no significant deleterious effects 
on the gastric mucosal metabolism perfusion rate as assessed by gastric 
tonometry despite a decrease in CI associated with MB-infusion. In the small 
subgroup o f patients with an abnormal P(g-a)CO2 gap (>20mmHg) at baseline, 
MB infusion resulted in a significant decrease in P(g-a)CO2. Due to the small 
number o f patients and the well-known limitations o f post-hoc subgroup analyses, 
one should interpret these results with caution.
The urinary excretion o f iFABP was highly elevated in all patients during this 
study, indicating significant mucosal cellular damage. A decreasing trend was 
shown after MB infusion, suggesting absence o f further harm or possibly a 
protective effect o f MB on enterocyte injury. These results should be interpreted 
with caution. The fall in corrected iFABP levels was not statistically significant. 
Other factors may have influenced the corrected iFABP levels such as: ongoing 
renal failure, which potentially could overestimate creatinine excretion; changes
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caused by sepsis resuscitation unrelated to MB. In addition, the high baseline 
levels o f iFABP in our study population may influence the ability to detect small 
changes induced by the treatment.
MB infusion decreased the CI in our patient population and transiently increased 
the MAP. This finding o f increased MAP and SVR has been reported in all studies 
of MB in sepsis8, 27.
The effects o f different vasopressors on gastrointestinal perfusion and 
mucosal cellular injury in septic shock is not straightforward and depends on the 
type o f vasopressor used and the clinical situation o f the patient n. We have 
previously shown in a comparable group o f septic shock patients, that vasopressin 
infusion in patients treated with high dose norepinephrine resulted in a decrease 
in gastrointestinal perfusion, reflected by a significant increase in gastric-arterial 
pCO2 gap 23. Differences between various vasoconstrictive agents is further 
illustrated by the observation o f LeDoux and co-workers, who showed that 
incremental doses o f norepinephrine markedly increased MAP from 65 to 85 
mmHg however, did not cause a significant change in gastrointestinal perfusion 
28. The influence of several other vasoactive therapies on gastrointestinal perfusion 
in septic shock has been described in a recent review article29. Adrenergic agents 
that increase blood pressure have variable effects on gastrointestinal perfusion. 
Our results suggest that, compared to other vasoactive drugs used in septic 
patients, MB may relatively preserve splanchnic mucosal perfusion.
An important mechanism that is potentially responsible for the effects o f MB 
infusion is selective inhibition o f production o f NO and cGMP by MB. Induction 
of the NO system induced by inflammation can be regarded as one o f the key 
mechanisms responsible for the mucosal microcirculatory defects observed n' 12. 
Animal studies have shown that NO acts as a final common pathway of mediators 
and neural pathways in the gastrointestinal tract and also is a major inhibitory 
component o f gastrointestinal function30. We have recently shown that MB 
infusion is associated with a decrease in NO production and an attenuation o f 
the urinary excretion o f renal tubular injury markers, indicating protection of 
renal function24. MB also reduced NO overproduction in the lungs in an animal 
sepsis model, which resulted in the attenuation o f lung injury31. These results 
suggest that excessive concentrations o f NO and free radicals may play a role in 
the development o f lung and other organ injury. In our study however, no 
significant change in extravascular lung water was found during and after 
infusion o f MB. This is consistent with the results o f another study, where MB
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administration in septic patients did not change pulmonary vascular permeability 
as assessed by extravascular lung water32.
MB administration at used dosage was found to be safe in the present study. 
This is consistent with previous studies and experience27. One case series reported 
the development o f self-limiting postoperative encephalopathy in patients who 
received preoperative MB infusion for localization o f parathyroid adenomas. The 
common factor in all five cases was female gender and preoperative use of 
serotonin-metabolism modifying agents33. MB should not be used in patients 
with documented hypersensitivity to MB, and used cautiously in patients with 
glucose-6-phosphate dehydrogenase deficiency because o f the risk o f developing 
Heinz body anemia. Intensive care practitioners should also be aware o f the fact 
that MB interferes with pulse oxymetry, resulting in falsely depressed oxygen 
saturation readings34.
There are several limitations to this “proof o f concept study” . Tonometry has 
known limitations and only provides information o f the site o f measurement. 
However, automated air tonometry has been well validated as a reproducible 
measure o f mucosal metabolism perfusion ratio 11. Because o f large inter­
individual differences, we conducted a before-during-after design, as a large 
randomized placebo-controlled set-up was not feasible. In addition, the sample 
size is relatively small. It was however adequately powered to detect clinically 
significant changes in P(g-a)CO2 gap over time as the patients served as their own 
controls. Furthermore, having used the same design in a previous study where 
we administered vasopressin to septic shock patients, we found that vasopressin 
resulted in an increase o f P(g-a)CO2 gap in all studied patients, independent of 
the baseline P(g-a)CO2 gap23, illustrating the high sensitivity to detect putative 
deleterious effects o f a vasoactive compound on gastric mucosal perfusion 
metabolism ratio. The patients included in the current study were severely ill, 
suffered from advanced multiorgan failure and needed high doses of 
norepinephrine, which makes generalization o f the results to other patients with 
less severe septic shock difficult. Finally, we only studied the short-term effects 
o f MB infusion in septic shock patients. Whether the effects would be different 
during ongoing infusion o f MB remains unknown. Future studies should 
investigate the effects o f MB in early septic shock, before the occurrence of 
significant organ failure and address the question whether MB infusion may 
prevent or ameliorate progression to organ failure by preserving gut perfusion. 
From a pathophysiological point o f view, early administration o f MB in
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hyperdynamic septic shock would be expected to be more efficacious than late in 
the course o f the disease process35. In addition, a large-scale randomized 
controlled study is necessary to test the effects o f MB infusion on clinically 
relevant endpoints such as organ failure and mortality.
In conclusion, although MB infusion in patients with severe septic shock and 
advanced multi-organ failure increases MAP and decreases CI, this does not result 
in significant changes in gastric mucosal perfusion metabolism ratio and release 
o f a mucosal cellular injury marker.
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Abstract
Objective: We previously demonstrated that up-regulation of renal inducible nitric 
oxide synthase (iNOS) is associated with proximal tubule injury during systemic 
inflammation in humans. In this study, we investigated the short-term effect of 
methylene blue, an inhibitor o f the NO pathway, on kidney damage and function 
in septic shock patients.
Design and setting: A prospective clinical study, conducted in an intensive care 
unit.
Patients: Nine patients (4M/5F, mean age 71 ± 3 yrs) with a proven or suspected 
bacterial infection and with refractory septic shock defined as a mean arterial 
pressure <70 mmHg despite norepinephrine infusion >0.2 pg/kg/min. 
Intervention: A 4 hours continuous i.v. infusion o f 1 mg/kg/h methylene blue. 
Measurements and Results: The urinary excretion o f NO metabolites decreased 
with (median [25-75% range]) 90%  [75-95] from baseline to 6 hours after 
methylene blue administration (P<0.05). The first 24 hours, the creatinine 
clearance improved with 51% [18-173] after methylene blue treatment (P<0.05), 
but was still strongly impaired. During the first 6 hours after start o f methylene 
blue treatment, both the urinary excretion o f cytosolic glutathione S-transferaseAi- 
1 and P1-1, markers for proximal and distal tubule damage respectively, decreased 
with 45% [10-70, P<0.05] and 70% [40-85, P<0.05] compared to baseline. After 
termination o f the methylene blue infusion, the NO metabolites and markers of 
tubular injury returned to pre-treatment levels.
Conclusion: In septic patients with refractory shock, short-term infusion of 
methylene blue is associated with a decrease in NO production and an attenuation 
o f the urinary excretion o f renal tubular injury markers.
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Introduction
Refractory septic shock remains the major cause o f death in noncoronary 
intensive care units, especially when accompanied by multiple organ failure, with 
an estimated mortality rate o f 50-60% 1. The incidence o f acute renal failure in 
refractory septic shock is approximately 4 0 -50 % 2.
Nitric oxide (NO) has emerged as an important contributory factor to the 
pathogenesis o f septic shock. We previously demonstrated that induction o f renal 
NO is associated with proximal tubule injury during systemic inflammation in 
hum ans3. NO stimulates soluble guanylate cyclase (sGC) by binding to its heme 
moiety, which generates cyclic guanosine monophosphate (cGMP) 4. In the 
kidney, NO and cGMP production are associated with lipopolysaccharide-induced 
renal proximal tubular cell toxicity5. Selective sGC inhibition during septic shock 
in rats resulted in an attenuation o f renal dysfuntion6, indicating that blocking 
sGC may be a potential therapeutic strategy to treat septic shock-associated renal 
failure.
Methylene blue binds to sGC, blocks cGMP production, and has the ability to 
inhibit NO synthases and to scavenge NO [7;8]. Although several controlled and 
uncontrolled clinical studies showed beneficial effects o f methylene blue on the 
hemodynamic instability during septic shock (reviewed in 9), there are no studies 
on the putative protective renal effects. We examined the short-term effects of 
continuous infusion o f low dose methylene blue (1 mg/kg/h) in patients with 
septic shock on urinary excretion o f the acute kidney injury markers, cytosolic 
glutathione S-transferases (GSTs) present in proximal tubule (GSTA1-1) and distal 
tubule (GSTP1-1)10.
Materials and methods 
Patients
The ethical committee o f the VieCuri Medical Centre Venlo and the Dutch central 
committee on research involving human subjects approved this study, and 
informed consent was obtained from the patients’ legal representatives. Patients 
with a proven or suspected bacterial infection were included when they met the 
criteria for refractory septic shock11, defined as mean arterial pressure (MAP) <70 
mmHg despite adequate fluid therapy and norepinephrine infusion at a rate >0.2
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pg/kg/min, existing for less than 24 hours. Patients were excluded i f  they were 
<18 years, pregnant or lactating, HIV seropositive or had acute ischemia or 
myocardial infarction <6 months prior to the study. Throughout the study, all 
patients received standard conventional therapy, including treatment with low- 
dose hydrocortisone (50 mg/24 hours). During the study period, aminoglycosides, 
drotrecogin alpha, and diuretics were not administered and no radiological 
examinations with potentially nephrotoxic contrast agents were performed. 
Eligible patients received a 4 hour continuous infusion o f 1 mg/kg/hour 
methylene blue (1% w/v), provided by the VieCuri Medical Centre pharmacy. 
Arterial blood and catheterized urine were collected at several time points during 
the first 24 hours. Clinical parameters, the severity o f illness using acute 
physiology and chronic health evaluation II (APACHE II) and sepsis-related organ 
failure assessment (SOFA) were recorded.
Chemical assays
Biochemical parameters were determined by routine clinical chemistry. 
Hemoglobin, methemoglobin and bilirubin were measured to assess possible 
side effects o f methylene blue, such as hemolytic anemia and 
methemoglobinemia 12 13. Total amount o f the stable NO metabolites, nitrate and 
nitrite, measure o f NO radicals production, and the amounts o f GSTA1-1 and 
GSTP1-1 in urine were assayed as described3. The blue colour in urine due to 
methylene blue excretion, did not affect the chemical assays.
Data analysis
Values are given as mean ± SEM or median [25-75% range] depending on their 
distribution. Differences between experimental groups were tested by analysis of 
variances (ANOVA) for repeated measures. A two-sided P-value <0.05 was 
considered significantly different.
Results 
Patients
Nine patients with septic shock were included (Table 4.1.). Seven patients 
ultimately died in the intensive care unit, one of refractory shock (within 12 hours) 
and six patients because of multiple organ failure. In the latter group, two patients
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Table 4.1
Baseline characteristics
Data are expressed as mean ± SEM or as median [25-75% range]. Demographics were 
assessed at inclusion o f the patients and SIRS criteria at the start o f the methylene 
blue treatment (< 24 hours). The high and low temperatures and leukocyte counts 
are gathered to demonstrate that patients included satisfied the SIRS criteria. 
a Patients were ventilated with a F iO 2 o f 54 ±  6 %  by Pressure Control (n=5) or 
Pressure Support (n=4), Ppeak 18 ±  2 cm H 2O , PEEP 14 ±  1 cm H 2O , leading to tidal 
volumes o f 10.8 ±  0.7 m l/kg ideal body weight for females and 10.4 ±  0.5 m l/kg ideal 
body weight for males. M: male, F: female, BMI: body mass index, MAP: mean arterial 
pressure).
died within 7 days and the remaining four patients within 28 days after 
intervention. The mean calculated predicted mortality rate was 61%  and all 
patients had at least three organ failures, reflecting a mean SOFA score o f 11.1 ±
0.9. The median stay at the intensive care unit was 16 days [7-24], the two 
survivors stayed 89 days [52-121] in hospital. Pathogenic organisms isolated by 
culture and site o f infection are illustrated in Table 4.2.
Median C-reactive protein was 178 mg/L [range 118-189], all patients had lactic 
acidemia (2.7 [2.1-3.7] mmol/L) and thrombocytopenia (68 [50-104] * i0 9/L). The 
median MAP increased slightly with 5 mmHg [2-11] from 69 [65-70] at baseline 
to 74 [68-82] mmHg 3 hours after start o f methylene blue (P<0.05), with no
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Table 4.2
Causes of septic shock
Patient number Type of organism Site of infection
Abdomen 
Abdomen 
Lung 
Lung 
Lung 
Abdomen 
Urinary tract 
Skin
Abdomen
1 Escherichia coli
2 Escherichia coli
3 Enterobacter aerogens
4 Klebsiella pneumonia
5 Pseudomonas aeruginosa
6 Escherichia coli
7 Escherichia coli
8 Pseudomonas aeruginosa
9 Escherichia coli
change in norepinephrine infusion rate. Methemoglobinemia or hemolytic 
anemia did not develop after methylene blue (data not shown). All methylene 
blue-treated patients showed blue-colouring o f urine and skin.
Methylene blue attenuates NO formation
The concentration NO metabolites in plasma was elevated in septic shock patients 
compared to healthy volunteers 3, but did not change after methylene blue 
administration (Fig. 4.1.A). In contrast, methylene blue significantly attenuated 
the urinary excretion o f NO metabolites by 90% [75-95%, P<0.05] from baseline 
(233 [112-536] pmol/mmol creatinine) to 6 hours (37 [10-87] pmol/mmol 
creatinine) after the start o f methylene blue (Fig. 4.1.B). At 4 hours, methylene 
blue infusion was stopped, after which the excretion o f urinary NO metabolites 
increased by 135% [65-795%, P<0.05] within 6 to 24 hours after methylene blue 
treatment (Fig. 4.1.B).
Methylene blue attenuates kidney damage
All patients showed impaired renal function with oliguria and mild proteinuria 
(Table 4.3.). One patient suffered from anuria during the first day. Six patients 
required continuous veno-venous hemofiltration renal replacement therapy with 
a flow o f 35 ml/kg (for 8.5 [4-13] days), o f which 3 during the methylene blue 
infusion. The creatinine clearance improved by 51% [18-173%, P<0.05] during the 
first 24 hours after methylene blue, but was still strongly impaired (Table 4.3.).
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Figure 4.1
NO metabolites in plasma and 
urine and the urinary excretion of 
tubular injury markers glutathione- 
S-transferase (GST)Ai-i and P1-1.
NO metabolite levels in plasm a (A, n=9) and 
urine (B, n=8) and levels o f GSTA 1-1 (C, 
proximal tubule, n=8) and G S T P 1-1 (D, distal 
tubule, n=8) were measured in urine at various 
tim e intervals after methylene blue (MB) 
adm inistration in septic shock patients. The 
urinary excretion of N O  metabolites and GSTs 
was corrected for creatinine excretion. Data are 
expressed as median [25-75 %  range] and 
analyzed by A N O V A  with repeated measures 
over the two tim e periods.
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Table 4.3.
Kidney function parameters of septic shock patients (n=8) treated with methylene blue
Data are expressed as median [25-75% range].
* significantly different compared to the baseline, P<0.05).
The urinary excretion o f both GSTA1-1 and GSTP1-1 was elevated in all septic 
shock patients, indicating both proximal and distal renal tubule damage. During 
the first 6 hours o f methylene blue, urinary excretion o f GSTA1-1 and GSTP1-1 
was attenuated by 45% [10-70%] and 70% [40-85%] compared to baseline levels 
(Fig. 4.1.C+D, P<0.05). After ending methylene blue infusion, urinary excretion 
o f GSTA1-1 and GSTP1-1 increased again, although not significantly (Fig. 
4.i.C+D).
Discussion
Several clinical studies in septic shock patients have investigated the effects of 
methylene bue on the heart, vascular wall and lungs9. This is the first report 
demonstrating that methylene blue attenuates kidney damage in human septic 
shock.
To determine the effect o f NO-pathway inhibition on renal damage, we examined 
the urinary excretion o f early tubular injury markers and found that methylene 
blue inhibited the NO-pathway and preserved the integrity o f renal tubules. After 
termination o f methylene blue infusion, these parameters returned to their
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elevated pre-treatment levels. Both plasma concentrations (> 2-fold) and urinary 
NO metabolites levels in our septic shock patients were much higher compared 
to healthy volunteers, as demonstrated earlier 3. Hydrocortisone may have 
inhibited iNOS activation, however, the patients received a continuous infusion 
of hydrocortisone that started before methylene blue infusion and continued 
during the 24 hours period. Therefore, the observation that urinary NO metabolite 
excretion was only attenuated in the first 6 hours after the start o f methylene blue 
suggests that this effect is not related to steroids. Although urinary NO metabolite 
excretion was attenuated, we did not find a reduction in plasma NO metabolites. 
This is in contrast with an earlier report, in which patients received a bolus 
injection o f methylene blue prior to the continuous infusion14.
Renal failure in septic shock patients is a complex and multifactorial disease 
process. During septic shock, the systemic vasodilation increases renal sympathetic 
activity and angiotensin concentration which results in intrarenal vasoconstriction 
with sodium and water retention and decreased glomerular filtration rate2. We 
previously demonstrated that induction o f renal iNOS, constitutively expressed in 
the kidney15, is associated with proximal tubule injury during systemic 
inflammation in humans.3 As a result o f its active secretory transport function and 
role in urine concentration, the proximal tubule is a susceptible target and often 
the first site o f damagel6. Therefore, inhibition o f peroxynitrite formation from 
excessively produced NO and superoxide17 by methylene blue may be beneficial 
for the kidney during septic shock, possibly explained by the local accumulation 
of methylene blue in renal proximal tubules18. Global hemodynamic variables can 
influence renal function, however, only a small but statistically significant increase 
was found for mean arterial pressure, whereas other global hemodynamic 
parameters did not change during methylene blue treatment.
Since the detailed nature o f our investigation, obviously these methods are 
not feasible in a large-scale clinical intervention study. The most elegant way to 
examine the effects o f methylene blue would be in a randomized, placebo­
controlled cross-over study. However, with such critically ill patients this design 
may be considered unethical. We deliberately chose a subgroup o f severe septic 
shock patients with a high chance o f sepsis-induced renal damage for two reasons: 
this is the group o f patients in which methylene blue is used as a ‘last resort 
therapy’, and second, to demonstrate the putative beneficial effects o f methylene 
blue on renal damage. With an estimated standard deviation o f 36% in urinary 
GST excretion, 80 patients would be needed to demonstrate with 80% power a
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10% reduction in renal injury. This number o f patients was not feasible for our 
investigations. Therefore we decided to determine the parameters before, during 
and after methylene blue infusion during a 24 h period, which allows each patient 
to serve as own control.
Because o f the observational nature and limited size o f the present study, and 
the heterogeneity o f the patient population, our findings warrant conformation 
on hard end points by a larger clinical trial. However, in our view, first a long­
term study is necessary to assess the safety o f chronic methylene blue 
administration in septic patients with refractory shock. Promising effects of 
methylene blue were found in a trial with vasoplegic patients after cardiac surgery 
treated with methylene blue 19, in which a reduction in both mortality and 
incidence o f renal failure was observed.
In conclusion, short-term infusion o f methylene blue in septic patients with 
refractory shock, is associated with a decrease in NO production and an 
attenuation o f the urinary excretion o f renal tubular injury markers.
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Abstract
Objectives: Hypertonic fluid resuscitation is thought to exert effects on global and 
regional circulation as well as on cardiac function. We assessed the short-term 
effects o f hypertonic fluid administration on hemodynamic parameters and 
cardiac function in septic shock patients.
Design: Double blind prospective randomized controlled trial.
Setting: Closed-format 15-bed mixed intensive care unit in a tertiary referral 
teaching hospital.
Patients: Patients > 18 yrs who met international criteria for septic shock within 
24 hrs o f ICU admission were eligible for enrollment.
Interventions: Patients were randomized to receive 250ml 7.2% NaCl/6% 
hydroxyethylstarch (HT) or 500ml 6% hydroxyethylstarch (IT). This trial is 
registered with ANZCTR.org.au as ACTRN12607000259448.
Measurements and Main Results: The following measurements were taken before 
and after fluid administration at regular intervals: blood pressure, central venous 
pressure (CVP), doses o f inotropic and vasopressor drugs, cardiac index (CI), 
stroke volume index (SVI), stroke volume variation (SVV), extravascular lung 
water index (EVLWI) and intrathoracic blood volume index (ITBVI). Systolic tissue 
Doppler velocities (TDI) o f the medial mitral annulus were measured using 
echocardiography to assess left ventricular contractility. To quantify the effect on 
vascular tone we did a log transformation o f the ratio mean arterial blood pressure 
divided by the norepinephrine infusion rate (log MAP/NE). Ongoing fluid 
requirements were recorded for 24 hours after the study fluid was administered. 
Compared to the IT group, HT treatment resulted in an improvement in log 
MAP/NA (p=.oo8), systolic TDI velocities (p=.03) and SVI (p=.oi7). No 
differences between the groups were found for preload parameters (CVP, SVV, 
ITBVI) or for afterload parameters (SVRI, MAP). HT treatment decreased the 
need for ongoing fluid resuscitation (2.8±i.5 liter/24 hours versus 4.i±i.6 liter/24 
hours in the IT group, p=.046). Lactate levels tended to be higher in the HT group 
at baseline (p=.09) and this remained so after treatment (p=.04).
Conclusions: Compared to IT fluid administration, HT improved the vascular tone 
and cardiac contractility independent o f changes in preload or afterload. The need 
for ongoing fluid resuscitation was also reduced.
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Introduction
Sepsis is the leading cause o f death in critically ill patients1. Recent definitions 
recognize the importance o f sepsis-induced myocardial depression and include a 
low cardiac index or echocardiographic evidence o f cardiac dysfunction as one of 
the criteria for diagnosis o f severe sepsis2. Although cardiac output is usually 
maintained or elevated in septic shock, intrinsic cardiac dysfunction is 
demonstrable in up to 40% of patents3. The pathophysiology o f sepsis-induced 
myocardial depression has not been fully elucidated but includes effects of 
cytokines and nitric oxide4.
Tissue Doppler imaging is an easy and reproducible quantitative 
measurement o f cardiac systolic and diastolic function. Recently, this technique 
has been shown to be useful as a way o f determining septic cardiac dysfunction, 
and hence providing additional prognostic information in septic patients5.
Fluid resuscitation, in order to restore intravascular volume and to ensure 
adequate tissue perfusion and oxygen delivery, is thought to be o f key importance 
in the treatment o f septic shock patients. Hypertonic fluid resuscitation has been 
successfully applied in the treatment o f various shock states, especially in 
hemorrhagic shock6'8. The macrocirculatory effects o f hypertonic infusion in 
hemorrhagic shock are characterized by rapid plasma volume expansion and a 
decrease in afterload. Experimental evidence also suggests a possible 
improvement o f myocardial contractility 9 10. Data in septic shock patients are 
scarce and currently there are reports regarding the direct effects o f hypertonic 
fluids on cardiac function in septic patients11 12.
In the present study we tested the hypothesis that the infusion o f hypertonic 
fluid in patients with septic shock improves the cardiovascular function.
Materials and Methods 
Patients
The study was performed between June 2007 and December 2008 in a closed- 
format 15-bed mixed intensive care unit (ICU) in a tertiary referral teaching 
hospital (Waikato Hospital, Hamilton, New Zealand). It was designed as a 
prospective, single-centre, randomized, controlled, double-blind clinical trial and 
is registered with ANZCTR.org.au as A CTRN 12607000259448. Consecutive
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adult patients with septic shock were screened for inclusion in the study. Septic 
shock was defined according to standardized criteria2. Inclusion criteria were the 
need for fluid resuscitation guided by stroke volume variation (SVV) or as per 
discretion o f the treating intensivist, and enrollment within 24 hours after ICU 
admission. Exclusion criteria were age <18 years, pregnancy, hyponatraemia as 
defined by a serum sodium level < 130 mmol/l, hypernatraemia as defined by a 
serum sodium level > 150 mmol/l, arrhythmias including atrial fibrillation and 
pacemaker rhythm, and myocardial ischemia or infarction < i month prior to the 
study. Patients fulfilling study criteria were randomized into two groups using 
sequentially numbered, opaque sealed envelopes. The study was approved by the 
Northern Y Regional Ethics Committee (NTY/06/08/070). We obtained written 
informed consent from patients or their surrogate decision makers, consistent 
with applicable laws.
Interventions
All patients had PiCCO catheters in situ as per routine management o f septic 
shock in our unit. The PiCCO plus(software V7.1, Pulsion Medical Systems, 
Munich) was calibrated according to the guidelines o f the manufacturer before 
the first measurement, then again after 1, 4 and 8 hours. After data collection at 
baseline, the treatment group received 250 ml o f 6% hydroxyethylstarch (HES) 
200 in 7.2% sodiumchloride (Hyperhes®, Fresenius Kabi, Germany), the control 
group received 500 ml o f 6% HES 200 in 0.9% sodiumchloride (Starquin®, 
Biomed, New Zealand). The rationale behind the different bolus sizes was that 
hypertonic colloids have been shown to have a sustained intravascular volume 
effect approximately twice that o f isotonic colloids 13. This way we aimed to 
minimize any differences in effect on plasma volume expansion and preload to 
achieve a better understanding o f the effects o f the hypertonic character o f the 
study fluid per se. Vasopressor doses were titrated by the bedside nursing staff to 
achieve a target mean arterial blood pressure (MAP) as defined by the treating 
intensivist as per routine practice. Ongoing fluid resuscitation was also per 
discretion o f the treating intensivist. Arterial blood samples were taken at baseline 
and after every 30 minutes for 4 hours and processed in a point o f care analyzer 
(ABL 800 Flex, Radiometer, Copenhagen) to measure levels o f lactate, sodium 
and chloride in addition to routine blood gases.
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Data collection
Demographic data and severity o f illness using APACHE II (acute physiology and 
chronic health evaluation II) and SOFA (sequential organ failure assessment) 
scores were recorded. Data on hospital mortality were collected after completion 
of the study.
The following hemodynamic variables were recorded every i5 minutes during 
4 hours: arterial blood pressure (systolic, diastolic, and mean), heart rate, cardiac 
index (CI), stroke volume index (SVI), stroke volume variation (SVV), systemic 
vascular resistance index (SVRI), and central venous pressure (CVP). The 
extravascular lung water index (EVLWI) and intrathoracic blood volume index 
(ITBVI) were recorded when the PiCCO was calibrated (t=0, i and 4 hours). The 
urine output was recorded hourly. Fluid responsiveness was defined as an 
increase in CI > i0%  measured 30 minutes after the fluid bolus. We performed 
a log transformation o f the ratio mean arterial blood pressure divided by the 
norepinephrine infusion rate (log MAP/NE). This mathematical technique allows 
us to quantify the effect on vascular tone and correct for the beside adjustments 
o f norepinephrine dose to achieve the target MAP.
The effect o f the intervention on cardiac function was assessed by 
echocardiography. Echocardiography was performed before and i hour after the 
infusion o f study fluid. All echo studies were performed by the same 
echocardiographer who was blinded to the treatment. The effect on diastolic 
function was assessed by measuring mitral valve inflow velocities using pulsed 
wave Doppler (E and A waves) and tissue Doppler imaging (TDI) o f the medial 
mitral valve annulus during diastole. The early diastolic (E') velocity o f the mitral 
annulus was assessed by TDI and the E/E' was calculated. LV diastolic 
dysfunction was defined as a composite o f E'<8cm/sec and/or mean E/ E'>i3. 
This was compared to E/A ratio to confirm presence or absence o f diastolic 
dysfunction. The systolic (Sm) velocity o f the mitral annulus was assessed by 
TDI and used as a measure for cardiac contractility in addition to stroke volume 
index as derived by PiCCO measurements. Doppler velocities measured 5 times 
were averaged.
Statistical Analysis
Data are presented as mean±SD or as median [25th - 75th percentile], depending 
on their distribution. Baseline characteristics were compared with a Student T- 
test or a Mann-Whitney-U test, as appropriate. Two way repeated measures
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ANOVA was used to compare the effect o f the treatments (between-group) and 
treatment-time interaction effects. All statistical analysis was done with NCSS 
2007 (version 07.1.13, NCCS, Kaysville, Utah).
Results
Patient Characteristics
Demographic characteristics are shown in table 1. Patients were randomized to 
receive either a hypertonic fluid bolus (HT, n=i2) or an isotonic fluid bolus (IT, 
n=i2). The patients in the two groups had comparable demographic
Table 1
Patient’s characteristics. (m, male; f, female; IT, isotonic solution; HT, hypertonic solution)
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characteristics and severity o f illness as measured by APACHE II (IT 2 3 ^ 7 .4  vs. 
HT 24.4±6.7, p=.75) and SOFA scores (IT 8.9±2.5 vs. HT 9 ^ 3 .4 ,  p=.5o). The 
hospital mortality rate was 25% (3/12) in the hypertonic group and 30% (4/12) in 
the isotonic group (p=.75).
Hemodynamic results
The hemodynamic results are summarized in Table 2 and Fig 1. The CVP 
increased significantly in both groups to a comparable degree (Fig 1A, p=o.86 
between groups). Measures for preload ITBVI and SVV were not significantly 
affected by the treatment (data not shown). Only 4/12 patients in the HT group 
and 3/12 o f patients in the IT group were found to be fluid responsive as defined 
by an increase in CI > 10% after 30 minutes. The norepinephrine infusion rate 
at baseline was nonsignificantly higher in the HT group compared to the IT group 
(15 [10.5-31.5] versus 8 [5.6-15] pg/min, p=o.i3). Compared to IT treatment, HT 
treatment resulted in a decrease in norepinephrine requirement (p=0.04) and an 
improvement in vascular hyporeactivity as defined by log MAP/NE (p=.008 
between groups, Fig iB).
The urine output showed an increasing trend in the HT group and a 
decreasing trend in the IT group that did not reach statistical significance between
Table 2
Time course of hemodynamic parameters.
Data are shown as m ean±SD or median [IQR]. HT, hypertonic solution; IT, isotonic solution; MAP, mean arterial pressure; 
NE, norepinephrine infusion rate; CVP, central venous pressure; CI, cardiac index; HR, heart rate; SVV, stroke volume 
variation.
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Figure 1
Changes in cardiovascular 
variables over time before and 
following isotonic fluid 
(dashed lines, crosses) and 
hypertonic fluid administration 
(solid line, open circles).
iA : CVP, central venous pressure, 
p=0.86 between groups; 
iB : log (M A P/N E), logarithmic 
transfomation o f mean arterial blood 
pressure divided by norepinephrine 
infusion rate, p=0.008 between groups; 
1C: SVI, stroke volume index, p =0.0i7 
between groups
time (min)
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Figure 2
Systolic tissue doppler velocity (Sm) 
of the medial mitral valve annulus 
before and 1 hour after isotonic fluid 
administration (dashed line, crosses) 
and hypertonic fluid administration 
(solid line, open circles), p=0.03 
between groups.
20
10 0 60 
Time (min)
the groups (p=o.i9). The HT group required less fluid resuscitation in the 24 
hours following the administration o f study fluid than the IT group (HT 2.8±i.5 
liter/24 hours versus IT 4.i± i.6  liter/24 hours, p=0.046). The EVLWI did not 
change over time and was not different between groups (data not shown).
Cardiac effects
In the HT group the systolic velocity o f the mitral annulus increased from i6±4 
cm/s to i8±5 cm/s as compared to a decrease from i5±6 cm/s to i3±4 cm/s in 
the IT group (p=.03 between groups, Fig 2). The number o f patients with diastolic 
dysfunction at baseline was 4/i2 in the HT group and 6/i2 in the IT group 
(p=.4i). Following the fluid bolus these numbers were 3/i2 in the HT group and 
8/i2 in the IT group (p=.04). All diastolic dysfunction was classified as mild (grade
i, impaired relaxation) with reversal o f E/A ratio.
There was an instant increase in SVI in the HT group (from 42±i3 ml/m2 at 
baseline to 49±i6 ml/m2 after 30 minutes, p=.ooi2) that lasted for 2 hours. No 
change in SVI was observed in the IT group (p=o.oi7 between groups, Fig iC). 
Because the change in SVI was accompanied by a decrease in heart rate in the 
HT group (p=.ooi4 between groups, Table 2), the cardiac index was not affected 
significantly over time and by the treatment (p=o.38 between groups, Table 2).
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Table 3
Metabolic variables over time in isotonic group (IT) and hypertonic group (HT).
Data reported as m ean±SD. Hb, haemoglobin; PaO2, arterial oxygen tension; P /F  ratio, ratio arterial oxygen 
tension/inspired oxygen fraction; Bic, arterial bicarbonate level.
Metabolic and respiratory variables
The course o f metabolic and respiratory variables is shown in Table 3. The lactate 
levels tended to be higher in the hypertonic group at baseline (p=.09) and this 
remained so after treatment (p=.04). The plasma sodium levels and the plasma 
chloride levels increased significantly in the HT group, but not in the IT group. 
This did not result in a significant change in the acid base status.
The P/F ratio decreased over time (Table 3, p=o.oo6) without being affected 
by the treatment group (difference between groups: p=o.i2).
Side effects
Both treatments were well tolerated in all patients. No neurologic dysfunction, 
arrhythmias, coagulation abnormalities or any other adverse effects were noted.
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Discussion
We conducted a study comparing the effects o f hypertonic and isotonic fluid 
administration in critically ill patients with septic shock within 24 hours of 
intensive care admission. We aimed to induce a comparable change in preload 
parameters by the two treatments and found a number o f significant differences 
between the groups after the intervention.
Hypertonic fluid increased cardiac contractility as assessed by systolic tissue 
Doppler velocities, and decreased the proportion o f patients with diastolic 
dysfunction. The improvement in cardiac contractility was confirmed by the 
observation that stroke volume index increased in the hypertonic group but not 
in the isotonic group. Importantly, the positive inotropic effect on the heart was 
not caused by a difference in preload or filling pressure as both treatments had 
similar effects on plasma volume expansion and preload as assessed by SVV, 
ITBVI and CVP. We specifically designed this study to eliminate differences in 
preload between the groups as caused by the fluid bolus by administering twice 
as much isotonic HES as hypertonic HES. Hypertonic fluids have been shown 
to increase intravascular volume more than isotonic fluids when given in the 
same quantity by mobilizing fluid from the intracellular compartmenti4, i5. In 
previous studies where this issue was not addressed, most o f the effects found 
on cardiac function were influenced by changes in preload and/or afterloadi6, i7. 
No changes in inotropic drugs were made during the study period. The effects 
on cardiac contractility were also not caused by significant changes in afterload 
as measured by SVRI or MAP, as in both groups the MAP was kept constant by 
titrating norepinephrine infusion rate to a prescribed target MAP. Cardiac 
contractility improved in the HT group despite a reduction in the norepinephrine 
dose in that group.
This positive effect o f hypertonic fluid on contractility in sepsis-induced 
myocardial depression has been described before in animal and human 
studies 6 i0 i8. Direct effects on myocardial cells could include a direct 
hyperosmolar effect that decreases myocardial edema and restores 
transmembrane potentialsI0, i8"20. Recently, a central mechanism involving cerebral 
periventricular sodium concentration and mediated by cerebral angiotensin II 
type i receptors has also been shown to contribute to the hemodynamic changes 
found after hypertonic fluid administration2i 22. Hypertonic fluid has not been 
shown to increase contractility in the absence o f sepsis or a systemic inflammatory
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statei6, 23, 24. We excluded patients with known and recently symptomatic coronary 
artery disease, because hypertonic fluids can potentially worsen coronary artery 
flow and cardiac contractility distal to coronary artery occlusion25, 26.
In addition to the cardiac effects, the norepinephrine dose could be reduced 
in the hypertonic group while maintaining predefined MAP targets, while in the 
isotonic group the norepinephrine dose did not change. Again, this was not 
caused by differences in plasma volume expansion as discussed before. This 
finding is consistent with other studies. In a randomized controlled study in 50 
children undergoing open-heart surgery, the hypertonic solution resulted in a 
decreased need for catecholamine support27. The mechanism by which hypertonic 
fluid might reduce norepinephrine requirement is unclear, but may include 
effects on transmembrane potentials, altered sensitivity to vasopressor drugs and 
immunomodulatory effects.
The hemodynamic effects o f hypertonic resuscitation are possibly dose 
dependent. For example, no hemodynamic changes were found after a small dose 
o f hypertonic saline (5 ml/kg 3.5% sodium chloride) in patients with severe sepsis 
compared to normal saline28. However, also no changes in sodium levels were 
found in this study raising the possibility that the dose used was insufficient to 
cause hemodynamic changes.
Finally, hypertonic fluid administration significantly decreased the need for 
ongoing fluid resuscitation in the 24 hours following administration. Because all 
the significant differences found in the measured hemodynamic parameters 
lasted less than 8 hours, this would suggest a different mechanism. Explanations 
could include a reduction in the severity o f capillary leak syndrome 27; an 
improvement in splanchnic perfusion resulting in an improved gut barrier and 
reduced inflammatory activity 29; immunomodulatory effects as have been 
previously describedii. In a recent clinical study, equivalent fluid balances were 
found between the group receiving hypertonic/dextran solution and the control 
group receiving normal salinei7. This study was different from ours in many 
aspects. Different study fluids were used and our patients were more severely ill 
indicated by higher APACHE II scores. All our patients were per definition on 
vasopressor support, compared to approximately half o f the patients in Oliveira’s 
study, suggesting a more severe inflammatory syndrome with a more profound 
vasodilatory shock in our patients.
In our study and numerous other studies, hypertonic fluid administration in 
shock states has been shown to be safe. We found a transient increase in plasma
1 2 2 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
H y p e r t o n i c  f l u i d  r e s u s c i t a t i o n
sodium and chloride levels without evidence o f harm and without a significant 
effect on the acid-base equilibrium. This is consistent with previous reportsi7, 30 3i. 
Our study has several limitations. We studied physiological end points in a “proof- 
of-concept” design in a relatively small number o f patients. The study was not 
designed nor powered to investigate important clinical endpoints such as organ 
failure and mortality. Future studies should look at timing, dose-response, and 
the effects o f repeated or continuous administration o f hypertonic fluids in septic 
patients. Ideally this should be followed by a large PRCT testing the hypothesis 
that early hypertonic fluid resuscitation improves outcome in sepsis.
In summary, our results demonstrate that in septic shock patients, hypertonic 
fluid can be safely administered and results in improved cardiac and 
hemodynamic function independent o f and in addition to the effects on plasma 
volume expansion.
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Abstract
Objective: Sustained abnormalities in the sublingual and intestinal mucosal 
microcirculation are associated with morbidity and mortality in septic patients. 
Hypertonic fluids improve microcirculatory blood flow in other shock states. We 
tested whether hypertonic versus isotonic fluid administration exerts different 
effects on the gastric mucosal metabolism perfusion ratio, as assessed by tonometry, 
and on the sublingual microcirculation, as assessed by Sidestream Dark Field (SDF) 
imaging, in fluid responsive and non-responsive septic shock patients.
Design: Prospective randomized placebo-controlled double blind clinical trial. 
Setting: Closed-format 15-bed mixed intensive care unit in a tertiary teaching 
hospital.
Patients: Adult patients fulfilling criteria for septic shock within 24 hours o f ICU. 
admission.
Interventions: Patients were randomly assigned to receive 250ml 7.2% NaCl /6% 
hydroxyethylstarch (HT group, n=i2) or 500ml 6% hydroxyethylstarch (IT group, 
n=i2) over 15 minutes.
Measurements and Main results: Primary outcome was P[g-a]CO2 gap as measured 
by gastric tonometry at baseline and every 30 min during 4 hours; and sublingual 
microcirculatory flow of small vessels as assessed by SDF imaging before and 1 
hour after fluid administration. Fluid responsiveness was defined as an increase in 
cardiac index >10% after fluid administration. The median [IQR] P[g-a]CO2 gap at 
baseline was elevated both in the HT group (21 [13-24] mmHg) and in the IT group 
(26 [20-51] mmHg, p=.i7), indicating gastrointestinal hypoperfusion. The median 
[IQR] microvascular flow index was decreased in both groups (HT 2.25 [1.83-2.67], 
IT 2.39 [1.39-2.53], p=.93). Following fluid administration, no differences were 
observed in the course o f the P[g-a]CO2 gap or in any o f the sublingual 
microvascular variables between the HT and the IT group. No difference was 
observed in the course o f the P[g-a]CO2 gap between fluid responders and non­
responders. The sublingual microcirculatory flow index significantly improved in 
fluid responders from 2.32 [1.63-2.79] at baseline to 2.90 [2.43-2.98], while no 
change was observed in non-responders (from 2.30 [1.25-2.63], to 2.38 [1.33-2.55], 
p=0.04), independent of the type o f fluid administered.
Conclusions: In fluid responsive patients, fluid administration promotes sublingual 
microcirculatory blood flow, independent o f fluid type. In septic shock patients, 
hypertonic fluid administration does not promote gastrointestinal mucosal 
perfusion or sublingual microcirculatory blood flow in comparison to isotonic fluid.
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Introduction
Adequate fluid resuscitation is an important element in the treatment o f septic 
shock patients1. Traditionally, fluid resuscitation is guided by global 
hemodynamic parameters such as blood pressure, cardiac output and oxygen- 
derived variables. Microcirculatory abnormalities in septic patients have been 
well recognized, classified and quantified over recent years2'4. Mucosal 
microcirculatory abnormalities in the gastrointestinal tract are reflected by an 
increased P[g-a]CO2 gap that can be detected by gastric tonometry5. Persisting 
sublingual as well as gastrointestinal microcirculatory alterations are associated 
with organ failure and mortality in septic shock, irrespective of normalization of 
systemic parameters6'8. Recent studies suggest that the effects o f isotonic fluid 
resuscitation result in an improved sublingual microcirculatory blood flow, both 
in non-septic and septic patients 9 10, whereas treatment strategies aimed to 
improve gastrointestinal hypoperfusion, including fluid resuscitation, have failed 
to correct mucosal perfusion abnormalities5.
Hypertonic fluid resuscitation has been studied extensively in experimental 
and human traumatic hemorrhagic shock. Compared to isotonic fluids, 
hypertonic fluids have been shown to cause hemodilution and to reduce shock- 
induced endothelial and red blood cells edema, increasing blood flow at the 
capillary level by reducing viscosity and hydraulic resistance to a greater extent11. 
In addition to immediate blood volume expansion and restoration o f cardiac 
output in animal models o f hemorrhagic shock, hypertonic fluid administration 
has been shown to correct microcirculatory alterations as assessed by intravital 
microscopy n' 12. Data concerning the effects o f hypertonic fluids in septic patients 
are scarce. Although several previous studies in patients with sepsis have shown 
transient improvements o f global perfusion13, 14, its effect on microcirculatory 
abnormalities is currently unknown.
We evaluated the effects o f hypertonic versus isotonic fluid administration on 
gastric mucosal perfusion and sublingual microcirculation in septic shock 
patients. We hypothesized that hypertonic fluid would improve both gastric 
mucosal perfusion and sublingual microcirculation, compared to isotonic fluid.
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Materials and Methods 
Patients
The study was designed as a prospective, randomized, controlled, double blind 
clinical trial and is registered with ANZCTR.org.au as ACTRN12607000259448. 
The study was approved by the Northern Y Regional Ethics Committee 
(NTY/06/08/070). We obtained written informed consent from patients or their 
surrogate decision makers. The study protocol and the systemic cardiovascular 
effects o f hypertonic versus isotonic fluid administration in the same group of 
patients will be described separately. Briefly, consecutive patients who fulfilled 
standard criteria for septic shock15 within 24 hours o f ICU admission were 
randomized to receive hypertonic fluid (HT group) or isotonic fluid (IT group).
Interventions
A gastric tonometry catheter (TonometricsTM-catheter, TONO-i6F) was inserted 
in the stomach. Calibration o f the tonometry module was performed according 
to the guidelines o f the manufacturer (Datex-Ohmeda Division, Helsinki, 
Finland). Enteral feeding was discontinued, and omeprazole (40 mg iv) 
administered 1 hour before the first tonometry measurements to decrease 
interindividual variability16.
Following collection o f baseline data, the HT group received 250 ml o f 6% 
hydroxyethylstarch 200/7.2%  sodiumchloride (H yperhes®, Fresenius Kabi, 
Germany) and the IT group received 500 ml 6% hydroxyethylstarch 200/0.9% 
sodiumchloride (Starquin®, Biomed, New Zealand), infused over 15 minutes. 
Because hypertonic fluids have been shown to increase plasma volume to a 
greater extent than isotonic fluids, we aimed to minimize this difference by 
administering twice the amount o f isotonic fluid compared to hypertonic fluid. 
Differences or treatment effects observed would therefore more likely be the result 
o f hypertonicity than caused by a difference in plasma volume expansion.
Measurements 
Gastric tonometry
The partial pressure o f CO2 in the stomach was measured by automated air 
tonometry using an equilibration time o f 10 minutes. PaCO2 was measured
1 3 2 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
H y p e r t o n i c  f l u i d  r e s u s c i t a t i o n
simultaneously with a point-of-care blood gas analyzer (ABL 800 Flex, 
Radiometer, Copenhagen), and the difference between gastric and partial CO2 
pressure (P[g-a]CO2 gap) was calculated every 30 minutes during 4 hours.
Sublingual microcirculation
The microcirculation was studied with Sidestream Dark Field (SDF) imaging 
using the M icroscan® (Microvision Medical, Amsterdam, the Netherlands). SDF 
imaging is a stroboscopic light emitting diode ring-based imaging modality that 
is incorporated in a handheld device17. The device illuminates an area o f interest 
for clinical observation o f the microcirculation. I f  a wavelength within the 
hemoglobin absorption spectrum (e.g., 530 nm) is chosen, red blood cells will 
appear dark and white blood cells may be visible as refringent bodies. The vessel 
walls are not visualized directly and imaging therefore depends on the presence 
of red blood cells. After the removal o f saliva and other secretions, the device was 
applied on the lateral side o f the tongue. Five sequences o f 10 seconds each from 
different areas were recorded by a research investigator who was blinded to the 
treatment and stored in AVI-format on a Macintosh Powerbook (Apple computers, 
California). The SDF movies were recorded at baseline and 1 hour after the 
administration o f study fluid. The video clips were blindly analysed offline by 
another investigator who had no involvement with the data collection. The images 
were presented in a random order to prevent inter-image coupling.
Semiquantitative analysis was performed as described in detail elsewhere4. 
SDF images were divided into four equal quadrants. Quantification o f flow (no 
flow: 0, intermittent flow: 1, sluggish flow: 2, and continuous flow: 3) was scored 
per quadrant for each vessel diameter cohort (small: 10 -25 pm, medium 26 ­
50pm, and large 51-100  pm). The microvascular flow index (MFI) was calculated 
as the sum of each quadrant score divided by the number o f quadrants in which 
the vessel type was visible. The final MFI was averaged over a maximum of 12 
quadrants (three regions, four quadrants per region) derived from the overall flow 
impressions o f all vessels with a particular range o f diameter in a given quadrant. 
The heterogeneity index was calculated, following the method o f Trzeciak and 
colleagues7, as the difference between the highest and lowest MFI, divided by the 
mean MFI of all sublingual sites at a single time point. Calculation o f total (small) 
vessel density was performed with the AVA 3.0 software package (MicroVision 
Medical, Amsterdam, The Netherlands), as described and validated recently18 
using a cut-off diameter for small vessels o f <20 pm. After stabilization o f the
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images using the AVA 3.0 software, we defined the perfused (small) vessel density 
and the proportion o f perfused (small) vessels (PPVs) in terms of the number and 
percentage o f crossings with perfused (small) vessels per total length o f three 
equidistant horizontal and three equidistant vertical lines19.
Statistical analysis
We anticipated a mean P[g-a]CO2 gap o f i0m m H g at baseline with a standard 
deviation (SD) o f 9 mmHg, based on an earlier study20. We calculated a sample 
size o f 24 patients to detect an absolute difference in P[g-a]CO2 gap o f i2mmHg 
in a two-sided test with an alpha level o f 0.05 and power >80%. The Statistical 
Package for Social Sciences (SPSS i5.i for Windows, Chicago IL) and the NCSS 
2007 (version 07.i.i3, Kaysville, Utah) were used for statistical analysis. Data are 
presented as mean ± SD or median [interquartile range, IQR] depending on the 
distribution. The effects on nonnormally distributed parameters were compared 
using the Mann-Whitney test and the Wilcoxon signed rank test for paired 
measurements. Two way repeated measures ANOVA was used to compare the 
effect o f the treatment on the (P[g-a]CO2 gap) by examining the interaction 
between treatment group and time. We considered a p value o f < 0.05 to be 
statistically significant.
Results 
Patient characteristics
Baseline characteristics o f the 2 groups o f patients are presented in Table i. Overall 
the baseline characteristics were well balanced between the groups, although the 
norepinephrine dose, SOFA score and plasma lactate level in the HT group 
tended to be higher (all p-values NS). A total o f 8 patients, 4 in each treatment 
group, were found to be fluid responsive, defined as an increase in cardiac index 
>i0%  measured 30 minutes after the fluid administration as compared to 
baseline. The hospital mortality rate was 25% (3/i2) in the HT group and 30% 
(4/i2) in the IT group (p=NS). More detailed cardiovascular and metabolic data 
from this study will be described in a separate paper. Briefly, following fluid 
administration, no differences were observed between the treatment groups with 
regards to preload variables (central venous pressure, stroke volume variation, 
intrathoracic blood volume index), mean arterial blood pressure or cardiac index.
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Table 1
Baseline characteristics.
A PA CH E, Acute Physiology and Chronic Health Evaluation; SO FA , Sequential Organ Failure Assessment. 
Data are presented as mean ± SD , as numbers (% ) or as median [interquartile range].
Tonometry
The median [IQR] P[g-a]CO2 gap at baseline was 26 [20-5i] mmHg in the IT group 
and 2i [i3-24] mmHg in the HT group (p=.i7), indicating gastrointestinal 
hypoperfusion. The time course o f P[g-a]CO2 gap in the two groups is shown in 
Figure i. The P[g-a]CO2 gap did not change significantly over time (p=.39) and 
there was no significant difference between the treatment groups (p=.3i).
Patients who were found to be fluid responsive had similar baseline P[g-a]CO2 
gap compared to patients who were not responsive to fluid (23 [9-34] mmHg 
versus 22 ^7-54], p=.54). The change in P[g-a]CO2 gap over time was not different 
between fluid responsive and fluid unresponsive patients (p=.64).
Sublingual microcirculation
The microvascular variables measured before and one hour after the fluid bolus 
are summarized in Table 2. At baseline, all variables were similar between the 
two treatment groups. The median [IQR] microvascular flow index was decreased 
in both groups (HT 2.25 ^.83-2.67], IT 2.39 ^.39-2.53], p=.93). Following the fluid 
bolus, no significant changes were found in any o f the microcirculatory 
measurements in either group compared to baseline or between the groups. In 
fluid responsive patients, small vessel MFI increased from 2.32 ^.63-2.79] at 
baseline to 2.90 [2.43-2.98], while no change was observed in non-responders 
(from 2.30 [i.25-2.63], to 2.38 [^33-2.55]), p=.04 between groups (Fig 2).
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Figure 1
Box plot demonstrating 
the time course of 
P[g-a]CO2 gap.
Dots represent outliers.
Black boxes IT group, 
gray boxes H T  group.
Tim e (min)
Figure 2
Box plot of microvascular 
flow index (MFI) in small 
vessels (<20 ^m) before 
and after fluid 
administration.
Black boxes fluid responsive 
patients, gray boxes fluid 
non-responders.
Time (min)
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Table 2
Microvascular variables.
MFI, microcirculatory blood flow index; TV D , total vessel density o f (small) vessels; PPV, proportion o f perfused (small) 
vessels; PVD, perfused (small) vessel density; p before, p value for difference in baseline measurements using Mann­
Whitney U test; p treatment, p value for difference caused by treatment using Sign test. Cut-off for small vessels <20pm . All 
data are presented as median [interquartile range].
Variables Group Before After p before p treatment
MFI small vessels IT 2.39 [1.39-2.53] 2.4 [2.29-2.56] 0.93 0.41
H T 2.25 [1.83-2.67] 2.67 [1.29-2.9]
MFI medium vessels IT 2.63 [2.05-2.91] 2.78 [2.68-2.89] 0.79 0.65
H T 2.65 [2.42-2.95] 2.88 [1.59-3]
MFI large vessels IT 3 [2.95-3] 3[2.83-3] 3.80. 0.58
H T 3 [2.85-3] 3 [2.69-3]
TV D , m m /m m 2 IT 13.2 [11.3-14.7] 12.8 [12.2-14] 0.45 0.68
H T 13.7 [13.2-14.5] 13.9 [12-16.5]
PPV, % IT 96 [91-100] 96 [92-98] 0.88 0.82
H T 97 [84-100] 99 [71-100]
PVD, 1/m m IT 8.67 [7.76-9.8] 8.5 [8.01-8.98] 0.74 1
H T 9.18 [8.19-10.08] 7.87 [6.13-11.1]
Heterogeneity index IT 0.47 [0.35-1.61] 0.62 [0.35-1.02] 0.60 0.66
H T 0.89 [0.5-0.93] 0.47 [0.17-1.57]
Discussion
In the present study, hypertonic fluid administration did not have a significant 
effect on the gastrointestinal mucosal metabolism perfusion ratio, as assessed by 
gastric tonometry, and on any o f the measured sublingual microvascular variables 
in comparison to isotonic fluid. To our knowledge, no other human data are 
currently available on the microcirculatory effects o f hypertonic fluid 
administration in sepsis.
With regards to the effects o f fluid resuscitation on gastrointestinal perfusion, 
experimental studies have shown conflicting results. Hypertonic saline 
resuscitation improved measures o f splanchnic perfusion to a greater extent 
compared to isotonic fluids in some animal studies o f hemorrhagic shock21-23. 
However, in other animal studies ofhemorrhagic shock, hypertonic saline improved 
cardiac output but muscle, intestinal and renal microvascular blood flow remained 
significantly depressed 24 25. In an animal model o f septic shock, large volume
E f f e c t s  o n  c i r c u l a t i o n , o r g a n  p e r f u s i o n  a n d  i m m u n e  s y s t e m !37
Part 3
isotonic fluid resuscitation was unable to restore the P[g-a]CO2 gap26. Hypertonic 
fluid administration in a porcine model o f acute hyperdynamic endotoxemia 
resulted in a persistently high oxygen delivery to splanchnic organs27. In a more 
recent animal study, hypertonic fluid administration failed to restore splanchnic 
perfusion variables, but reduced the degree o f gut epithelial cells apoptosis28.
Gastrointestinal mucosal hypoperfusion is thought to be a contributing factor 
in the pathophysiology o f multi-organ failure. Failure to improve microcirculatory 
abnormalities present in the gastrointestinal system detected by an increased P[g- 
a]CO2 gap during tonometry is associated with a poor outcome5, 8. Nevertheless, 
treatment strategies aimed at improving the gastrointestinal hypoperfusion in 
human studies have so far failed to correct mucosal perfusion abnormalities and 
hence have not shown to improve outcome5, 29"31. Our study was not designed nor 
powered to examine the effects o f the fluid administration on endpoints such as 
survival, or to correlate survival to the P[g-a]CO2 gap.
In addition, we also did not find any improvement or recruitment o f the 
sublingual microcirculation regardless o f the fluid administered, indicating that 
hypertonic fluid administration exerts no immediate intrinsic effects on the 
sublingual microcirculation in septic shock patients. This finding is in contrast 
with previous studies in hemorrhagic shock models and patients. Several reasons 
may be put forward to explain these differences. First, septic shock is essentially 
a different disease process with specific distributive microcirculatory 
abnormalities as compared to hemorrhagic shock. Second, fluid resuscitation in 
hemorrhagic shock studies is likely to result in an improvement in global 
perfusion, as most subjects would be expected to be fluid responsive. The different 
effects on microvascular variables between hypertonic and isotonic fluids in these 
studies may simply be explained by a more profound macrocirculatory effect 
(plasma volume expansion) o f hypertonic fluids. Indeed, in all studies that 
compared hypertonic with isotonic fluid administration, hypertonic fluid 
invariably increased preload, cardiac output and blood pressure significantly more 
than isotonic fluids. Our study was specifically designed to investigate the effects 
of hypertonic fluids per se while preventing a different effect on preload or volume 
status, and this aim was achieved as measures o f preload and afterload were not 
different between the groups before or after fluid administration (data not shown). 
Finally, different methods have been used to measure and describe the 
microcirculation in the past. In the present study we used a relatively new and
1 3 8 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
H y p e r t o n i c  f l u i d  r e s u s c i t a t i o n
well-validated instrument, and the analysis was performed in accordance with the 
recommendations o f a recent round table conference consensus19.
Interestingly, in the subgroup o f patients that were defined as fluid responsive, 
fluid administration resulted in a significant improvement in the sublingual 
microvascular variable MFI, independent o f the type o f fluid administered. The 
proportion o f fluid responders was similar in the HT group and the IT group. 
This improvement in microvascular flow therefore seems to be the result o f an 
overall improvement in preload and global perfusion (cardiac index) and again 
no intrinsic difference between the two fluids was found. In the non-responders, 
fluid resuscitation did not increase cardiac index and did not improve the 
microcirculation. These findings are consistent with a previous report in which 
fluid resuscitation improved the sublingual microcirculation in 20 septic shock 
patients who were predicted and found to be fluid responsive10. Despite the 
improvement observed in sublingual microcirculation, fluid responders did not 
show a significant improvement in P[g-a]CO2 gap compared to non-responders. 
This finding illustrates that the relationship between sublingual and 
gastrointestinal microcirculation is not straightforward. For example, in a model 
o f endotoxemia, fluid resuscitation corrected both serosal intestinal and 
sublingual microcirculation, but was unable to restore intestinal mucosal 
perfusion32. In a different study, orthogonal polarization spectral imaging was 
performed of the sublingual and intestinal microcirculation in 23 patients with 
abdominal sepsis and a newly constructed intestinal stoma. On day 1 o f sepsis, a 
complete dispersion o f microcirculatory flow between the different microvascular 
beds was observed33. When dobutamine was administered to septic patients, 
resulting in an increased cardiac index, a significant correlation between 
sublingual and gastric mucosal CO2 pressures as well as with the proportion of 
well-perfused sublingual capillaries was found34. It is difficult to compare this 
study with our study as we examined the effects o f fluid resuscitation as opposed 
to dobutamine infusion. Conceivably, different interventions may have different 
effects on microcirculatory variables.
Our study has several limitations. The HT group tended to be sicker with higher 
SOFA scores, higher norepinephrine infusion rate and higher lactate levels, 
although none o f these differences reached statistical significance. In addition, 
tonometry only provides information o f the site o f measurement, and mucosal
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blood flow in sepsis has been shown to be heterogeneous. However, it is 
considered to be a well validated and reproducible measure o f mucosal 
metabolism perfusion ratio5. Because the sublingual microcirculation was only 
measured before and 1 hour after fluid administration, we cannot rule out that 
differences between the treatment groups may have occurred later in time. For 
example, in a recent randomized controlled study investigating the effects of 
nitroglycerin on the sublingual microcirculation in septic patients, protocollized 
resuscitation improved small vessel MFI gradually over 24 hours35.
In conclusion, administration o f hypertonic fluid in early septic shock is not 
superior to isotonic fluid with regards to gastric mucosal metabolism perfusion 
ratio and sublingual microcirculation. In fluid responsive patients with septic 
shock, fluid resuscitation improves the sublingual microvascular flow, but not the 
gastric mucosal metabolism perfusion ratio, irrespective o f the type o f fluid used. 
The use o f hypertonic fluids instead o f isotonic fluids to improve the 
microcirculation and splanchnic perfusion in septic shock patients is not 
warranted.
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Abstract
Objective: To investigate the effect o f hypertonic fluid administration on 
inflammatory mediator gene expression in septic patients.
Design and Setting: Prospective, randomized, controlled, double-blind clinical 
study in a 15-bed mixed intensive care unit in a tertiary referral teaching hospital. 
Interventions: Twenty-four patients with septic shock were randomized to receive 
a bolus o f hypertonic fluid (HT, 6% HES/7.2% NaCl) or isotonic fluid (IT, 6% 
HES/0.9% NaCl). This trial is registered with ANZCTR.org.au as 
ACTRN12607000259448.
Measurements and Main Results: Blood samples were taken before and at regular 
time intervals after the fluid administration. Real-time reverse transcriptase 
polymerase chain reaction (RT rtPCR) was used to quantify mRNA expression of 
different inflammatory mediators in peripheral leukocytes. In the HT group as 
compared to the IT group, levels o f gene expression o f MMP9 and L-selectin were 
significantly suppressed (p=.0002 and p=.007, respectively), and CDiib gene 
expression was elevated (p=.02). No differences were found in the other mediators 
examined.
Conclusions: In septic shock patients, hypertonic fluid administration as compared 
to isotonic fluid modulates expression o f genes that are implicated in leukocyte- 
endothelial interaction and capillary leakage. This difference could have beneficial 
clinical consequences on the course o f sepsis and development of multi-organ 
failure.
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Introduction
Small volume hypertonic fluid resuscitation has been investigated extensively, 
especially in hemorrhagic shock. The immediate effects include intravascular 
volume expansion, restoration o f cardiac output and blood pressure, and possibly 
improvement o f regional and microcirculatory blood flow1. Hypertonic 
resuscitation also exerts immunologic and anti-inflammatory effects, which may 
be o f potential benefit in the early resuscitation and management o f septic shock2. 
Different conventional hemodynamic optimization strategies in septic patients 
result in distinct biomarker patterns3. In addition to the anti-inflammatory effects 
o f resuscitation with isotonic fluids4, volume resuscitation with hypertonic fluids 
appears to exert intrinsic beneficial effects, modulating the inflammatory 
response and apoptosis in trauma and sepsis 5 6. Amongst these effects are the 
attenuation o f neutrophil cytotoxicity and inhibition o f the interaction between 
neutrophils, platelets and endothelium7. Hypertonic saline alters neutrophil cell 
shape resulting in cytoskeleton remodelling, which has implications for signal 
transduction and the cytotoxic response. The anti-inflammatory effects on 
neutrophils, oxidative burst and cytokine release are mediated through the 
signalling molecule mitogen-activated protein kinase (MAPK) p38, and suggest 
the existence o f an osmolarity sensing system in immune cells o f humans 8 9.
The immune response during inflammation and sepsis is complex and 
involves a network o f control elements that includes pathogen associated 
molecular patterns, cell adhesion molecules, pro- and anti-inflammatory 
mediators released by activated macrophages and complement activation. Plasma 
levels o f inflammatory mediators in sepsis reflect the overflow o f these mediators 
into the bloodstream and may give limited insight into the actual activation o f the 
leucocytes and the innate immune system 10. In a previous study, we have 
described the use o f real time reverse transcriptase polymerase chain reaction 
(RT rtPCR) to quantify inflammatory mediator expression in circulating 
leukocytes o f septic patients n.
The aim o f the present study was to quantify the changes in inflammatory 
mediator expression in circulating leukocytes, obtained from septic shock patients 
who were randomly assigned to receive a bolus o f hypertonic or isotonic fluid.
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Methods
Following approval by the Northern Y Regional Ethics Committee 
(NTY/06/08/070) we conducted a single-centre double blind prospective 
randomized controlled study in the Intensive Care Unit o f a tertiary referral 
teaching hospital. Informed consent was obtained from patients or their nearest 
relative. This study is part o f a trial investigating the cardiovascular effects and 
the effects on gastric and sublingual microcirculation o f hypertonic and isotonic 
resuscitation, which will be published separately. The trial is registered with 
ANZCTR.org.au as ACTRN12607000259448.
Study protocol
Consecutive adult patients with septic shock were screened for inclusion in the 
study. Septic shock was defined according to standardized criteria12. The study 
protocol is described in detail elsewhere. In short, patients were randomized to 
receive 250ml NaCl 7.2% /6%  hydroxyethylstarch (hypertonic group, HT) or 
500ml 6% HES (isotonic group, IT) to achieve a comparable increase in preload. 
Blood samples were taken from the arterial catheter at baseline and after 4, 8, 12 
and 24 hours after fluid infusion for further analyses.
Laboratory methods
Real-time reverse transcriptase polymerase chain reaction (RT rtPCR) was used 
to quantify mRNA expression o f different inflammatory mediators in peripheral 
leukocytes. Based on their importance in the immune response and pathology of 
sepsis, we chose 10 representative genes from a variety o f different groups of 
inflammatory mediators: inflammatory cytokine interleukin-6 (IL-6), anti­
inflammatory cytokine interleukin-10 (IL-10), chemokine interleukin-8 (IL-8), 
intercellular adhesion molecule-1 (ICAM-i), monocyte chemoattractive protein-1 
(MCP-i), tissue factor (TF), integrin cluster o f differentiation molecule CDiib, L- 
selectin, matrix metalloproteinase-9 (MMP9) and a housekeeper gene 3 2 
microglobulin (B2M). Table 1 shows the abbreviation, major activity and the 
source o f expression o f the investigated mRNA transcripts. A housekeeper gene 
was used to correct for the absolute amounts o f total mRNA variations between 
different samples. To quantify the level o f hypertonicity that was achieved, plasma 
sodium levels [Na+] were measured every 30 min using a point-of-care blood gas 
analyzer (ABL 800 Flex, Radiometer, Copenhagen).
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Table 1
Sources and biological effect of investigated inflammatory mediators
Laboratory protocol
One ml o f blood was added to 4ml o f 5M guanidine thiocyanate (GITC) solution 
to preserve the RNA. Total cellular RNA was isolated from the cell samples using 
the following method. 0.5 ml 2M sodium acetate (pH 4), and 2.0 ml o f 100%  
ethanol were added to the GITC-lysed blood and the sample mixed and allowed 
to stand in an ice bucket for 10 mins before being centrifuged for 15 mins at 15000 
( g) at 4°C. The supernatant was carefully decanted so as not to disturb the pellet, 
which was resupended in 0.5 ml o f GITC solution and then mixed. When the 
pellet was dissolved, 50pl o f 2M sodium acetate was added followed by 0.5ml of 
water- saturated phenol. The solution was placed on ice for i0m ins and then 
200pl o f chloroform added and the tube vortexed before being centrifuged at 
i6,000g for 10 mins. The top layer was removed to new tube and an equal volume
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of 100%  Analar Isopropanol added and mixed by invertion, following which the 
sample was placed on ice for 10-15 mins to precipitate the total RNA. The tube 
was recentrifuged at i6 ,000g for 10 mins, the supernatant removed and the pellet 
resuspended in 1 ml 70% ethanol, then centrifuged at 16000 (rpm or g) for 5 
mins. The ethanol was removed and the pellet briefly air dried. The pellet was 
resuspended in 18 ^l o f Tris/Mn RNA buffer and 2pl o f Promega DNase solution 
was added and the sample incubated, shaking at 37oC for 30 min to digest any 
contaminating DNA. 2 |jl Stop solution was added, heated and shaken at 65oC 
for 10 minutes, with the samples then put on ice. Quality and quantity o f RNA 
checked on a Nanodrop instrument by measuring absorbance at 260-,280 and 
203-nm wavelength.
A cDNA copy o f total RNA was prepared using the SuperScript III reverse 
transcriptase first strand cDNA synthesis kit (Invitrogen, Carlsbad, CA) according 
to the manufacturers instructions, using oligo(dT)i5 (Roche Molecular Systems, 
Pleasanton, CA) to prime the reactions. Briefly Reverse transcription reactions 
were performed using a PTC200 DNA engine,( BioRad, Hercules, USA) in tubes 
using 1.0 to 1.5 pg RNA, ipL o f 50 pM Oligo dT (Roche, Auckland, NZ) and sterile 
MQ water to achieve the desired volume. The tube was then heated to 70°C for 5 
min to destroy any RNA secondary structures. The tubes were cooled on ice before 
the reverse transcriptase components were added. The enzyme mix for each 
sample contained 2.5 pL sterile MQ water, 4 pL 5X first strand buffer, i pL 0.i M 
DTT, i pL dNTP mix (i0 mM), to which was added 0.5 pL SuperScriptIII 
(Invitrogen). This was added to the 0.2 mL tubes containing the RNA and Oligo 
dT mixture using an electronic dispenser, mixed, then spun down (5 k rpm for 
20 seconds) and left at 25°C for 5 minutes before incubating at 50°C for i hour. 
The reaction was then halted by heating at 70°C for i5 minutes.
A check o f cDNA production was performed by amplification o f the housekeeping 
gene 3 2 M using 0.5 pL cDNA samples with negative controls. The cycle time 
and temperature settings were initially 95 °C, 2 minutes; then 40 repeating cycles 
o f 94 °C, 20 seconds; 55 °C, 20 seconds, 68 °C, 30 seconds; before a final step of 
68 °C for 5 minutes . The cDNA samples were stored at -70oC until used in 
reverse transcriptase polymerase chain reaction (rtPCR).
Real-time rtPCR quantification
PCR products were labelled with SYBR® 82 (Invitrogen). RT rtPCR was 
performed in i00  pL thin-walled tubes (Corbett Research) and monitored in a
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Rotor-Gene™ 6000 (Corbett Research). Each 20 pL reaction mixture contained 
Real-time PCR Mastermix (i0x Thermostart® Reaction Buffer (AB Ltd.), i/20,000 
dilution o f SYBR® 82, 5mM MgCl2 pH 8.5, 0.5 U ofABGene Thermostart® DNA 
polymerase (AB Ltd.) and 5 pmol o f forward and reverse primers) and 
approximately ipL o f cDNA.
Following an initial denaturation step at 95°C for i5 minutes, 40 cycles were 
performed using 94°C for 20 seconds, annealing at 55°C for 20 seconds, 
extension at 68°C for 30 seconds, and fluorescence acquisition at 80°C for i0 
seconds using the yellow channel (excitation at 530 nm, detection at 555 nm). 
Following amplification in each run, a dissociation melt curve was determined. 
PCR products were heated from 75°C to 99°C in 0.5°C increments every 5 
seconds. All melt curves showed a single peak consistent with the presence o f a 
single amplicon. Each reaction was run in duplicate, and the Ct values (Roto-Gene 
software, version i.7) and PCR efficiencies averagedi3. The mean Ct and PCR 
efficiency values were used to estimate the initial copy number (ICN) o f mRNA 
transcripts o f each particular gene, including the house-keeping gene (B2M)i4. 
Specimens in which the RNA yield, quality or amplification efficiency were 
compromised, were rejected for analysis.
Data analysis
The level o f gene expression was quantified using the initial copy number. We 
did a logarithmic transformation on this number to achieve a normal distribution 
o f the data, and hence to allow the use o f repeated measures analysis o f variance 
(ANOVA). ‘Treatment-group’ was the between-subject variable, and ‘time’ was the 
within-subject variable. The ‘timextreatment-group’ interaction term was the 
indication o f the evolution o f different responses between the two treatment 
groups. We used the Tukey-Kramer Multiple-Comparison test for post-hoc 
comparisons at different times. The effects on nonnormally distributed 
parameters were compared using the Mann-Whitney test and the Wilcoxon 
signed rank test for paired measurements. Because o f the explorative nature of 
this study, correction for multiple testing was not performed. All statistical 
calculations were performed using NCSS 2007 (version 0 7 .^ 3 , NCCS, Kaysville, 
Utah).
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Results
Baseline characteristics are shown in Table 2. The treatment groups had similar 
severity o f disease, as expressed by APACHE II and SOFA scores. No differences 
in baseline counts o f white blood cells (WBC) and polymorphonuclear cells 
(PMN) were present (Table 2).
Gene expression at baseline
The expression at baseline o f all measured mediators was comparable between 
the two groups (Table 3). The genes IL-6 and TF were insufficiently expressed to 
use for further data analysis. Patients with abdominal sepsis had significantly 
more variability in the baseline gene expression as compared with the other sepsis 
patients (SD 4.1 ± 0.8 versus 2.8 ± 0.8, p=0.03). The expression o f MMP9 in 
patients with abdominal sepsis tended to be higher compared to patients with 
pulmonary or other sepsis (16.5 ± 3.5, versus 13.9 ± 2.6 and 15.2 ± 3.7), but this 
difference did not reach statistical significance (p=.2i and p=.57, respectively).
Treatment effects
In the HT group, [Na+] increased from 135 ± 5 mmol/l at baseline to 143 ± 7 
mmol/l after 30 mins (p<.oooi). This corresponds with a plasma osmolality of 
approximately 300 mOsm/kg. No significant change in [Na+] was found in the 
IT group. The WBC count following study fluid administration did not change 
significantly from baseline (IT 11 [8-17] xi09/l, p=.54; HT 17 [11-25] xi09/l, p=.52) 
and was not different between the treatment groups (p=.i5). The PMN count after 
treatment was also not different from baseline (IT i0 [7-i6] xi09/l, p=.44; HT i5 
[8-22] xi09/l, p=.98) or between groups (p=.28).
The expression o f the investigated genes over time in both treatment groups 
is shown in Table 3. MMP9 showed a significant effect over time (ANOVA, 
p=0.00i, expression at 24hr different from expression at 8hrs and i2hrs (post­
hoc test)) and the interaction term (ANOVA, p=0.0002). This indicates that the 
MMP9 expression at 24hrs decreased in the HT group, whereas in the IT group 
the MMP9 expression was still elevated (Figure iA). L-selectin expression was 
also more suppressed after more than 4hrs in the HT group, as compared to the 
IT group (ANOVA, p=0.007, Figure iB). CDiib showed a significant increase in 
expression over the first 8hrs (time ANOVA, p=0.04), an effect that was more 
pronounced in the HT compared to the IT group (ANOVA, p=0.02). However,
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Table 2
Baseline characteristics.
A PA CH E, Acute Physiology and Chronic Health Evaluation; SO FA , Sequential Organ Failure Assessment; W BC, white blood 
cell count; PM N, polymorphonuclear leucocytes. Data are presented as mean ± SD , as numbers (% )  or as median 
[interquartile range].
Table 3
Expression of genes expressed as log initial copy number at different time points.
Data are shown as mean ± SD. HT, hypertonic group. IT, isotonic group.
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Figure 1
Changes in inflammatory 
mediators over time for the two 
treatment groups.
HT, hypertonic group; IT, isotonic group. 
Data are expressed as mean (SD) o f the 
logarithm of the initial copy number.
MMP-9
Time (hrs) 
L-selectin
Time (hrs)
C D iib
Time (hrs)
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after 12 hrs the levels returned to time=o levels in the IT group, but remained 
elevated in the HT group (Figure 1C). The other mediators ICAM, IL8, IL-10 and 
MCP-i did not show any statistically significant changes over time or between 
treatment groups.
Discussion
In this study we examined the effects o f hypertonic versus isotonic fluid 
administration on circulating leukocyte expression o f important inflammatory 
mediators in septic shock patients. To our knowledge this has not been studied 
before in this group o f patients.
Hypertonic fluid administration resulted in a different gene expression 
pattern compared to isotonic fluid. In the HT group, the expression o f MMP9 
and L-selectin was suppressed as compared to the IT group. CDiib remained 
elevated after 12 hours in the HT group while returning to baseline in the IT 
group. These differences may have clinical relevance.
MMP9 is released from granules o f neutrophils and induces capillary leakage 
by degrading endothelial membranes. High plasma levels o f this inflammatory 
marker as well as high mRNA expression in septic patients have been reported 
previously 111 i5, l6. Both plasma MMP9 concentrations and monocyte MMP9 
mRNA levels were significantly higher in non-survivors than in survivors of septic 
shockl6. Hypertonic fluid administration has been shown to reduce capillary 
leakage and improve capillary blood flow in several studies6 17. This effect has 
been attributed mainly to the direct osmotic effects on endothelial cell swelling 
and luminal narrowing18, 19. Our finding suggests that suppression o f MMP9 
could offer an additional explanation by which hypertonic fluids reduce capillary 
leakage and oedema formation. Although we did not specifically investigate the 
degree o f capillary leakage in our study, we did find that patients treated with 
hypertonic fluid needed significantly less fluid in the following 24 hours 
compared to patients in the IT arm (HT 2.8±i.5 liter/24 hours versus IT 4.i±i.6 
liter/24 hours, p=0.046) (unpublished data).
L-selectin is a transmembrane glycoprotein expressed on leucocytes, involved 
in rolling and adhesion o f leucocytes along vessel walls adjacent to the site of 
injury. The strength o f the binding is enhanced by shear stress20. In our study, 
expression o f L-selectin was depressed in the HT group. This finding is consistent
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with previous findings and suggests that hypertonic fluid modulates the immune 
response by preventing neutrophil adhesion to the endothelium 2 2i'23. In several 
animal models o f shock, intravital microscopy was used to visualize neutrophil 
rolling and adhesion to the endothelium in a real-time fashion. Hypertonic 
resuscitation decreased neutrophil rolling and adherence in these studies 6 i7.
The mediator CDiib is member o f the integrin family, which is responsible 
for adhesion o f leucocytes to endothelial cells. These integrins are expressed 
constitutively and kept largely in an inactive state to undergo in situ activation 
upon leukocyte-endothelial contact by both biochemical and mechanical signals. 
This activation process takes place within fractions o f seconds by in situ signals 
transduced to the rolling leukocyte as it encounters specialized endothelial- 
displayed chemoattractants24, 25. Our finding o f elevated gene expression of CDiib 
after i2 hours in the HT group compared to control is not easy to interpret. 
Because we did multiple comparisons in our study, we cannot rule out that the 
difference in CDiib expression is caused by chance. Presuming the difference is 
not caused by chance, one could hypothesize that hypertonic fluid reduces 
activation o f integrins either directly or by inhibiting activation stimulating 
factors. This in turn could stimulate a feedback loop resulting in increased gene 
expression, but this is highly speculative as the process o f leukocyte adhesion is 
complex and regulated by multiple factors. Rizoli and co-workers showed in 
animal models o f hemorrhagic shock that hypertonic fluid prevents LPS- 
stimulated expression and activation o f CDiib in the lung 26, 27. In a randomized 
controlled study by the same group in patients with traumatic hemorrhagic shock 
hypertonic fluid abolished shock-induced CDiib up-regulation 28. There are 
important differences between these studies and ours that could account for the 
different findings. Hemorrhagic shock and septic shock are distinctly different 
disease processes with important differences in immune response. Furthermore, 
timing o f the intervention may be important29. In the animal experiments 
described, hypertonic fluid was given before the LPS challenge, which is obviously 
unachievable in patients already in septic shock.
We were unable to measure sufficient expression o f the inflammatory genes 
for IL-6 and TF to include them in our analysis. A possible explanation could be, 
that our measurements essentially targeted gene expression in neutrophils, while 
IL-6 is mainly expressed in monocytes and TF in (sub) endothelium. One could 
also speculate that high blood levels o f inflammatory peptides may result in 
homeostatic suppression o f the associated genes.
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Similar to our previous studyii, there was a trend towards increased expression 
o f MMP9 in patients with abdominal sepsis compared to other forms o f sepsis, 
although in the present study this difference did not reach statistical significance. 
This observation reiterates that the inflammatory response in sepsis is 
heterogeneous depending on the source and the infecting organism.
Our study has several limitations. Septic shock patients are not a homogenous 
population and the expression o f inflammatory mediators is highly variable and 
not only dependent on the source o f sepsis but also on the genetic make up of 
the host, which defines the immune response 30. We did not directly measure 
inflammatory mediator peptide levels in the peripheral blood, which is the more 
common way to study the immune response to sepsis. The levels and dynamics 
of these mediators correlate with outcome3i'33. One o f the main problems when 
measuring inflammatory mediator peptide levels in the peripheral blood is that 
only the endocrine overflow is measured, not the local autocrine and paracrine 
receptor binding effects, i0 ii. On the other hand, measuring expression o f the 
inflammatory mediator genes may not reflect the functional activity o f the end­
protein, as this also depends on translation and various post-translational 
modifications that determine whether the protein becomes active. Currently there 
are no methods to reliably measure functional protein activity. In addition, 
inflammatory gene activation tends to be a slow process and can take many hours 
depending on the gene measured. This is in contrast to the immediate and short­
term changes observed in inflammatory mediator peptide levels in peripheral 
blood, and could account for the time course o f changes found in our study. In 
addition, our methodology does not allow us to distinguish between direct effects 
and indirect effects, e.g., downstream in a cascade o f events, or induced by a 
change in the level o f inhibition. Finally, the level o f hypertonicity that was 
achieved in the HT group may not have been optimal to significantly influence 
immune function. It has been proposed that the level o f hypertonicity should 
probably exceed 330 mOsm/kg in order to benefit patients in terms o f immune 
function 34.
In conclusion, we have shown that in septic shock patients, hypertonic fluid as 
compared to isotonic fluid modulates expression o f several, but not all measured 
genes that are implicated in neutrophil-endothelial interaction and capillary 
leakage. This difference could have beneficial clinical consequences pertaining 
the course o f sepsis and development o f multi-organ failure. To our knowledge,
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Context
Sepsis places a significant burden on healthcare resources and presents a major 
challenge to both clinicians and researchers. Despite best efforts, approximately 
half the patients that develop septic shock, the most severe form o f sepsis, 
progress to multi-organ failure and death. Improved understanding o f the 
pathophysiology o f sepsis and, consequently, better treatment modalities are 
urgently needed.
The hemodynamic changes observed during septic shock include severe 
vasodilation, myocardial depression, capillary leakage and impaired 
microcirculatory blood flow, resulting in redistribution o f regional blood flow. 
Microcirculatory abnormalities in septic patients have been well recognized, 
classified and quantified over recent years. Persisting microcirculatory alterations 
are associated with organ failure and mortality in septic shock, irrespective of 
normalization o f systemic parameters. Gastrointestinal microcirculatory 
abnormalities are thought to be important in septic shock patients, both as an 
indicator o f inadequate resuscitation and potentially as a mechanism by which 
multi-organ failure may occur. Mucosal hypoperfusion in the gastrointestinal tract 
is reflected by an increased gastric to arterial CO2 pressure gradient (P[g-a]CO2 
gap) that can be detected by gastric tonometry.
Conventional septic shock therapy includes supportive treatment such as fluid 
resuscitation, administration o f vasopressors (adrenergic and nonadrenergic 
drugs), respiratory and renal supportive measures, and the administration of 
antibiotics and other forms o f source control. New vasopressors have been 
proposed, as well as alternative agents for fluid resuscitation. These new therapies 
may have beneficial or detrimental effects not only on systemic hemodynamics, 
but also on the (gastrointestinal) microcirculation and on the immune system.
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Conventional vasopressors and fluids are often ineffective to completely reverse 
the circulatory abnormalities in septic shock patients. Therefore, the aim of this 
thesis was to investigate new vasopressors (vasopressin and methylene blue), as 
well as a different approach to fluid resuscitation (hypertonic fluids). We 
simultaneously examined the effects o f these treatments on the macrocirculation 
and the microcirculation, as there is often a disjunction between the two.
Thesis
In part i o f this thesis, the various issues concerning gastrointestinal perfusion 
in septic shock were reviewed. We discuss gastrointestinal mucosal 
hypoperfusion as to the underlying mechanism resulting in multiple organ 
dysfunction, as well as its role as a prognostic marker. The different available 
measurement techniques (tonometry, laser Doppler flowmetry, reflectance 
spectrophotometry, near-infrared spectroscopy, orthogonal polarisation spectral 
imaging, indocyanine green clearance, hepatic vein catheterisation and 
measurements o f plasma D-lactate) are described, including advantages and 
disadvantages for their use in everyday clinical practice. Finally, we present an 
overview o f studies targeting correction o f the perfusion abnormalities and the 
effects o f these interventions on patient outcome. Summarizing the data, we 
concluded that normal regulation o f gastrointestinal blood flow is impaired in 
septic shock patients, resulting in mucosal hypoperfusion. Gastrointestinal 
mucosal hypoperfusion is an important marker, and probably also a cause, of 
poor prognosis in septic patients. Impaired gut barrier function could play a role 
in amplification o f systemic inflammation, causing distant multiple organ 
dysfunction. The aim of monitoring splanchnic perfusion is to detect and thereby 
to be able to prevent and reverse tissue hypoperfusion. Several techniques have 
been developed to measure gastrointestinal perfusion. These methods share the 
ability to predict outcome in septic shock patients. Gastric tonometry is the most 
widely used technique because o f its non-invasiveness and ease o f use. However, 
as treatment strategies aimed at improving gastrointestinal perfusion have not 
been able to correct mucosal perfusion abnormalities and hence have not shown 
to improve outcome, the use o f these tools in clinical decision-making is 
currently limited. New treatment strategies for septic shock should be tested for 
their effects on gastrointestinal perfusion, to further clarify its role in patient
i 6 4 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
management, and to prevent therapies detrimental to gastrointestinal perfusion 
being implemented.
In part 2, we examined the effects o f the vasoconstrictive agents vasopressin and 
methylene blue in septic shock patients.
In chapter 2.i, we investigated the effects o f vasopressin infusion on global 
hemodynamics and on the gastrointestinal perfusion as assessed with gastric 
tonometry in septic shock patients. Previous studies have reported that 
vasopressin deficiency in septic shock is an important pathway contributing to 
vasodilation and hence trials investigating the risks and benefits o f vasopressin 
administration in septic shock need to be conducted. Vasopressin is known to 
exert vasoconstrictive properties throughout the gastrointestinal system and as 
such, is being used for treatment o f oesophageal varices bleeding. We 
demonstrated in our study that low dose vasopressin infusion (0.04 U/min) in 
septic shock patients increased plasma vasopressin levels from i7 pg/ml at 
baseline to 230 pg/ml after 4 hours o f infusion, and increased mean arterial blood 
pressure from 6i mmHg at baseline to 68 mmHg after 4 hours o f vasopressin 
infusion. This was accompanied by an increase in the median P[g-a]CO2 gap from 
5 mmHg at baseline to i9 mmHg after 4 hours, indicating development of 
splanchnic hypoperfusion. We recommended that, in the view of this potential 
detrimental effect, vasopressin treatment o f septic shock patients should be 
limited to controlled clinical trials until its effect on clinical outcome such as organ 
failure and mortality has been clarified. Recently, the results o f a large clinical 
trial have been published, comparing vasopressin versus norepinephrine infusion 
in patients with septic shock. The investigators showed that low-dose vasopressin 
did not reduce mortality rates as compared with norepinephrine among patients 
with septic shock who were treated with catecholamine vasopressors. However, 
in the prospectively defined stratum of less severe septic shock, the mortality rate 
was lower in the vasopressin group than in the norepinephrine group. Based on 
these and our observations, we recommend now that vasopressin should not be 
administered to patients with severe septic shock with a norepinephrine 
requirement o f > i5 pg/min.
In chapter 2.2, we examined the effect o f methylene blue (MB) infusion on gastric 
tonometry and intestinal fatty acid binding protein (iFABP) levels in septic shock
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patients. Previous studies have shown that iFABP is a useful biochemical marker 
of enterocyte injury and gut ischemia in experimental models and in humans. In 
addition, iFABP levels correlate with clinical development o f the systemic 
inflammatory response syndrome (SIRS) and with outcome in critically ill 
patients. Excessive nitric oxide (NO) production is a key factor in the 
pathophysiology o f septic shock and contributes to pathological vasodilation and 
the development o f multiple organ dysfunction. MB inhibits several steps in the 
NO pathway. In several clinical studies, MB administration in septic patients 
improved hemodynamic parameters. In our study in patients with septic shock 
and advanced multi-organ failure, MB infusion at a dose o f i mg/kg/hr increased 
the median arterial blood pressure from 70 to 77 mmHg, and decreased the 
cardiac index (CI) from 4.4 to 3.6 l/min/m2. Importantly, these hemodynamic 
changes were not associated with deterioration o f the gastric mucosal perfusion 
metabolism ratio as indicated by tonometry, and by the release o f iFABP. In the 
subgroup o f patients with an elevated baseline P[g-a]CO2 gradient, defined as > 
20 mmHg, the median P[g-a]CO2 gradient decreased from 45 mmHg before 
infusion to 4i at the end o f the 4 h infusion and decreased further to 32 mmHg
2 hours after cessation o f MB infusion. We concluded that MB infusion in 
patients with severe septic shock and advanced multi-organ failure increased MAP 
and decreased CI, without compromising and potentially even protecting the 
gastrointestinal mucosa.
In chapter 2.3, we investigated the effects o f MB infusion on NO production and 
kidney damage and function in the same group o f septic shock patients. We found 
that the urinary excretion o f NO metabolites decreased with 90% from baseline 
to 6 hours after MB administration. The first 24 hours, the creatinine clearance 
improved with 5i% after MB treatment. During the first 6 hours after start o f MB 
treatment, both the urinary excretion o f cytosolic glutathione S-transferase Ai-i 
and Pi-i, markers for proximal and distal tubule damage respectively, decreased 
with 45% and 70% compared to baseline. After termination o f the MB infusion, 
the NO metabolites and markers o f tubular injury returned to pre-treatment 
levels. In conclusion, MB induced modulation o f the NO pathways and exerted 
short-term beneficial effects on kidney function.
In part 3, we studied the effects o f hypertonic fluid administration. Fluid 
resuscitation to improve and restore oxygen delivery is an important element of
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the treatment o f septic shock. Different resuscitation solutions have different 
effects on the global, regional and microcirculation, as well as different intrinsic 
effects on the immune system. Hypertonic solutions have been studied 
predominantly in traumatic hemorrhagic shock. Specific effects on the circulation 
and the immune system have been identified in these studies, which could 
theoretically be beneficial in septic shock. However, studies in septic shock 
patients are scarce. We conducted a prospective, randomized, controlled, double 
blind, single centre, clinical trial to compare the effects o f hypertonic and isotonic 
fluid administration in septic shock patients.
In chapter 3.1 we report the effects o f hypertonic and isotonic fluid administration 
on the global cardiovascular function. Our results showed that in septic shock 
patients, hypertonic fluid can be safely administered and results in improved 
systolic and diastolic cardiac function as assessed with echocardiography and with 
pulse contour analysis derived stroke volume index. We also demonstrated an 
improvement o f the vascular tone, resulting in a decreased requirement for 
norepinephrine. Finally, the need for ongoing fluid resuscitation was reduced in 
the hypertonic group (2.8 liter/24 hours versus 4.1 liter/24 hours in the isotonic 
group), indicating an improvement o f the sepsis-induced capillary leakage. All 
these effects were independent o f and in addition to the effects on plasma volume 
expansion, evidenced by similar values for central venous pressure, stroke volume 
variation and intrathoracic blood volume index in both groups.
In chapter 3.2, we examined the effects on gastrointestinal perfusion as assessed 
with tonometry, as well as the effects on the sublingual microcirculation as 
assessed by Sidestream Dark Field (SDF) imaging. The median P[g-a]CO2 gap at 
baseline was elevated both in the hypertonic group and in the isotonic group (21 
and 26 mmHg, respectively), indicating gastrointestinal hypoperfusion. The 
median sublingual microvascular flow index was also decreased in both groups 
(hypertonic 2.25, isotonic 2.39). Following fluid administration, no differences 
were observed in the course o f the P[g-a]CO2 gap or in any o f the sublingual 
microvascular variables between the hypertonic and the isotonic group. Our study 
showed that administration o f hypertonic fluid in early septic shock was not 
superior to isotonic fluid with regards to gastric mucosal metabolism perfusion 
ratio and sublingual microcirculation. In addition, we found that in fluid 
responsive patients, fluid resuscitation improved the sublingual microvascular
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flow, but not the gastric mucosal metabolism perfusion ratio, irrespective o f the 
type o f fluid used. We concluded that the administration o f hypertonic fluids to 
improve the microcirculation and splanchnic perfusion in septic shock patients 
is not warranted.
Finally, in chapter 3.3 we investigated whether hypertonic fluid had specific 
immunomodulatory effects in septic shock patients. Hypertonic fluid 
administration resulted in a different gene expression pattern compared to 
isotonic fluid. In the hypertonic group, the expression o f MMP9 and L-selectin 
was suppressed as compared to the isotonic group. CDiib remained elevated after 
i2 hours in the hypertonic group while returning to baseline in the isotonic group. 
MMP9 induces capillary leakage by degrading endothelial membranes. L-selectin 
is a transmembrane glycoprotein expressed on leukocytes, involved in rolling and 
adhesion o f leukocytes along vessel walls adjacent to the site o f injury. The 
mediator CDiib is member o f the integrin family, which is responsible for 
adhesion o f leucocytes to endothelial cells. Our results showed that in septic shock 
patients, hypertonic fluid as compared to isotonic fluid modulated the expression 
o f genes that are implicated in neutrophil-endothelial interaction and capillary 
leakage. These findings could offer an alternative explanation for the observed 
decreased need for ongoing fluid resuscitation in the hypertonic group, described 
in chapter 3.i. Immunomodulation with hypertonic fluids could have useful 
clinical consequences on the course o f sepsis and development o f multi-organ 
failure.
Conclusions
The research presented in this thesis has contributed to a better understanding 
o f potential beneficial as well as detrimental effects exerted by selected new 
hemodynamic treatments for patients with septic shock.
Our studies confirmed that in septic shock, gastrointestinal mucosal perfusion 
is highly abnormal. Attempts to improve this parameter with nonconventional 
vasopressors and fluid resuscitation were not successful, despite an improvement 
in global hemodynamic parameters such as blood pressure. This lack o f effective 
treatments is consistent with the literature and also reiterates that the routine use
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of tonometry as therapeutic target for sepsis treatment is not warranted. However, 
tonometry and other measurement techniques o f gastrointestinal mucosal 
perfusion continue to be important research tools to investigate potential 
beneficial or detrimental effects o f new sepsis treatment strategies.
Vasopressin carries the potential for worsening the splanchnic hypoperfusion and 
should be avoided in patients who require high doses o f norepinephrine, and be 
used with caution in other patients. Methylene blue infusion selectively inhibits 
the nitric oxide pathway in septic patients and has potential protective effects on 
gastrointestinal and kidney perfusion and function. Further studies should be 
conducted to investigate the effects o f methylene blue treatment on relevant 
clinical outcome parameters such as organ failure and mortality.
Hypertonic resuscitation does not promote the sublingual and gastric 
microcirculatory flow in sepsis, contrary to what was expected from preclinical 
research and studies conducted in other shock states. In the subgroup o f fluid 
responsive patients, fluid administration improves the sublingual 
microcirculation irrespective o f the tonicity o f the fluid. We were the first to show 
that hypertonic fluid administration improves septic cardiac systolic and diastolic 
dysfunction as well as the global hemodynamic situation independent o f the 
degree of plasma volume expansion. This intrinsic effect o f induced hypertonicity 
also modulates expression o f genes that are implicated in capillary leakage and 
the need for ongoing fluid resuscitation is reduced. These results warrant further 
investigation. Future research should concentrate on the effects o f repeated or 
ongoing hypertonic fluid administration, as well as the timing and the optimal 
dose, and ultimately the effects on hard clinical endpoints such as patient 
outcome.
E f f e c t s  o n  c i r c u l a t i o n , o r g a n  p e r f u s i o n  a n d  i m m u n e  s y s t e m 1 6 9
i70 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
S a m e n v a t t i n g
Achtergrond
Het ziektebeeld sepsis trekt een zware wissel op het gezondheidszorgbudget en 
vormt een grote uitdaging voor zowel artsen als onderzoekers. Ondanks alle 
inspanningen ontwikkelt de helft van de patiënten met septische shock -  de 
ernstigste vorm van sepsis -  multiorgaan falen en komt te overlijden. Het is 
daarom van uitermate groot belang om de pathofysiologie van sepsis beter te leren 
begrijpen, zodat zodoende betere behandelstrategieën ontwikkeld kunnen 
worden.
De hemodynamische veranderingen waarmee septische shock gepaard gaat zijn 
ernstige vaatverwijding, verminderde hartfunctie, capillaire lekkage en gestoorde 
doorbloeding van de haarvaatjes (microcirculatie), hetgeen resulteert in 
redistributie van de regionale doorbloeding. De afwijkingen van de 
microcirculatie die worden waargenomen bij patiënten met sepsis, zijn recent 
geclassificeerd en gekwantificeerd. Indien de waargenomen afwijkingen van de 
microcirculatie persisteren ondanks behandeling, is dit geassocieerd met een 
grotere kans op orgaanfalen en overlijden. Dit fenomeen is onafhankelijk van de 
effecten van de behandeling op de globale bloedsomloop. De microcirculatie van 
het maagdarmstelsel is ook afwijkend bij patiënten met septische shock. Dit zou 
zowel een uiting kunnen zijn van inadequate behandeling, alsmede een 
mechanisme waardoor multiorgaan falen zou kunnen ontstaan. Verminderde 
doorbloeding van het slijmvlies van het maagdarmstelsel kan worden vastgesteld 
aan de hand van een toegenomen verschil tussen de CO2 druk in de maag en in 
het bloed (P[g-a]CO2 gradiënt), hetgeen kan worden gemeten met behulp van 
tonometrie.
De conventionele behandeling van septische shock omvat ondermeer het 
toedienen van vocht, toediening van bloeddrukverhogende medicijnen 
(vaatvernauwers), ondersteuning van de ademhaling en de nierfunctie, naast het 
onder controle krijgen van de infectie door toediening van antibiotica en met
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andere maatregelen. Er zijn nieuwe vaatvernauwers en infuusvloeistoffen 
beschikbaar, welke zowel gunstige als ongunstige effecten zouden kunnen 
hebben op de globale bloedsomloop, op de microcirculatie en op het 
immuunsysteem.
Conventionele vaatvernauwers en infuusvloeistoffen zijn vaak niet in staat om de 
afwijkende bloedsomloop bij patiënten met septische shock volledig te herstellen. 
Daarom was het doel van dit proefschrift, om nieuwe vaatvernauwers 
(vasopressine en methyleen blauw), alsmede een alternatieve vloeistofstrategie 
(hypertone infuusvloeistof) te onderzoeken. We hebben de effecten van deze 
behandelingen onderzocht op de globale bloedsomloop en op de microcirculatie, 
omdat deze effecten vaak niet met elkaar overeenstemmen.
Proefschrift
In het eerste deel van dit proefschrift werden verschillende zaken met betrekking 
tot de doorbloeding van het maagdarmstelsel bij septische shock patiënten belicht. 
We bediscussiëren in hoeverre een verminderde doorbloeding van het slijmvlies 
van het maagdarmstelsel zou kunnen leiden tot multiorgaan falen, en welke rol 
deze afwijkingen zouden kunnen spelen bij het voorspellen van de prognose van 
de patiënt. Vervolgens bespreken we de achtergrond van de verschillende 
beschikbare meetmethoden (tonometrie, laser Doppler fluxmetrie, reflectance 
spectrophotometrie, near-infrared spectroscopy, orthogonale polarisatie spectraal 
imaging, indocyanine groen klaring, vena hepaticus katheterisatie en meting van 
de plasmaconcentratie van D-lactaat), alsook voordelen en beperkingen van deze 
technieken voor klinisch gebruik. Tenslotte presenteren we een overzicht van 
studies waarin onderzocht werd of behandeling, gericht op verbetering van de 
gestoorde doorbloeding van het maagdarmstelsel, ook een effect heeft op de 
uitkomst van patiënten. Samenvattend concluderen we dat de normale regulatie 
van de bloeddoorstroming van het maagdarmstelsel verstoord is bij patiënten met 
septische shock, resulterend in verminderde doorbloeding van het slijmvlies. 
Deze abnormale doorbloeding is geassocieerd met een slechte prognose. Een 
gestoorde darmbarrière functie zou kunnen leiden tot amplificatie van 
systemische inflammatie respons, resulterend in orgaanfalen. Het doel van het 
meten van de doorbloeding van het maagdarmstelsel is het opsporen, en zo het
1 7 2 N o v e l  h e m o d y n a m i c  t h e r a p i e s  i n  s e p t i c  s h o c k ;
voorkomen of behandelen van verstoorde doorbloeding. Verschillende 
meetmethoden zijn ontwikkeld die het vermogen delen om de uitkomst van 
patiënten met septische shock te voorspellen. De meest gebruikte methode is 
tonometrie van de maag, omdat deze minimaal invasieve techniek eenvoudig toe 
te passen en goed reproduceerbaar is. Studies waarin getracht werd de abnormale 
doorbloeding van het maagdarmstelsel te verbeteren, faalden in deze opzet en 
lieten dus ook geen positieve invloed zien op de uitkomst van patiënten. Dit is de 
reden dat in de alledaagse praktijk, het meten van de doorbloeding van het 
maagdarmstelsel slechts een beperkte rol heeft. Het effect van nieuwe 
behandelmethoden voor septische shock op de doorbloeding van het 
maagdarmstelsel dient echter wel getest te worden, opdat het belang voor de 
behandeling van patiënten beter kan worden begrepen, en ook om te voorkomen 
dat een behandeling met nadelige effecten wordt geïmplementeerd.
In het tweede deel onderzochten we de effecten van de vaatvernauwende 
middelen vasopressine en methyleen blauw bij patiënten met septische shock.
In hoofdstuk 2.1 bestudeerden we de effecten van vasopressine toediening aan 
septische shock patiënten, op de globale bloedsomloop en op de doorbloeding 
van het maagdarmstelsel met behulp van tonometrie. Eerdere studies hebben 
aangetoond dat een tekort aan vasopressine bij septische shock patiënten een 
belangrijke oorzaak is van de geobserveerde vaatverwijding. De positieve en 
negatieve effecten van toediening van vasopressine aan septische shock patiënten 
dienen aldus onderzocht te worden. Vasopressine wordt ook gebruikt bij de 
behandeling van spataderen in de slokdarm die bloeden, vanwege het 
vaatvernauwende effect in het maagdarmstelsel.
In onze studie toonden we aan, dat een 4 uur durende infusie van een lage 
dosis vasopressine (0.04 U/min) aan patiënten met septische shock resulteerde 
in een toename van de plasma concentratie van vasopressine van 17 tot 230 pg/ml 
en in een toename van de gemiddelde bloeddruk van 61 tot 68 mmHg. Dit ging 
echter gepaard met een toename in de P[g-a]CO2 gradiënt van 5 naar 19 mmHg, 
hetgeen een afname van de doorbloeding van het maagdarmstelsel impliceert. 
We concludeerden dat, vanwege dit potentiële nadelige effect, behandeling van 
septische shock patiënten met vasopressine gelimiteerd dient te blijven tot 
gecontroleerde klinische studies, totdat het effect op uitkomstparameters zoals 
orgaanfalen en sterfte is opgehelderd. Recent zijn de resultaten van een grote
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studie gepubliceerd, waarin vasopressine vergeleken werd met noradrenaline bij 
patiënten met septische shock. De onderzoekers toonden aan dat behandeling 
met een lage dosis vasopressine niet resulteerde in een daling van de mortaliteit 
vergeleken met noradrenaline. In de vooraf gedefinieerde subgroep van patiënten 
met een minder ernstige vorm van septische shock was de mortaliteit in de 
vasopressine groep wel lager dan in de noradrenaline groep. Gebaseerd op deze 
en onze resultaten is onze aanbeveling, dat vasopressine niet dient te worden 
gebruikt bij patiënten met septische shock die > 15 pg/min noradrenaline 
toegediend krijgen.
In hoofdstuk 2.2 onderzochten we de effecten van methyleen blauw (MB) infusie 
op de P[g-a]CO2 gradiënt en op de concentratie van intestinaal vetzuur bindend 
eiwit (intestinal fatty acid binding protein, iFABP) bij patiënten met septische 
shock. Eerder werd aangetoond, zowel in experimentele modellen als bij mensen, 
dat iFABP een biochemische marker is voor schade aan darmepitheelcellen en 
van zuurstoftekort van de darm. Bovendien correleert de iFABP concentratie met 
de klinische ontwikkeling van het systemische inflammatoire respons syndroom, 
alsmede met de prognose van kritisch zieke patiënten. Overmatige 
stikstomonoxide (nitric oxide, NO) productie speelt een centrale rol bij de 
pathofysiologie van septische shock en draagt bij aan het ontstaan van 
pathologische vaatverwijding en de ontwikkeling van multiorgaan falen. MB remt 
diverse stappen van het NO metabolisme. In verschillende klinische studies werd 
aangetoond dat MB verschillende hemodynamische parameters verbetert.
In onze studie bij patiënten met septische shock en gevorderd multiorgaan 
falen, resulteerde MB infusie (dosis 1 mg/kg/uur) tot een toename van de 
gemiddelde bloeddruk van 70 naar 77 mmHg en tot een afname van het 
hartminuutvolume (geïndexeerd, CI) van 4.4 naar 3.6 l/min/m 2. Deze 
hemodynamische veranderingen gingen niet gepaard met een toename van de 
P[g-a]CO2 gradiënt of van de iFABP concentratie. In de subgroep van patiënten 
met een verhoogde P[g-a]CO2 gradiënt aan het begin van de studie (> 20 mmHg) 
nam de P[g-a]CO2 gradiënt af van 45 tot 41 mmHg na 4 uur MB infusie, en verder 
tot 32 mmHg 2 uren na het staken van de MB toediening. We concludeerden dat 
MB infusie aan patiënten met ernstige septische shock en multiorgaan falen de 
bloeddruk verhoogt en het hartminuutvolume verlaagt, zonder een nadelig effect 
uit te oefenen en mogelijk met een beschermend effect op het slijmvlies van het 
maagdarmstelsel.
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In hoofdstuk 2.3 onderzochten we de effecten van MB infusie op de productie 
van NO en op nierfunctie en nierschade in dezelfde groep patiënten. We toonden 
aan dat tijdens behandeling met MB de uitscheiding van NO metabolieten in de 
urine afnam met 90%. De creatinineklaring (maat voor de nierfunctie) verbeterde 
met 51% in de eerste 24 uren na behandeling met MB. De uitscheiding in de 
urine van de cytosolic glutathion S-transferase A1-1 en P1-1, markers voor 
celschade aan respectievelijk de proximale en distale tubulus, nam af met 45% 
en 70%. Na het staken van de MB infusie bereikten de concentraties van NO 
metabolieten en de markers voor schade aan de tubuluscellen weer hun 
uitgangswaarde. We concludeerden dat MB infusie het metabolisme van NO 
moduleerde en in ieder geval kortdurend de nierschade die door sepsis was 
ontstaan verminderde.
In het derde deel van dit proefschrift onderzochten we de effecten van toediening 
van hypertone infuusvloeistof. Vloeistoftoediening (volumeresuscitatie) is een 
belangrijk element van de behandeling van septische shock, bedoeld om het 
zuurstoftransport naar cellen en organen te herstellen o f verbeteren. 
Verschillende infuusmiddelen hebben verschillende effecten op de globale en 
regionale bloedsomloop, op de microcirculatie, alsmede op de werking van het 
immuunsysteem. Hypertone vloeistoffen zijn voornamelijk bestudeerd in de 
setting van verbloedingsshock, bijvoorbeeld na een trauma. Deze studies hebben 
laten zien dat hypertone vloeistoffen specifieke effecten op de bloedsomloop en 
op het immuunsysteem uitoefenen, welke op theoretische gronden nuttig zouden 
kunnen zijn bij de behandeling van septische shock. Studies bij patiënten met 
septische shock zijn echter schaars. Wij voerden een prospectieve, 
gerandomiseerde, gecontroleerde, dubbelblinde, klinische studie uit om de 
effecten van hypertone en isotone infuusvloeistof te vergelijken bij patiënten met 
septische shock.
In hoofdstuk 3.1 vergeleken we de effecten van toediening van hypertone en 
isotone infuusvloeistoffen op de globale bloedsomloop en de hartfunctie. Onze 
resultaten toonden aan dat het veilig is om hypertone vloeistof toe te dienen aan 
patiënten met septische shock. Zowel de systolische als de diastolische hartfunctie 
verbeterde, gemeten met behulp van echocardiografie en met pols contour 
analyse. Verder verbeterde ook de vaattonus, zodat de noradrenaline toediening 
kon worden verminderd. Tenslotte hadden de patiënten in de hypertone groep
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minder vloeistofinfusie nodig in de 24 uur na de studie (2,8 liter versus 4,1 liter 
in de isotone groep), hetgeen een verbetering van het capillaire lek syndroom 
suggereert. Al deze effecten waren onafhankelijk van de mate van plasmavolume 
expansie, aannemelijk gemaakt door vergelijkbare waarden van centraal veneuze 
druk, slagvolume variatie en intrathoracaal bloedvolume in beide groepen.
In hoofdstuk 3.2 onderzochten we de effecten op de doorbloeding van het 
maagdarmstelsel met behulp van tonometrie van de maag, alsmede de effecten 
op de microcirculatie onder de tong, gemeten met Sidestream Dark Field imaging 
(SDF). De P[g-a]CO2 gradiënt voor het begin van de studie was verhoogd in beide 
groepen (21 mmHg in de hypertone groep, 26 mmHg in de isotone groep), 
hetgeen een gestoorde doorbloeding van het maagdarmstelsel suggereert. De 
microcirculatie onder de tong was ook gestoord in beide groepen (microvascular 
flow index 2.25 in de hypertone groep en 2.39 in de isotone groep). Na de 
vloeistoftoediening werden geen verschillen waargenomen tussen beide groepen 
wat betreft de P[g-a]CO2 gradiënt en de metingen van de microcirculatie onder 
de tong. We toonden aldus aan dat hypertone vloeistof toediening niet beter is 
dan isotone vloeistof wat betreft de doorbloeding van het maagdarmstelsel en de 
microcirculatie onder de tong. Bij patiënten die vloeistofresponsief waren, 
gedefinieerd als een toename van het hartminuutvolume >10%  na 
vloeistoftoediening, verbeterde vloeistoftoediening de microcirculatie onder de 
tong, maar niet de P[g-a]CO2 gradiënt. Dit effect was onafhankelijk van het type 
vloeistof dat werd toegediend. We concludeerden dat de toediening van hypertone 
infuusvloeistoffen aan patiënten met septische shock, met als doel verbetering 
van de microcirculatie en de doorbloeding van het maagdarmstelsel, niet 
gerechtvaardigd is.
In hoofdstuk 3.3 tenslotte, onderzochten we o f hypertone infuusvloeistof 
specifieke effecten op het immuunsysteem van septische shock patiënten heeft. 
Toediening van hypertone vloeistof resulteerde in een ander patroon van expressie 
van genen die coderen voor ontstekingsmediatoren, dan isotone vloeistof. De 
expressie van MMP9 en L-selektine was onderdrukt in de hypertone groep 
vergeleken met de isotone groep. CDiib was verhoogd na 12 uren in de hypertone 
groep maar niet in de isotone groep. MMP9 induceert capillaire lekkage door 
degradatie van de vaatwandmembraan. L-selektine is een transmembraan 
glycoproteïne dat tot expressie komt op de membraan van witte bloedcellen. Het
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is betrokken bij het rollen van witte bloedcellen en het tot stand komen van de 
verbinding tussen witte bloedcellen en de vaatwand ter plaatse van schade of 
infectie. CDiib behoort tot de familie van integrines, welke verantwoordelijk is 
voor het plakken van witte bloedcellen aan vaatwandcellen. Onze resultaten 
toonden aan, dat hypertone vloeistof in vergelijking met isotone vloeistof een 
modulerende werking uitoefent op de expressie van genen die betrokken zijn bij 
de interactie tussen witte bloedcellen en vaatwandcellen, en bij het ontstaan van 
capillaire lekkage. Deze observaties zouden een alternatieve verklaring kunnen 
geven voor de afgenomen vloeistofbehoefte in de hypertone groep, zoals 
beschreven in hoofdstuk 3.1. Modulatie van het immuunsysteem door toediening 
van hypertone vloeistof zou gunstige effecten kunnen hebben op het beloop van 
sepsis en het ontstaan van multiorgaan falen.
Conclusies
Het onderzoek dat gepresenteerd wordt in dit proefschrift heeft bijgedragen tot 
een beter begrip van potentieel gunstige zowel als ongunstige effecten van 
geselecteerde nieuwe hemodynamische behandelingen voor patiënten met 
septische shock.
Onze studies bevestigen dat de doorbloeding van het maagdarmstelsel bij 
septische shock patiënten ernstig verstoord is. Pogingen om deze afwijkingen te 
corrigeren met behulp van onconventionele vaatvernauwers en vloeistof- 
toediening waren niet succesvol, ondanks de waargenomen verbetering van de 
globale bloedsomloop. Deze observatie komt overeen met de literatuur. Het 
gebrek aan effectieve behandelmethoden om de doorbloeding van het 
maagdarmstelsel te verbeteren betekent ook, dat routine gebruik van 
meetmethoden zoals tonometrie ter optimalisatie van de behandeling niet 
aangeraden kan worden. Tonometrie en andere meetmethoden om de 
doorbloeding van het maagdarmstelsel te meten zijn echter wel van groot belang 
als onderzoeksinstrumenten waarmee potentiële gunstige en ongunstige effecten 
van nieuwe behandelmethoden voor sepsis kunnen worden vastgesteld.
Vasopressine vermindert de doorbloeding van het maagdarmstelsel en dient te 
worden vermeden bij septische patiënten die een hoge noradrenalinebehoefte
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hebben, en met beleid te worden gebruikt in alle andere patiënten. Methyleen 
blauwtoediening remt het NO-metabolisme bij patiënten met septische shock op 
een selectieve manier, en oefent een potentieel beschermend effect uit op het 
maagdarmstelsel en op de nieren. Verder onderzoek dient te worden verricht om 
te onderzoeken welke effecten MB behandeling heeft op belangrijke klinische 
parameters zoals orgaanfalen en sterfte.
Toediening van hypertone infuusvloeistof leidt niet tot een verbetering van de 
doorbloeding van het maagdarmstelsel en van de microcirculatie onder de tong, 
ondanks dat dit werd verwacht op basis van experimentele studies en studies bij 
verbloedingsshock. Vloeistoftoediening leidt wel tot verbetering van de 
microcirculatie onder de tong bij patiënten die vloeistofresponsief zijn, ongeacht 
de toniciteit van de toegediende vloeistof. Wij hebben bovendien als eerste 
aangetoond, dat toediening van hypertone vloeistof de hartfunctie en de globale 
bloedsomloop verbetert bij patiënten met septische shock, onafhankelijk van de 
mate van plasmavolume expansie. Dit intrinsieke effect van het induceren van 
een hypertone status leidt ook tot modulatie van genen die betrokken zijn bij het 
capillair lek syndroom en resulteert in een afgenomen vloeistofbehoefte. Deze 
resultaten geven aanleiding tot verder onderzoek. Dit onderzoek dient gericht te 
worden op de effecten van herhaalde o f continue toediening van hypertone 
vloeistof, alsook op de relatie tussen dosis en timing op het effect. Uiteindelijk 
dient onderzocht te worden, welke effecten hypertone vloeistofresuscitatie heeft 
op harde klinische eindpunten zoals sterfte.
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A c k n o w l e d g m e n t s
I have always skipped this section when reading other peoples’ theses: too 
predictable, too politically correct, too commonplace and cliché. However, now 
it is my turn to thank many people and I finally understand that this section is 
actually the most important part o f every doctoral thesis. Obtaining a PhD is 
not something one can do on its own. It requires a tight and strong team; 
working in close cooperation, joint action resulting in the ultimate synergism; a 
combined victory!
Gladly and proudly I introduce to you my accomplices. I f  anyone feels left out, I 
am happy to refer that person to my wife who is a therapist specialised in loss 
and grief management.
Professor van der Hoeven, dear Hans, a great colleague and extraordinary teacher. 
Without you, all o f this would never have happened. You taught me the nuts 
and bolts o f Intensive Care Medicine in ’s-Hertogenbosch and directed me 
towards research. Reviewing my manuscripts at 2am, don’t you ever sleep?
Professor Pickkers, dear Peter, my private knight in shiny armour. Here are the 
superlatives you specifically asked for: magnificent, wonderful, marvellous, 
supreme, consummate, outstanding, remarkable, fine, choice, first-rate, first- 
class, premier, prime, unsurpassed, unequalled, unparalleled, unrivalled and 
preeminent. World-famous for your tequila inspired dance moves. Peter, you 
have been an enormous support. Good luck in your well deserved position as 
professor.
Professor Sleigh, dear Jamie, probably the most intelligent and yet modest person 
I have ever met. Data (and whiskey) analysis and statistical calculations at the 
speed o f light. Scientist, artist and musician. Thank you for being such a 
supportive friend.
Norbert Foudraine, highly regarded colleague and co-researcher. Thank you for a 
pleasant time and a successful study at the VieCuri Medical Centre in Venlo.
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Suzanne Heemskerk. To translate and use your own words: Despite the fact we 
have only ever met at conferences, our cooperation has resulted in the 
publication o f two manuscripts. And with regards to the blue urine: My 
pleasure!
Christiaan Boerma, King o f the Microcirculation. The interpretation and 
quantification o f microcirculation movies is so much more difficult and time­
consuming than the actual recording o f the movies. You saved the day!
Dr. Ray Cursons, thank you for processing so many real time rtPCR assays in 
your Molecular Genetics Lab at the Waikato University. It’s amazing how you 
always manage to find your desk amongst all those enormous piles o f articles 
in your office.
Thanks to everyone else who made my research possible: The Waikato Medical 
Research Foundation for partially funding my hypertonic study; colleagues in 
Holland and New Zealand; medical and nursing staff; research coordinators; 
laboratory personnel; and most o f all a tremendous thank you to all patients 
and their close relatives who, in times o f critical illness, grief and uncertainty, 
still considered participation in a research project.
My supervisors o f Training Dr. Paul “Lasix” Gerlach and Dr. Warmold “Walking 
Encyclopaedia” van den Wall Bake in Veldhoven; Professor “Ome” Jos van der Meer 
(during your speech you mentioned that I always gave other people the 
impression that they could learn a lot from me... some things never change!);
Dr. Frederik “Mulisch” Santman: Thank you all for your support, trust and for a 
thorough training in Internal Medicine and Intensive Care Medicine.
Ine and Bart, artists, designers and dear friends. You managed to magically 
transform a pile o f paperwork into a beautiful doctoral thesis. Without your 
help everyone would have received a bunch o f copied pages, held together by a 
paperclip. Thanks a lot!
My dear parents, you have always supported me despite the fact that some 
decisions I made in life were difficult for you. This thesis may seem a bit 
abstract and technical to you, but it is because o f you that I managed to achieve
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this. You have created the right conditions and environment, and gave me the 
opportunity to study and develop m yself into the person I am now. Brother 
Huub, solid rock o f positive and sporty energy. Brother Eric, it is your fault that I 
am an intensive care physician; because you realised I was too bright to become 
a surgeon. Omi Mieke, definitely the exception to the rule when it comes to 
mothers-in-law! Opa “Lummel” Ben, I wish you could have been here with us.
We all miss you very much.
Rob and Peter, my paranymphs and best friends. Inseparable three musketeers 
for as long as I can remember. It takes more than the Wikipedia definition of 
paranymph (paratrooper and nymphomaniac?) to keep you guys away (as long 
as you did not have to wear a dress). Together till the end!
Last but most definitely not least, my beautiful family. Son Luka, full o f passion 
and emotion, strong yet vulnerable, always asking profound questions about 
life and the universe. You could not believe that your dad was going to be one o f 
the wisest persons in the world. And who am I to contradict that? Daughter 
Rifka, determined enough to walk at the age o f 9 months. Always dancing and 
singing, full o f radiant energy, a ray o f sunshine in my life. My beautiful wife 
Marquita, full o f love and patience. Thank you for always being there for me.
I promise I will never attempt to obtain another PhD!
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C u r r i c u l u m  V it a e
Frank van Haren was born on the 20th o f September 1968 in Hengelo, the 
Netherlands. He finished his secondary school (Atheneum) at the Twickel College 
in Hengelo in 1986. He started his medical training that same year at the 
University o f Nijmegen, receiving his Doctoraal Certificate in 199 1 and his Arts 
Certificate in 1993. His research project: “The role o f ornithine-decarboxylase 
activity to detect colorectal malignancies” was nominated for the Hippocrates 
Award for Medicine and for the Parke-Davis Award for Gastroenterology.
Specialist training in the field o f Internal Medicine (“ Internist”) was undertaken 
at the St. Joseph Hospital in Veldhoven (Supervisor of Training Dr P.G.G. Gerlach) 
and the University Nijmegen Medical Centre (Prof. Dr J.W.M. van der Meer) and 
finished at the turn o f the century. Later in the year 2000, the requirements were 
met for specialist registration in Intensive Care Medicine (“ Intensivist” ), 
completed at the University Nijmegen Medical Centre (Dr F.W. Santman). In 
2001 Frank passed the European Diploma in Intensive Care Medicine in Rome, 
Italy.
He worked as Intensive Care specialist in the Jeroen Bosch Hospital in ‘s- 
Hertogenbosch from 2001-2003 and in the VieCuri Medical Centre in Venlo from 
2003-2005. Educational activities in the Netherlands included: Instructor 
Fundamental Critical Care Support (FCCS ); Instructor Advanced Trauma Life 
Support (ATLS ); Instructor Advanced Paediatric Life Support (APLS ); Lecturer 
on “Ethics in the ICU” and “Nutritional support in the ICU” for the Dutch 
national intensive care training programme; and Lecturer for the Dutch Society 
of Transplantation Medicine. As a member o f the Working Group on Nutrition 
and Metabolism of the Dutch Society o f Intensive Care Medicine, he co-authored 
the Dutch guidelines for Nutrition in the Intensive Care Unit. He presented 
several research and state-of-the-art topics at national and international 
conferences.
Frank moved to Hamilton, New Zealand in 2005, together with his wife Marquita, 
son Luka and daughter Rifka. Following completion o f the Overseas Trained
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Specialist assessment, he fulfilled requirements for Australian and New Zealand 
registration in Intensive Care Medicine in 2006 and received his Fellowship of 
the Joint Faculty o f Intensive Care Medicine (now College o f Intensive Care 
Medicine, CICM). In 2008 he completed the Postgraduate Diploma in 
Perioperative and Critical Care Echocardiography at the University o f Melbourne, 
Australia.
Currently Frank works as Intensive Care Specialist in the Waikato Hospital, a 
tertiary referral and teaching hospital in Hamilton, New Zealand. He is Supervisor 
o f Training for the CICM Intensive Care C24 core-training programme. In 
addition, Frank is Medical Director o f the Intensive Care Department at the 
Southern Cross Hospital, a large private hospital in Hamilton. He has been 
appointed Honorary Clinical Senior Lecturer o f the Waikato Clinical School, 
University o f Auckland.
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